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Neuron-glia communication is crucial to the development, plasticity, and repair of the 
nervous system (NS).  While neurons are well known to conduct electrical impulses that transfer 
biological information and stimuli throughout the NS, our understanding of the roles of glia 
continues to evolve from when the cells were largely believed to act solely for neuronal support. 
Recent decades of research has shown that glia can alter metabolism, conduct impulses and 
change phenotype for NS repair. NG interactions have, thereby, become heavily researched in 
varied areas of biomedical engineering, including embryogenesis, neural regeneration, growth, 
and intracellular synaptic activity. However, while NG interactions are known to regulate 
survival, differentiation, communication, and targeted migration of neural cells, the molecular 
signals that orchestrate these behaviors remain incompletely understood. As a result, many 
emerging studies have embraced microfluidics to regulate the spatial and temporal stimuli 
delivered to neural cell groups and measure subsequent NG responses.  
The overall objective of this thesis was to examine emergent NG behavior in response to 
chemical stimuli within controlled microfluidic environments. Experiments examined NG 
behavior in the central and peripheral NS critical to neural repair. In the first model, we 
examined the behavior of transformed glial progenitors (in the form of Medulloblastoma (MB)), 
known to emulate developmental processes, to external stimuli using controlled 
microenvironments. We used a microfluidic system called the bridged lane, which allows for 
 vi 
steady-state, 1D, controllable concentration gradients along the length of its’ microchannel. The 
system was used to evaluate in vitro migratory responses of MB-derived cells to external 
signaling from Epidermal Growth Factor (EGF) and stromal cell-derived factor 1-alpha (SDF-1). 
Data demonstrated that MB cells exhibit dosage-dependent chemotaxis towards increasing 
concentration gradients. However, as glial behaviors are intricately linked with that of neuronal 
cells, we next used a more comprehensive neural model to examine the collective behavior of 
neural progenitors in response to chemotactic stimulation. Experiments examined the collective 
behavior of NG progenitor cell populations in response to stimulation via fibroblast growth 
factor (FGF) gradients using a developmental model of the central nervous system (CNS) in the 
Drosophila Melanogaster, 3rd instar larvae stage.  Surprisingly, our data demonstrated that cells 
migrated larger distances and with higher directionality within collective groups of both neuronal 
and glial progenitors than in populations of glia only. Taken together, these results helped 
elucidate different modalities for directed movement that can be used for therapeutic techniques 
that leverage the interdependent NG relationship.  
The last model examined NG contributions to the formation of neuromuscular junctions 
(NMJ) in the peripheral nervous system (PNS). The glial component of the NMJ, the Schwann 
cells (SCs), are essential to NMJ development and function including remodeling and 
regeneration. SCs are critical for PNS regeneration, where studies have shown SC are able to 
trans-differentiate in order to create glial bridges that bypass non-functional neuronal nodes and 
isolate damaged neurons. However recent NMJ models mainly focus on motor neurons (MN) 
and muscle cells (MCs), some in vitro work has been utilized to study SCs, but their overall roles 
still remain to be well-defined and studied. To that end, the experiments used a 
compartmentalized microfluidic platform to demonstrate reproducible differentiation of skeletal 
 vii 
myotubes with increased viability and length following the time-dependent addition of neuronal 
and glial cells. We lastly probed the guidance cues and migratory patterns of NGs towards 
various growth factors to elucidate emergent NMJ response. Our data illustrated there is a co-
culture effect on receptor expression dependent on stimulation time.  The data point to SCs as 
key players in stabilizing and maintaining in vitro NMJ models that will aid the development and 
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The functionality of the nervous system is based on the interactions of its cellular 
constituents, neurons, and glial cells. Neurons perceive, integrate and transmit information, 
whereas glial cells perform a number of different tasks to guarantee and modulate neuronal 
function 4. The relevance of glial cells for neuronal network properties is reflected by the 
proportional increase of their number with increasing complexity of the nervous system. 
Whereas in complex mammalian brains the glia outnumbers neurons by far, invertebrates such as 
Drosophila have comparably few glial cells. It has become increasingly obvious that reciprocal 
neuron–glia interactions have an essential role in enabling our brain to function properly. There 
is no doubt that neurons provide the mechanics of neural computing but the more complex and 
efficient a nervous system is, the more glial cells are present. In insects and other more primitive 
organisms, only a small percentage of all neural cells are of glial type, whereas in humans, glial 
cells outnumber neurons by a factor of ten 5. Herein, we explore the NG relationship within 
various cellular models, existing in the central and peripheral nervous systems. In the central 
nervous system (CNS), we focused on two models, pediatric cancer-stem cell migration and NG 
collective migration within Drosophila 3rd instar larvae, respectively. In the peripheral nervous 
system (PNS), we focused on the neuromuscular junction, which is a chemical synapse 
responsible for the proper functioning of voluntary muscle movement. 
 
1.2. Background: Structure and Function 
 
The bi-directional communication between neurons and glia is essential for axonal 
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conduction, synaptic transmission, and information processing and thus is required for normal 
functioning of the nervous system during development and throughout adult life. The signals 
between neurons and glia include ion fluxes, neurotransmitters, cell adhesion molecules, and 
specialized signaling molecules released from synaptic and nonsynaptic regions of the neuron6, 7. 
Glia communicate with other glial cells through intracellular waves of calcium and via 
intercellular diffusion of chemical messengers. By releasing neurotransmitters and other 
extracellular signaling molecules, glia can affect neuronal excitability and synaptic transmission 
and perhaps coordinate activity across networks of neurons all by sensing activity-dependent 
changes in the chemical environment shared by the two cell types 7, 8. Conversely, neural impulse 
activity regulates a wide range of glial activities, including their proliferation, differentiation, and 
myelination.  
1.2.1. CNS Synapses 
 
  A synapse is a specialized structure between a neuron and another cell (neuron, muscle 
fiber, or gland cell), across which a nerve impulse is transferred by a direct electrical connection 
or by a chemical compound called neurotransmitter. -The close relation between astrocytes, 
synapses, and neurons prompted the “tripartite synapse” hypothesis 9, 10. According to this 
hypothesis, synapses are comprised of three parts, the presynaptic terminal, postsynaptic 
membrane, and associated glial cells. The astrocyte processes possess neurotransmitter 
receptors. The receptors expressed by astrocytes match the neurotransmitters released at the 
synapses they cover. Neurotransmitters released by the presynaptic terminal, which themselves 
have metabotropic receptors for the transmitters they release, activate receptors in both the 
postsynaptic neuron and the associated astrocyte. This results in the generation of a 
postsynaptic potential in the postsynaptic neuron and a Ca2+ signal in the astrocyte 11. 
 3 
 
What are the support cells and their roles? 
 
The CNS mainly consists of 
the brain and the spinal cord. Its 
main function is to receive and 
integrate sensory information and to 
respond accordingly. The CNS 
consists of neurons and glial cells, as 
shown in Figure 1. Glial cells are the 
support cells of the nervous system, 
also known as neuroglia.  
 
Neurons: A neuron is the basic structural and functional unit of the nervous system. A neuron 
has four main components: dendrites, a cell body, axons, and the synaptic terminal. Dendrites 
receive and collect information from one end of the cell to the other by generating and 
propagating electrical signals. Neurons can communicate with their neighboring cells by 
releasing neurotransmitters through a synapse, which is a space between two cells.   
 
Astrocytes:  are the non-myelin forming glial cells that are closely associated with neurons in 
the brain. Astrocytes ensheath synaptic junctions, associate with nodes of Ranvier, and respond 
to disease and injury by clearing cellular debris, secreting trophic factors and forming scars. 
Some astrocytes span the entire width of the brain radially, providing scaffolding along which 
neurons migrate during fetal development. Others stretch from blood capillaries to neurons, 
transporting ions and other substances to sustain neurons and to regulate the extracellular 
environment.  
Figure 1: Cells of the CNS1. 
 4 
Oligodendrocytes: are myelin-forming cells, that wrap layers of myelin membrane around 
axons to insulate them from electrical impulses, similar to that of Schwann cells (SCs) in the 
PNS. They are responsible for the high-speed propagation of information in axons and are active 
partner for neurons. These glia also provide trophic support, affect the structure of axons, and 
modify electrical properties by controlling their diameter, and clustering of specific ion channels 
at the node and paranode region 12. Only axons larger than 1micron are myelinated 13.  
 
Microglia: derive from bone marrow monocyte precursors 14. They respond to injury or disease 
by engulfing cellular debris and triggering inflammatory responses. They are essentially the 
immune cells of the CNS.  Activation of miroglia is not well understood but it is hypothesized 
that both a lack of trophic/regulatory molecules released during normal CNS activity and the 
appearance of abnormal molecules could be a trigger.  Neurotransmitters regulate microglial 
activation since it has receptors for glutamate, dopamine, -aminobutyric acid (GABA), and 
noradrenaline 7, 8. Therefore, any changes in astrocyte-neuron activity can trigger an alerted state 
in microglia. Hence, astrocytes and neurons provide robust regulation of microglial activation.  
What is the importance of CNS glia? 
 
Astrocytes, in the CNS, have the capacity to alter synaptic transmission by sensing 
changes in Ca2+ (calcium). They use purinergic receptors for NG signaling. A rise in cytoplasmic 
Ca2+ in an astrocyte is associated with changes in synaptic strength in adjacent synapses in 
culture 15, 16 or in the intact retina 17. Interestingly, sudden increases or decreases in spike firing 
are both observed after a transient rise in astrocytic cytoplasmic Ca2+. Whether the response to 
astrocyte activation is inhibitory or excitatory may be determined by differential effects on 
neurotransmitter release or uptake or by astrocytes activating an intervening inhibitory neuron in 
the synaptic circuit 18, 19. In each case, imaging techniques reveal that the rise in cytoplasmic 
 5 
Ca2+ concentration in astrocytes is accompanied by an increase in extracellular concentration of 
ATP 20. Similar responses are exhibited by terminal SCs in the PNS.  
In a similar fashion, astrocytes can communicate with adjoining astrocytes via extracellular 
signaling molecules that are released and then the signal is propagated along. Molecules such as 
glutamate sensed at synapses cause cytoplasmic Ca2+ changes in astrocytes as well as ATP 
secretion, which activates membrane P2Y receptors generating an increase in intracellular Ca2+, 
and calcium-dependent secretion of glutamate are all responsible for spreading signals among 
cell through the brain and modulate activity at nearby synapses 7. Overall, these mechanisms 
involved not only enable astrocytes to help disseminate information but also help regulate the 
ionic extracellular environment, providing potential evidence for regulating synaptic strength in a 
bi-directional manner.  
Chemical signaling and regulation in the CNS 
In brief, chemical communication coordinates behavior of nerve and glial cells in various 
processes such as differentiation. Molecular signaling mediates all brain function and it is quite a 
complex network of chemical pathways that are involved and have evolved from development 
into adults. There are different types of signaling mechanisms such as electrical which allows for 
synaptic transmission which utilizes action potentials, and subsequent release of 
neurotransmitters. Other well-characterized signaling mechanism include paracrine signaling, 
which acts over a longer range and involves the secretion of chemical signals onto a group of 
target cells, and endocrine signaling, which refers to the secretion of hormones into the 
bloodstream where they can affect targets throughout the body 21. In embryogenesis, chemical 
signaling, and the resultant cell migration are critical for orientation of the tissue structures of the 
CNS. Neurons form first and are followed by glia. This process occurs through migration of 
 6 
neurons from the neural plate along glial tracks and is regulated by lineage differentiation and 
subsequent chemical gradient signaling.  
Molecular signaling tightly regulates determination of cell lineage fate in development. The 
maintenance of stem and progenitor states is performed by extracellular chemical environment, 
as is the progression of differentiation. Molecules involved in the progression of differentiation 
in neurons and glia are vast and some are summarized here: sonic hedgehog signaling (SHH), 
retinoic acid (RA), Wnts, bone morphogenic proteins (BMPs), fibroblast growth factor (FGF), 
epidermal growth factor (EGF), Notch, and purinergic ligands 22, 23.  
RA plays important roles in many aspects of neural development and activity. These include 
axon regeneration in the adult, neuronal differentiation and patterning of the neural plate and 
neural tube in the early embryos 24. RA is implicated in specifically organizing the posterior 
hindbrain and anterior spinal cord. Similarly, RA works synergistically with other molecules 
such as sonic hedgehog (Shh), FGF and bone morphogenetic protein (BMP), to determine the 
fates of sensory neurons, inter neurons and motor neurons 23. 
Shh is a protein essential for embryonic development i.e. growth and pattering of the brain and 
spinal cord. They are also necessary for the differentiation of motor neurons in the ventral spinal 
cord. Shh acts as a morphogen, and induces different cells fates at different concentration 
thresholds, low concentrations induce ventral neurons, high induce motor neurons and very high 
floor plate cells. Aberrant regulation and transduction of the Shh signaling pathway has been 
implicated in birth defects, tissue regeneration, stem cell renewal, and cancer growth 25. With the 
aid of Shh signaling, BMPs generate ventral regions of the forebrain. Loss of BMP signaling is 
implicated in neural induction but later in development, BMP promotes the generation of 
neuronal and astro-glial cells but prevents oligo-glial differentiation 23.   
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FGF signaling has been implicated in the induction and patterning of neural tissues in vertebrate 
embryos. They have been associated in promoting proliferation, isolation, and maintenance of 
neural progenitor cells via basic FGF, FGF2 23. It has also been noted that FGF signaling works 
in association with other pathways such as Wnt, Shh, Notch and TGFβ (transforming growth 
factor).  
Purinergic regulation also contributes to neural stem cell maintenance and differentiation 26 as 
well as information propagation in the brain between astrocytes-neurons and astrocytes-
astrocytes in adults. The principle molecules active in this signaling are ATP and adenosine. We 
have previously discussed the extent to which ATP release by astrocytes activates P2Y surfaces 
receptors which initiates Ca2+ signaling. In specific, P2Y1 metabotropic receptor has been 
implicated in modulating neurogenesis changes depending on the physiological conditions and 
the simultaneous presence of EGF and FGF. In fact, specific stimulation of this receptor in 
neural progenitor cells increases cell proliferation and migration, but only when the growth 
factor concentration is low or absent 26, 27. Conversely, when the growth factor concentration is 
higher, activation of P2Y1 has an anti-proliferative effect. 
Chemical composition of extracellular matrix (ECM) molecules can also impact CNS cell 
response. The stiffness and elasticity of the matrix 28, its protein composition, and chemical 
structure, as well as ECM fiber size, pore size and distribution 29 have all been shown to affect 
cell migration is meaningful ways. For example, matrix stiffness can determine cell fate, 
differentiation, and tissue function 30-33, while ECM elasticity can influence how a cell senses 
and perceives external forces 34-36. Further, ECM chemical components affect matrix-ligand and 
integrin-receptor interactions, which directly impact signal transduction cascades and cell-to-cell 
communication that regulate such critical processes as gene expression and transcription. 
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Role of progenitors in cancer progression 
 
Cancer results from abnormal cell division and proliferation, both of which are largely 
governed by stem and progenitor cell populations. CNS progenitors may be the cell of mutation, 
i.e. the source of the tumor, or can act in a supportive manner within the tumor niche. Two major 
types of primary brain tumors are gliomas and medulloblastoma (MB); the most common tumors 
diagnosed in adult and pediatric brain, respectively. Gliomas are tumors derived from glia or 
glial precursors. The exact cause of gliomas is not known. Glioblastoma (GBM), the most 
common and aggressive subtype of the malignant gliomas, is characterized by intense 
proliferation, invasion, and intra-tumor heterogeneity. GBM and MB both have the ability to 
self-renew and proliferate which is integral to tumor development and perpetuation.  
Cancer stem cell (CSC) theory: Current theory states that tumor-initiating cells or CSCs are 
characterized as a small fraction of cancer cells that have an indefinite ability for self-renewal 
and pluripotency and are responsible for initiating and sustaining of the bulk of cancer 37. CSCs 
are thought to have originated from the transformation of neural stem cells (NSCs) and their 
progenitors or they dedifferentiate from mature brain cells and reacquire phenotypic and 
functional similarities of NSCs. A recent study by Chaffer et al.38 found that transformed human 
CD44lo cancerous mammary epithelial cells could spontaneously dedifferentiate into CD44hi-
CSCs in vivo, indicating the existence of bidirectional inter-conversions between CSC and non-
CSC cancer cells. De-differentiation is implicated to be driven by genetic regulation from 
exogenous factors such as EGF and PDGF, especially in the maintenance of neurospheres in 
culture. PDGF autocrine stimulation was shown to dedifferentiate cultured astrocytes and 
induced oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in 
vivo when infected with PDGF-encoding or EGF-encoding retroviruses 39. 
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Some cancers, such as MBs, are thought to originate in the cerebellum, with approximately 25% 
originating from granule neuron precursor cells (GNPCs) after aberrant activation of the Shh 
pathway 40. Dysregulation of Shh signaling has been implicated in glioma development as well 
through glioma-associated oncogene (Gli) transcription factors 41. While the role of Shh 
signaling is well established in CNS cancer pathology, its role in gliomagenesis remains 
controversial because a lack of animal models 42. A recent study in zebrafish showed that 
activated Shh signaling was tumorigenic; development of retinal and brain tumors was observed 
when Smoothened (Smoa1), Hedgehog ligand involved in the signaling transfer of Gli, in neural 
progenitor cells was expressed as well as overexpression of progenitor markers such as GFAP, 
Sox2 and S100  42.  
 
In MB, the Patched (Ptc) receptor is an antagonist of the Shh signaling pathway, and mutations 
of Ptc will activate the pathway. Therefore, Shh blockage via a small molecule inhibitor in mice 
harboring a Patched (ptc1) mutation eliminated MB 43. Similarly, blockage of the Shh signaling 
pathway depletes the CSC populations in GBM 44. Several Hh signaling pathway inhibitors, such 
as vismodegib and sonidegib, have been developed for cancer treatment. These drugs are 
regarded as promising cancer therapies, especially for patients with refractory/advanced cancers 
41. 
 
Cell migration is a critical step in the process of metastatic propagation of tumor cells from the 
primary tumor to local and distant sites 45. Migration of tumor cells is controlled by numerous 
factors, including chemoattractants, chemorepellents, extracellular matrix components, and 
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electric fields as purported by several reports 45-48. For the treatment of CNS cancers, it is critical 
to understand the underlying mechanisms of tumor growth and renewal by progenitor cell pools. 
Studying the mechanisms of chemotaxis and cell-cell communication for CNS cancer 
subpopulations is also of critical interest for developing new targets and improving the efficacy 
of current treatments.  
 
Mechanism for tumor migration: migration of cancer cells is highly complex, involving 
interactions with ECM, and chemoattractants/molecules that either diffuse from blood vessels 
and/or are produced by neighboring cells. As such the molecular mechanisms involved in tumor 
migration and metastasis are poorly understood. It has been speculated that diffusible signals via 
cytokines and generation of concentration gradients provide cues for migration away from the 
primary tumor site. Studies exploring CNS tumor cell invasion has identified four commonly 
overexpressed tyrosine kinases for anti-invasive therapies: EGFR (epidermal growth factor 
receptor), c-MET, PDGFR (platelet-derived growth factor receptor), and VEGF (Vascular 
epidermal growth factor receptor) 40, 49. Tumor cell migration can vary but three main modes of 
migration are suspected: mesenchymal, amoeboid, and collective migration49.   
Mesenchymal migration is predominantly found in fibrosarcoma’s, gliomas, and in epithelial 
cancers following progressive dedifferentiation. Cells undergo movement patterns seen in 
mammalian cell migration: cell polarization, protrusion of leading edge, traction at the trailing 
edge, and detachment 40. These movements are dependent on integrin-mediated adhesion 
dynamics after which proteases are released to cleave ECM attachments, cell contraction occurs, 
focal contacts disassemble, and filaments turnover.  
On the other hand, amoeboid migration utilizes “fast gliding” mechanism driven by weak or less 
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adhesive interactions with the substrate 49. Lymphocytes and neutrophils exhibit this shape-
driven movement dictated by cortical filamentous actin, where mature focal contacts, stress 
fibers, and focalized proteolytic activity are lacking 50. Such shape-driven migration allows cells 
to circumnavigate, rather than degrade, surrounding ECM. Amoeboid movement allows cancer 
cells to undergo early detachment and metastatic spread from primary tumors most commonly 
observed in small-cell lung carcinomas and lymphomas.  
Lastly, collective migration is a well-described phenomenon that occurs during embryogenesis, 
such as the migration of cell clusters or sheets in the ectoderm following the closure of the neural 
tube 51.  In vitro studies of keratinocyte sheets 52 and cell collective from tumor explants and cell 
lines 53 showed that aggregated cells can move as a functional unit, where cell-cell adhesion that 
occurs in cell groups leads to a specific form of cortical actin filament assembly along cell 
junctions. This allows the formation of a larger-sized, multicellular contractile body 53. Here, a 
subset of highly motile cells at the front of the body are designated as “path-generating cells”, 
that create migration traction via pseudopod activity 53; cells in inner and trailing regions are 
passively dragged during dissemination. In tumors, collective migration has been observed as 
protruding sheets that maintain contact with primary site, or as cell clusters that detach from their 
origin and extend along paths of least resistance 40. To further add on to the complexity of the 
tumor niche, cells may transition between collective and individual cell migration with 
dedifferentiated cells to increase dissemination and metastatic spread 49. 
Approaches for the study of NGs  
 
Briefly, advances in microfabrication techniques have made microfluidic system easier to 
design and manufacture; with the majority of the devices constructed of using 
polydimethylsiloxane (PDMS) via soft lithographic techniques pioneered by the Whitesides 
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group 54. Microfluidics is a powerful tool that is becoming an increasingly useful for cell 
biologists and engineers alike, owing to its ability to precisely control, monitor, and manipulate 
cellular microenvironments.  
 
Tumor models: Applications of microdevices for cancer studies utilized 2D and 3D coated 
microchannels with various ECM proteins to illustrate the selectivity of cancer cell migration in 
distinct ECMs, as well as, to measure traction forces and leading edge protrusions of a variety of 
cancer cell types 55. Further, systems have been developed that generate linear and non-linear 
cytokine gradients in order to more accurately investigate the chemotactic behavior of cells 
derived from primary tumors. Outside of tumor models, microfluidic platforms are highly 
dynamic and facilitate study of various aspects such as CNS axonal injury, regeneration, 
immunoassays, sorting and manipulation of cells, and transport mechanisms. Taylor et al.56 
Developed a microfluidic platform enabling them to selectively lesion axons and biochemically 
analyze their somata for immediate early gene expression. 
 
Drosophila Model: Drosophila melanogaster, also commonly known as the fruit fly, is a 
versatile model organism that has been used in research to study a broad range of phenomena 
from multiple aspects of development to biological mechanisms underlying disease such as 
neurodegeneration. It is a highly versatile system, with the availability of live imaging of biological 
processes. Various signaling pathways, such as Shh, have been extensively studied in 
Drosophila as the biochemical pathway is highly conserved from Drosophila to mammals. 
Drosophila cells have been used in genome-wide RNA interference screens to rapidly identify 
cellular factors required for replication of influenza and dengue viruses 57. 
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At its larval stages, Drosophila contains different types of sensory neurons that are patterned in a 
segmental configuration. They sense various environmental cues such as mechanical, visual and 
chemical and relay information to the CNS to help elicit stereotypic motor behaviors. This simple 
architecture continues to be exploited for studying numerous developmental-genetic and 
neurobiological problems primarily through deploying surgical, histological, transgenic and 
behavioral methods 58. To that end, microfluidics have been employed to study such systems for 
imaging, drug screening 59, 60, and migratory responses to diffusible signals 61, 62. 
1.2.2. PNS Synapses: What is the Neuromuscular Junction (NMJ)? 
 
The neuromuscular junction (NMJ) is a type of a specialized chemical synapse between 
myelinated motor nerve axon and muscle 
fibers. The NMJ connects the nervous 
system to the muscular system via these 
chemical synapses. It is an integral part of 
an efficient biological amplification system, 
which converts minute nerve action 
potentials into muscle contraction. Action 
potentials are the basic mechanism for the 
transmission of information in the nervous 
system and in all types of muscle.  
 
In brief, the skeletal muscle fibers are 
innervated by motor neurons whose cell 
Figure 2: Schematic showing motor neuron 
extension from the ventral horn in the spinal 
cord to the specialized connection with the 
muscle2. 
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bodies are located in the ventral horn of the spinal cord. Motor neurons have long axons that 
branch extensively near the point of contact with the target skeletal muscle, also known as the 
nerve terminal region. This is the region where the nerve axon makes contact with skeletal 
muscle and is called a synapse. In this case, we have a specialized synapse called the NMJ or the 
motor end plate. The basic arrangement of a chemical synapse, at the NMJ, consists of a 
presynaptic membrane, a synaptic cleft, and a postsynaptic membrane. The gap between the pre-
and postsynaptic membranes is known as the synaptic cleft. Information is transmitted across the 
synaptic cleft via neurotransmitters, a substance that is released from the presynaptic terminal 
and binds to the receptors on the postsynaptic terminal.  
 
The main function of the NMJ is to transmit signals from motor neurons to skeletal muscle fibers 
quickly and reliably to ensure precise control of skeletal muscle contraction and therefore 
voluntary movement. The highly specialized architecture of the NMJ helps to ensure its’ 
functional reliability, where the Schwann cells (SCs) help to maintain this structure. The glial 
component of the NMJ is the SCs, which have been shown in research to be essential in the 
development and function of the NMJ where they play many important roles in the remodeling 
and regeneration. SCs also form the myelin sheath around motor nerve fibers which helps 
increase the conduction velocity of the action potential along the nerve axon.  
What are the support cells and their roles at the NMJ? 
Anatomically the NMJ is divided into two parts, the first part consists of the axon 
terminal of a motor neuron and the second part consists of the motor end plate of a muscle fiber. 
At the axon terminal, glial cells in the central nervous system (CNS) and peripheral nervous 
system (PNS) support the nervous tissue. Glial cells are non-neuronal cells that maintain 
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homeostasis, form myelin, and protect the neurons in the brain and the PNS. Neuroscience 
currently identifies four main functions of glial cells: 1) to surround neurons and potentially hold 
them in place, 2) to supply nutrients and trophic factors to neurons, 3) to insulate one neuron 
from another, and 4) to remove dead neurons or other debris. The motor end plate consists of 
myofibers or muscle fiber, which is the smallest contractile unit of skeletal muscle. Skeletal 
muscle is responsible for the voluntary movement of bones that underlies movement and work 
production.   
 
Motor neurons (MNs): A neuron is the basic structural and functional unit of the nervous 
system. The glial cells help to maintain and support the neurons. A neuron has four main 
components: dendrites, a cell body, axons, and the synaptic terminals (Figure 2). Dendrites 
receive and collect signals coming from other cells. The signal is then transmitted from the 
dendrites to the cell body, where the signal is processed. The axons take the signal away from the 
cell body and the signal travels down the axon towards the synaptic terminal. When the signal 
reaches the synaptic terminal, it comes into contact with sacs of chemicals known as 
neurotransmitters. The signal causes the sacs of chemicals to merge with the outer membrane 
releasing the neurotransmitters to the receiving muscle fiber, which has receptors on its 
membrane for these neurotransmitters. Thus, the signal is transferred from a neuron to a muscle 
fiber.  
 
Schwann Cells: Schwann cells (SCs) are the main glial cells in the PNS. SCs are intimately 
associated with the nerve terminal and form a cap over the face of the nerve membrane that is 
located away from the muscle membrane, also known as perisynaptic Schwann cells 63. They 
 16 
also form a dense myelin sheath (Figure 2) to insulate the motor axon allowing for action 
potentials to travel at a greater velocity towards the nerve terminal. A single SC makes up a 
single segment of an axon’s myelin sheath64. Therefore, multiple SCs are required for the entire 
length of the axon. A single axon can be several millimeters long. Further SCs are also invovled 
in cleaning up debris and guiding the regrowth of motor axons after nerve injury as well as 
modulating synaptic transmission 
 
Skeletal Muscle Cells (Myocytes): Skeletal muscle is a striated muscle that is attached to the 
bone via tendons. The function of tendons is to help transmit the load that is generated from the 
muscles to the bones. They also act as stabilizers for joints due to their viscoelastic properties. 
Skeletal muscles have various levels of organization as shown in Figure 2. Briefly, skeletal 
muscle is composed of dense bundles of muscle fibers connected together. Each fiber is a long, 
thin, multinucleated cell that is highly specialized for its contractile function65. There are two 
types of muscle fibers: type I (slow) and types II (fast) and each contain these multinucleated 
cells called myocytes 66. The multinucleated cell state arises from the fusion of embryonic cells 
called myoblasts during muscle differentiation 65. Each muscle fiber contains multiple myofibrils 
which are 1-2m in diameter 65. These muscle fibers allow for the contraction of the muscle by 
the sliding movement along the actin and myosin filaments. So, when a neural impulse is 
delivered to the muscle, by the motor neurons originating in the CNS, the muscle contracts to 
allow for body movement or reaction to the impulse. 
 
What is the importance of Schwann cells at the NMJ? 
 
Schwann cells (SCs) are the main glial cells that maintain homeostasis, form myelin, and 
provide support and protection for neurons in the peripheral nervous system (PNS). There are 
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two types of SCs, myelinating and non-myelinating. Myelinating SCs warp around axons of 
motor sensory neurons to form the insulating myelin sheath. The myelin helps increase the 
conductance of the nerve impulse to travel at a greater velocity down the axon. SCs are also 
present perisynaptically on the nerve terminal plasma membrane, forming a cap. These SCs are 
called perisynaptic Schwann cells (PSCs). PSCs are non-myelinating SCs and they are important 
because recent research has shown them to be essential for the maintenance and development of 
the NMJ. PSCs and SCs have been found to play a role in nerve development and regeneration, 
trophic support for neurons, as well as modulation of the neuromuscular synaptic activity.   
 
Role of Schwann cells in regeneration 
 
Three general themes will be discussed in 
relation to PSC contribution to synapse plasticity 
and stability: 1) PSCs respond to changes in 
neurotransmitter release and denervation with 
changes in protein markers, 2) PSC/SCs interact 
with other elements of the NMJ and help re-
establish synapses during reinnervation, and 3) 
PSCs respond to and contain numerous molecules 
known for trophic and synapse organization 
properties 67. Studies have shown and supported 
the hypothesis that PSCs extend elaborate 
processes ahead of and guide nerve terminals 
during sprouting and followed by denervation 68. Following denervation, PSCs invade the 
synaptic cleft and can release ACh in a fashion that is dependent on gene transcription as well as 
Figure 3: The proposed role of Schwann 
cells in inducing and guiding nerve 
sprouting in partially denervated muscle 
3. 
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functional expression of new neurotransmitter receptors 69, 70. This phenomenon is most likely 
due to cytoskeletal changes which were observed via changes in glial fibrillary acidic protein 
(GFAP). Studies done in frog NMJs after axotomy and blocking of Ca2+ channels with ω -
conotoxin-GVIA revealed GFAP expression is markedly increased 71. Upon further 
investigation, it was indicated that GFAP expression does not result from the nerve cut but is 
related to synaptic activity. Specifically GFAP expression was directly dependent on reduced 
presynaptic transmitter release, not secondary changes affected via the muscle fiber, because 
blocking postsynaptic AChRs was not associated with these effects 67, 71. Moreover, growth-
associated protein 43 (GAP-43) and p75 (low-affinity NGF receptor) has been reported to be 
upregulated after axotomy. The GAP-43 expression likely results from a loss of nerve contact or 
degeneration products as GAP-43 levels drop after reinnervation72. 
 
In mammals, during synaptic remodeling and reinnervation, PSCs guide nerve terminal sprouts 
(Figure 2).  Studies have shown this importance by partial denervation of the nerve. When nerve 
inputs to the same muscle are partially damaged, PSCs from the denervated junctions extend 
processes and form PSC bridges by contacting PSC processes from adjacent innervated 
junctions70. A similar process is involved with full denervation. During the reinnervation 
process, regenerating axons that found endplates after following myelinating SC tubes to the 
muscle did not stop. In fact, they continued to grow beyond the endplate region, where they 
followed the PSC process extensions very closely. In this manner, the processes act as a bridge 
between endplates for reinnervating axons.  
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In vitro studies of co-cultures of the NMJ 
Multiple studies in the CNS have already proven that astrocytes play multiple roles in 
synapse formation, plasticity, and function. Therefore, the contribution of glial cells should be 
taken into consideration in synapse studies for a robust model and the NMJ should be considered 
a tripartite structure73, 74. Multiple motor neuron-muscle co-cultures have been described in 
Xenopus75, 76, chick77-79, mouse80, 81, and rat tissues82, 83, as well as utilizing embryonic hSC-
derived motor neurons synapsed to myotubes from the C2C12 cell line 84, 85. Recently, Umbach 
et al.86 looked at functional NMJs via co-cultures between embryonic stem cell-derived motor 
neurons and C2C12 myoblasts to encourage active NMJ formation and to develop an in vitro 
assay to measure synapse activity of motor neurons at the NMJ. Although no SCs were 
incorporated, some of the factors released by SCs such as brain-derived neurotrophic factor 
(BDNF), glial-cell line derived neurotrophic factor (GDNF), and ciliary neurotrophic factor 
(CNTF) were added to the co-cultures. This allowed motor axons to make contacts with muscle 
cells. But the authors emphasized that their cultures only survived a maximum of 8-9 days, 
which could be due to the absence of support from SCs.  
 
Current in vitro models used for the study of nerve regeneration and motor neuron diseases 
include, cell culture, three-dimensional tissue (3-D) slices, and animals87, 88. Animal models are 
very useful in reproducing injury models, but it is very difficult to study the effects of a specific 
cell type or cell-cell communication in whole organisms. When cultured in vitro, the lifespan of 
purified primary motor neurons is short and not well suited for long-term study of chronic 
injuries89. Gingras et al.90 described an in vitro long-term culture model for the study of axonal 
migration and myelination of motor neurons in a 3-D collagen-chitosan sponge supported by 
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Schwann cells and fibroblasts. The study showed that vigorous neurite elongation was detected 
in the sponges after only 14 days of neuron culture, reaching more than 850m90. The model 
allowed for the maturation of motor fibers as one-third of them were positive for neurofilament 
H. Neurites were subject to myelination when Schwann cells were present, as shown by myelin 
basic protein immunostaining. This model showed spontaneous formation of thick myelin 
sheaths around motor axons after 28 days in culture90.  
 
Similarly, Hyung et al.91 recently developed a co-culture model, utilizing primary motor neurons 
and Schwann cells harvested from CD-1 mice, to show in vitro myelination on a 3mm Matrigel 
hydrogel. Dissociated MNs were seeded onto a feeder layer of SCs, which interact with and wrap 
around the axons of MNs as they differentiate in culture. Their study showed that the MN-SC co-
cultures survived over 3 weeks and extended long axons. Co-labeling of myelin basic protein 
(MBP) and neuronal microtubules revealed that SC formed myelin sheaths by wrapping around 
the axons of MNs. The authors also studied the effects of an antioxidant substance, coenzyme 
Q10(Co-Q10), that markedly facilitated myelination91. In this study, SCs are cultured for 7DIV 
before MNs are added atop of the SC feeder layer, with MNs displaying increases in axon 
diameter by 21DIV. This study is an enhancement of the work done by Gingras et al. and 
Haastert et al.92 The study by Gingras et al. required 21 days of culture before the addition of 
MNs and showed efficient axon outgrowth via addition of exogenous neurotrophic factors as 
mentioned above. On the other hand, Haastert et al. reported that when cultured on a feeder layer 
of SCs, MNs without neurotrophic support matured in culture for 20DIV, but that fraction of 
MNs gradually reduced from 70% 3DIV down to 12% on 20DIV. In this co-culture system 
although MNs matured with enlarged somas myelination of MN axons via SCs was lacking92. 
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Taken together, Hyung et al. were able to show myelin sheaths around MN axons on DIV 14 and 
DIV 21 via transmission electron microscopy along with immunolabeling of their cultures. These 
studies highlight the importance of SCs, but also a need for supportive matrix molecules, various 
enzymes, and trophic factors for enhanced myelination of MN axons.  
 
Schwann cells are known to secrete growth factors and extracellular matrix molecules that 
promote neuronal survival and help guide MN axons during regeneration after nerve injury93. 
Establishing co-cultures between neuronal and Schwann cell lines has been considered difficult, 
probably because of their high proliferative activity and phenotypic differences from primary 
cultured cells94. Transplantation of SCs is a promising strategy for enhancing peripheral nerve 
regeneration. However it has been shown that after in vitro expansion on SCs, they tend to de-
differentiate into a state that is usually observed in vivo after injury93. A recently study by Jesuraj 
et al.93, explored the role of GDNF as a promoter for the differentiation of SCs into their native 
phenotype in vitro through stimulation of the GDNF family receptor (GFR)-1 to remyelinate 
regenerating axons. Their study was able to show that when SCs are activated, (GFR)-1 
promotes phosphorylation of Fyn that is responsible for mediating downstream signaling for 
differentiation and proliferation. They used inhibitors to block Fyn activation and demonstrated 
that the cultures require GDNF-mediated differentiation. However, the knockdown studies also 
showed that when these cultures were supplemented with GDNF, Fyn activation is restored to 
baseline levels, thus suggesting an alternative mechanism may also be involved. One suggestion 
is that NCAM levels increase in SCs in response to GDNF therefore there may be some 
homophilic binding occurring to stimulate the activation of Fyn95, 96.  
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Dorsal root ganglion (DRG)/Schwann cell co-culture models have also been established and 
widely used for PNS myelination. In these models, DRGs are isolated from 14-day-old rat 
embryos, while Schwann cells are purified from the sciatic nerves from 3-4 day rat pups97. 
However, the potential of the DRG/Schwann cell co-cultures are compromised by the scarcity of 
rat PNS mutants and by the difficulty encountered in adapting the model for use with mouse 
cells, for which there are already numerous spontaneous and bio-engineered mutants 98. Thus, 
there has been a huge effort put forth into developing protocols for mouse co-culture models. 
One study we described was by Umbach et al. where they utilized mouse embryonic stem cell-
derived MNs co-culture with C2C12 differentiated myoblasts. One downside to working with 
mouse models and co-cultures is the high cost associated in culturing these cells. For optimal 
results associated with mouse co-cultures, protocols established by Päiväläinen et al.97, require 3-
dimensional substratum, a myelination-promoting culture medium containing pituitary extract, 
N2 supplement and forskolin, and low serum concentration.   
 
Studying such complex mechanism of NMJ myelination and regeneration via animal models or 
in vitro cultures is highly important and has provided much needed insights. But animal models 
are highly complex, have a potential for low reproducibility, is time consuming, and labor 
intensive99. More importantly, they do not allow for the study at the single-cell level necessary 
for determining precise mechanisms. On the other hand, in vitro models allow the study of 
biochemical pathways, gene expression, and phenotypic changes at the single neuronal axon 
level, which is extremely relevant in various platforms of study99. Recent advances in 
microfabrication technologies, such as photolithography, have provided an advanced culture 
platforms allowing compartmentalization of sub-cellular components of neurons, allowing the 
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users to grown and manipulate neurons for various modeling and study of axonal behavior and 
co-culture systems.  
1.2.3. Overview of microfabrication techniques: What is microfluidics, system 
design, and manufacturing?  
Microfluidics is the study of designing and manufacturing device systems that process or 
manipulate small amounts of fluids microliter (10-6) to picoliter (10-12) in networks of low 
dimensional (micron-sized) channels. These systems allow specific analytical study of various 
chemical and biological systems and have been extensively used for the study of cell behavior. 
Fabrication of microfluidic devices in poly(dimethylsiloxane) (PDMS) by soft lithography 
provides faster access, are less expensive, and do not require a cleanroom for fabrication. Soft 
lithography or micromolding, is a set of techniques based on printing and molding using 
elastomeric stamps in PDMS with the pattern of interest 100. Soft lithography has the ability to 
control the surface molecular structures, fabricate channel structures appropriate for 
microfluidics, and maintain the ability to manipulate cells. Some applications of soft 
photolithography have been to generate controlled microenvironments that establish chemical 
concentration gradients and to study the migration of cells towards these chemical gradients101. 
Others have utilized soft lithography techniques to develop microfluidic platforms capable of 
controlling temperature gradients in an environment that mimics the range of physiological 
conditions for therapeutic treatments102.  
 
In brief, photolithography is a process used to transfer a pattern from a mask onto a thin film of 
photosensitive polymer (photoresist) and then onto the surface of a substrate. The most common 
substrates for soft lithography are amorphous glass (SiO2) and monocrystalline silicone (Si). 
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These photosensitive polymers, also known as photoresist, can be both positive and negative. A 
positive photoresist becomes soluble when exposed to certain wavelengths of UV light, whereas 
the negative photoresist crosslinks when exposed to light. Following this, a solvent is utilized to 
remove the un-crosslinked photoresist and the polymerized features remain. The patterns that we 
are creating on the silicone substrates are determined by the design of the photomask, which 
blocks the features that are exposed to light and thus crosslinked/polymerized. The thickness of 
the features on the silicone substrate are determined by the application of the photoresist layer, 
which is typically done by controlling the rotational velocity of the circular substrate and using 
photoresists of varied velocity103. This process then creates a master mold, with which we can 
now shape elastomers for the purpose of device manufacture103. PDMS is usually used due to its 
flexibility, ease of surface modification, oxygen permeability, and optical clarity 104. After the 
PDMS device has been manufactured, the device is bonded to a glass surface; this creates a 
closed fluidic system to analyze various biological and chemical cues.  
 
Photolithographic techniques have been utilized in pharmaceutical and medicinal research as this 
technique offers highly reproducible mass-fabrication of systems with complex geometries and 
functionalities such as novel drug delivery systems and biosensors105. With the help of 
photolithography, one can manipulate the channel dimensions in such a way that pure one-
dimensional flow is being tested. This is the type of accuracy photolithography provides. When 
fabricating a device for the NMJ we must consider the geometry, materials, and any potential 
confinements issues that we might encounter. Motor neuron axons can be millimeters long 
therefore when designing compartmentalized systems and to create axonal guidance we should 
take such dimensions into account. We do not want to design a system that will create 
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confinement issues for the cells causing cell death. There is a minimal thickness (20μm)106 below 
which fluid and molecular transport parameters limit cell viability in vitro. Further when cells are 
encased with impermeable materials such as glass, this prevents perfusion, thus sufficient 
medium volume space is required to maintain viable cells. Therefore, we must take into account 
the fabrication and functional limits when designing systems. 
 
Microfluidics use for study of co-cultures  
A microfluidic system can be described as a set of channels that have micron-scale-
dimensions (typically between 5-500m), and are used to manipulate fluids104. Although 
traditional in vitro culture techniques have elucidated significantly to our understanding of how 
neurons behave. These models lack the ability to provide controlled environments to grow or 
guide neurons, or enable precise probing of cells99. Microfluidic technologies enable the 
development of powerful platforms to grow and manipulate neurons in order to model and study 
axon injuries. Techniques such as photolithography, etching, and deposition methods to construct 
microscopic structures in glass, silicone, or polymeric materials such as PDMS can be utilized to 
develop microfluidic systems. Such devices provide perfusion to cells or enable probing of cells 
and cell compartments with chemical reagents as well as precise control over cellular 
microenvironments107. Microfluidic platforms further facilitate study at the single-cell resolution 
of axons isolated from soma through compartmentalization. The most well-known microfluidic 
devices for neuronal study are compartmentalized LOC (lab on a chip) systems fabricated 
through PDMS soft lithography104. PDMS has several properties making it an excellent choice 
for biological studies: as a material it is inexpensive, flexible, and easily fabricated and bonded 
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on other substrates/materials, biologically inert, non-toxic to cells, impermeable to water, 
permeable to gases and optically transparent down to 230nm, facilitating microscopy104.  
Compartmentalization enables more in-depth studies of myelination, injury models, neurite 
outgrowth, drug screening and protection, signaling, as well as the study of networks ranging 
from cellular to organ levels in organotypic cultures56, 108. One of the first most cited microfluidic 
LOC device designed to study neurons in their various compartment structures (soma, axon, 
dendrites) was the device created by Jeon’s group56. Several studies since then have used this 
type of device or its derivative for examining axon injury, regeneration, or formation and 
function of co-culture systems. Peyrin et al.109 developed a three-compartment microfluidic 
device to study simultaneous axonal degeneration and death mechanisms of CNS axons 
subjected to axotomy with precise spatio-temporal control. The injury was induced by a brief and 
isolated flux of detergent in the central compartment. In their proof of concept for the device, 
they observed rapid Wallerian-like degeneration in the distal axons subjected to axotomy, 
consistent with in vivo axotomy. Li et al.110 developed an integrated microfluidic platform to 
chemically induce axonal injury and study the recovery and regeneration of axon either in co-
culture with glial cells in a controllable chamber using valves or treatment with 
monosialoganglioside, a drug aiding neuronal regeneration. Their results indicated that axons 
were more resistant to injury upon localized application of acrylamide compared with the soma, 
and that axons had self-destruct programs different from the soma, where injury to the soma 
caused secondary axon collapse.  
LOC devices that mimic the repulsive or attractive chemical cues present in the regeneration 
environment provide insights into how to best guide re-growing axons towards appropriate 
targets. In the event of injury, neurites need to perform the non-trivial tasks of reorganizing and 
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re-establishing existing connections. Kothapalli et al. 111 developed a novel microfluidic device 
to study neurite guidance under the influence of chemogradients. The neurons were cultured in 
microchannels on a physiological three-dimensional environment of collagen type I, and 
gradients were established of chemoattractants. The gradients developed were stable up to 48 h. 
This time frame allowed for the qualitative and quantitative study of neurite turning, providing 
valuable insights into the development, maintenance and reorganization of complex neural 
networks. The ability to monitor and guide regrowing axons can enhance our efforts in 
promoting functional recovery.  
Park et al.112 utilized microfabrication techniques to establish a microfluidic platform with 100 
parallel microchannels separating two culture compartments to establish a co-culture between 
mouse embryonic stem cell (mESC)-derived MNs and C2C12 myotubes. They were able to 
elucidate the proper timing required to differentiate and have stable interactions between the two 
cells types where both compartments were coated with poly-D-lysine and Matrigel. Similarly, 
Southam et al.113 utilized a derivative of the device developed by Jeon’s group sold by Xona 
Microfluidics, where they developed a protocol describing in vitro development of robust motor 
neuron axon growth within cultures with glia and skeletal myocytes, primary cells obtained from 
rats. Within 10 days in vitro (DIV) culture of motor neurons with glia, the axons can be seen 
reaching from the proximal side to the distal side of the device. The cultures lasted for 18DIV, as 
the viability of the motor neurons was continuous improved with the addition of glia and muscle 
cells at defined times at each stage of development. Immunocytochemical staining of the spinal 
cultures showed that predominantly astrocytes (15+/-2)%, oligodendrocytes (27+/-3)%, and 
microglia (7+/-2)%, with a minor population of fibroblasts (10+/-6)% was present113. Such 
populations of glia are present in the CNS.  
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Similarly microfluidic models have been utilized by Zahavi et al.114 to show bidirectional 
molecular communication between motor neurons and the muscle through microgrooves to form 
functional NMJs. Using this system, the authors were able to differentiate between the proximal 
and distal effects of oxidative stress and glial-derived neurotrophic factor (GDNF), 
demonstrating a dying-back-degeneration and retrograde transmission of pro-survival signaling, 
respectively. In their study, GDNF facilitated axon growth at the distal side and signals for cell 
survival in the soma. Hence, retrograde transport of muscle-secreted GDNF in motor neuron 
axons was observed, which is supported by a study by Coulpier and Ibanez (2004)115 that showed 
retrograde-only transport of survival signaling as well as neurite extension upon distal 
application of GDNF in sympathetic neurons114. Furthermore, they show that GDNF acts 
differently on motor neuron axons versus soma, promoting axonal growth and innervation only 
when applied locally to axons. As proven by a study showing that the conditional ablation of the 
GDNF receptor RET in motor neurons leads to a reduced number of NMJs and severe disruption 
of pre-synaptic terminals116, suggesting a local BDNF effect. 
1.2.4. Neuron-Glia in Disease, Injury, and Limitations  
Onset of neurodegenerative diseases and injuries represent a major health problem, 
especially within the aging population. Some of these disorders include but are not limited to 
Alzheimer’s (3 million cases/year), Parkinson’s (200,000 cases/year), Huntington’s (200,000 
cases/year), Amyotrophic lateral Sclerosis (ALS-20,000 cases/year), Multiple Sclerosis (MS-
200,000 cases/year), spinal cord injury (SCI) and Guillan-Barre Syndrome (Peripheral nerve 
demyelination-20,000 cases/year). Although the symptoms are divergent, there is a progressive 
loss of neurons in specific regions and a subsequent onset of gliosis.  
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Reactive glial changes occur in most, if not all, neurodegenerative diseases. These changes 
include gliosis in astrocytes and activation of microglia, where a dense glial scar is formed that 
has both positive and negative consequences 117. The glial scar promotes repair by limiting tissue 
damage but such reactive and inflammatory responses make significant contributions to neuronal 
damage in neurodegenerative diseases especially since the ECM molecules comprising the glial 
scar are potent inhibitors of axon regeneration 118, 119. Similarly, dysregulation of 
oligodendrocytes (OL)-mediated metabolic support of neurons might contribute to neuronal 
death in multiple neurodegenerative diseases, including MS and ALS, where myelin loss directly 
affects nerve transmission 120. 
 
SCI and peripheral nerve injuries (PNI) can be caused by automobile accidents or sports injuries. 
Some of the injuries and diseases lead to numbness, loss of function, and even paralysis, 
depending on the severity of damage. So, to date these injuries continue to be a major clinical 
challenge. 20 million Americans suffer from peripheral nerve injury caused by trauma and 
medical disorders. Nerve injuries result in approximately $150 billion spent in annual health-care 
dollars in the United States 121. The national prevalence for SCIs is 270,000 cases 122. Whereas, 
diseases or injuries causing de-myelination can result from genetic (Charcot-Marie-Tooth (PNS) 
or hypomyelinating disease (CNS)), autoimmune (Guillain-Barré syndrome (PNS) or MS 
(PNS)), metabolic (diabetic neuropathy), and mechanical (spinal cord injury and carpal tunnel 
syndrome) 119.  
 
There are currently no cures for demyelinating diseases or injuries. Proteomic analyses of myelin 
from different demyelinating disease models may provide insights into pathogenesis and 
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potential treatments for these diseases 119. Also, not all injuries are repairable, depending on the 
severity of the damage, surgical intervention is required. Consequently, over 200,000 peripheral 
nerve repair procedures are performed annually in the US 123. There are also quite a few 
limitations and challenges to studying these models in research, as there is no confirmed in vitro 
model faithfully emulating disease or injury of the mature spinal neurons 124. Having multiple 
neighbors as support cells for adult primary cells as well as being able to generate and maintain 
populations of adult mouse-derived mature spinal neurons in vitro is needed- as a decline in 
intrinsic survival capacity has been observed without trophic support and neighboring cells. 
Also, despite multiple studies demonstrating the beneficial effect of Schwann cells on 
neuroregeneration in conventional co-culture systems, no study has thus far succeeded in 
incorporating Schwann cells into in vitro model of NMJs 124. This difficulty can presumably be 
overcome by adopting a compartmented culture method.  
1.3. Specific aims and summary 
In vivo, the interaction of neurons and glia are crucial for the development of the nervous 
system (NS). These interactions are facilitated by the fine-tuned migration of neurons and glia 
along dedicated trajectories. Neurons are widely known to conduct electrical impulses/currents, 
elucidating their role in the transfer of information throughout the NS. Glial cells, in the central 
(CNS) and peripheral nervous systems (PNS), are mostly known to support the nervous tissue. 
The global objective for this project was to examine emergent NG behavior in response to 
chemical stimuli within microfluidic environments. Understanding how the environment 
stimulates NGs to precise locations in the nervous system is of fundamental importance in 
biology and medicine, as abnormal migration is the basis of a variety of human neurological 
diseases and dysfunction6. In this body of work, we observed the synergistic relationship of NGs 
 31 
in three cellular models encompassing the central and peripheral NS. Hence the following aims 
are proposed to help elucidate their influence.  
 
Aim 1: Evaluate the chemosensitivity of transformed-glial progenitor cells (t-GPCs). In the 
brain, cell migration is important during development, plasticity, function, and repair. In 
addition, it’s also important in cancers and diseases as it is well accepted that cancer cells have 
progenitor and stem-cell like properties in that they have the ability to de-differentiate. The focus 
of this aim is on directed cell migration to external chemical cues also known as chemotaxis. We 
utilize GPCs from Medulloblastoma (MB), which is a CNS glial tumor that metastasizes to the 
spinal column. Due to these cells ability to retain their stem and progenitor like properties we 
refer to them as t-GPCs. MB provided a model for t-GPCs, believed to be critical for motility 
and metastasis. These studies include:  
1A: Identify growth factors with highest chemosensitivity for t-GPCs. 
1B: Measure in vitro migratory behavior of t-GPCs in controlled microenvironments. 
Summary: The behavior of transformed NG progenitors was examined (in the form of 
Medulloblastoma (MB)), known to emulate developmental processes, to external stimuli 
using controlled microenvironments. We used a microfluidic system called the bridged 
lane, which allows for steady-state, 1D, controllable concentration gradients along the 
length of its’ microchannel. The system was used to evaluate in vitro migratory responses 
of MB-derived cells such as the fraction of motile cells, directionality, and cell path 
length under Epidermal Growth Factor (EGF) and stromal cell-derived factor 1-alpha 
(SDF-1) stimulation. The data demonstrated MB cells traverse from high to low ligand 
concentration gradients and respond strongly to EGF in a dosage and gradient-
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dependent manner while exhibiting increased EGF-R activation. In addition, high 
concentration gradient fields of EGF caused more cells to move longer distances in a 
highly directional manner as opposed to SDF-1. This work provides evidence that EGF 
and its receptor play an important role in MB migration than previously documented. 
 
Aim 2: Examine how GPC chemotaxis is influenced by NG collective behavior. Analyzing 
migration responses of neural-glial progenitor cells derived from Drosophila Melanogaster 
towards fibroblast growth factor (FGF). These studies include: 
2A: Evaluate the behavior of GPCs collectively with Neuronal Progenitor Cells (NPCs). 
2B: Examine the collective chemotaxis behavior in a microfluidic environment. 
Summary: A more comprehensive neural model was utilized to examine the collective 
behavior of neural progenitors in response to chemotactic stimulation. Experiments 
examined the collective behavior of NG progenitor cell populations in response to 
stimulation via fibroblast growth factor (FGF) gradients using a developmental model of 
the central nervous system (CNS) in the Drosophila Melanogaster, 3rd instar larvae 
stage.  Surprisingly, our data demonstrated that cells migrated larger distances and with 
higher directionality within collective groups of both neuronal and glial progenitors than 
in populations of glia only.    
 
Aim 3: Manipulate collective NG behavior to develop an in vitro model of the 
Neuromuscular Junction (NMJ). SCs originate from the highly motile neural crest. However, 
the guidance signals for these SCs are unknown. Neurotrophins are expressed early in 
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developing embryos and have been shown to be critical for the survival and pattering of glia and 
neurons 125. These studies aim to examine:  
3A: Modality of collective chemotactic NG response in the PNS. 
3B: Examine the influence of NG response for tri-cellular NMJ model.  
Summary: This model was developed to build upon our previous understanding of 
coordinated NG responses. We also hypothesized that glial involvement is much more 
dynamic and is necessary for synaptogenesis as well as overall remodeling and regeneration. 
Therefore, we moved into a larger system in the PNS-the Neuromuscular Junction (NMJ), to 
further our understanding into NG responses for repair strategies. Initially this study probed 
the guidance cues and migratory patterns of NGs towards various growth factors to 
elucidate emergent NMJ response. Our data illustrated there is a co-culture effect on 
receptor expression dependent on stimulation time. This study aimed to identify different 
growth factors potential for migratory response. BDNF was utilized in microfluidic studies, 
as it is known for its maintenance capacity upon neurons & to observe its collective response 
on NGs. Subsequently, the experiments utilized a compartmentalized microfluidic platform to 
demonstrate reproducible differentiation of skeletal myotubes with increased viability and 
length following the time-dependent addition of NG cells. Our data validated our hypothesis 
and showed that NG interactions are important in their maintenance capacity for the number 
of SKM myotubes present for the tri-culture model. We further validated this response by 
observing mean fluorescence activity in tri-cultures versus SKM myotubes alone (control). 
Results displayed higher presence of alpha-bungarotoxin, post-synaptic nicotinic 
acetylcholine receptor marker on SKM myotubes, in tri-cultures versus control samples.  
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2. EGF as a New Therapeutic Target for Medulloblastoma 
Metastasis (PMID 26594253) 
 
2.1. Chapter Summary 
 
Medulloblastoma (MB) is a malignant pediatric brain tumor known for its aggressive metastatic 
potential. Despite the well-documented migration of MB cells to other parts of the brain and 
spinal column, MB chemotaxis is poorly understood. Herein, we examined the in vitro migratory 
and cellular responses of MB-derived cells to external signaling of Epidermal Growth Factor 
(EGF), hepatocyte growth factor (HGF), platelet-derived growth factor (PDGF-BB), and the 
stromal cell-derived factors 1-alpha (SDF-1). Experiments utilized transwell assays and 
immunocytochemistry to identify receptor activation in MB migration, and used a microfluidic 
platform to examine directionality, trajectory, and gradient-dependence of motile cells. Data 
illustrates that MB-derived cells respond strongly to EGF in a dosage and gradient-dependent 
manner with increased EGF-R activation and show that high EGF gradient fields cause an 
increased number of cells to migrate longer directed distances. Our results provide evidence that 
EGF and its receptor play a more important role in MB chemotactic migration than previously 














Medulloblastoma (MB) is a family of highly-invasive tumors most commonly diagnosed in the 
pediatric central nervous system 126-130. While clinical treatments have more than doubled the 
overall 5-year survival rate to upwards of 60% 129, 131-133, additional therapies are needed to target 
the aggressive MB migration that is uncharacteristic of other brain tumors, but is a hallmark of 
MB recurrence, metastasis, and radioresistivity 129, 130, 134-139. The migration of cancer cells within 
the CNS is decidedly complex, affected by cellular interactions with heterogeneous extracellular 
matrix (ECM) as well as mixed cellular responses to concentration fields of biomolecules 40, 140-
143. However, the mechanisms behind the migration of MB-derived cells along CNS gradients of 
biomolecular concentration, or chemotaxis, remain understudied and incompletely understood129, 
140. Particular complexities arise in MB, because chemoattractant fields that rouse cells away 
from primary tumors can be secreted by healthy or transformed distant and neighboring cells 40, 
144-148. Further, clinical studies have illustrated that the spread of MB cells occurs predominantly 
to the spinal column via a combination of two-dimensional (2D) and three-dimensional (3D) 
movements 76, 149-152. Such spreading results from tumor cells that drop into the cerebrospinal 
fluid and tend to seed in parts of the spine 153-157. As a result, the movement of MB cells on the 
surface of the spinal column can be examined on 2D substrata to plausibly physiologically 
approximate the metastatic behavior of these pediatric brain tumors.  
 
Traditional cell migration studies have looked to transwell 158-160 and wound healing assays 161-163 
to report numbers of cells that become motile in response to external signaling from growth 
factors, such as Epidermal Growth Factor (EGF) and Platelet-Derived Growth Factor (PDGF) 
164. However, chemotaxis is becoming more-commonly examined via the physical 
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microenvironment of the cell, where dynamic concentration fields facilitate ligand-receptor 
bindings which initiate signal transduction cascades 40, 165, 166. Here, precise manipulation of the 
cell microenvironment has been facilitated by the wide-adaptation of benchtop microfluidic 
devices 160, 167, 168, which enable multifaceted evaluation of cell migratory behaviors in lieu of 
cell numbers alone. A large number of laboratories have demonstrated concentration- and 
concentration gradient-dependent behavior of non-cancerous cells, such as fibroblasts 169, retinal 
progenitor cells 170 and keratinocytes 171, as well as tumors found in breast 172, colon 173 and CNS 
cancers 174.  Our own laboratory has illustrated that select populations of cells derived from CNS 
tumors can respond acutely via migration to ultra-low concentration gradients of select 
chemoattractants 140, 169, 174, while others have shown greater chemotactic response with specific 
dosage 148, 175, 176. Microfluidic analysis is, thus, well positioned to meaningfully aid in the 
development of migration-targeted therapies for MB via insight of migratory parameters relevant 
to metastasis, such as cell distance traveled, motility, gradient-sensitivity, ECM interaction and 
numerous others.  
 
In this work, we examine MB migratory behavior in response to external signaling from 4 of the 
most extensively studied chemoattractants of CNS tumors using benchtop assays and 
microfluidics: Epidermal Growth Factor (EGF), Platelet-derived Growth Factor (PDGF), 
Hepatocyte Growth Factor (HGF), and Stromal Derived Growth Factor (SDF-1 or CXCL12). 
Our results illustrate that MB-derived cells exhibit gradient-dependent behavior in EGF fields, 
which are able to guide MB along longer migration distances with superior directionality and 
increased receptor activation. These results distinguish EGF as a principal molecule with 
meaningful potential impact as an anti-migratory therapeutic to MB metastasis.  
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2.3. Materials and Methods 
2.3.1. Cell culture 
In vitro cell culture was maintained using Daoy cell line (ATCC, Cat. No.HTB-186) 140, 142, 
Eagle's Minimal Essential Medium (EMEM) (VWR, Cat. No.12001-582) supplemented with 
10% fetal bovine serum (VWR, Cat. No.45000-734), 2% L-glutamine (VWR, Cat. No.45000-
676) and 1% Penicilin-Streptomycin (VWR, Cat. No.45000-650). Intact monolayers were 
maintained, and harvested cells were seeded onto sterile polystyrene tissue culture flasks (VWR, 
Cat. No.BD353136). MB cells were incubated at 37 ºC with 5% CO2 with cell medium changed 
every 2 days. Cell migration experiments were initiated with cells that were inserted into 
microchannel after MB cells reached 80% confluence. 
2.3.2. Cell Migration Assay 
The Boyden chamber assay 140, 174 was used to measure the number of MB cells that migrated 
towards different concentrations of external growth factors. This widely used assay consists of 
two compartments filled with EMEM medium and separated by an 8 micron-porous membrane 
(VWR, Cat. No.62406-198), as shown in Figure 4A. MB cells were seeded in the upper 
compartment and were allowed to migrate through the porous membrane into the lower 
compartment for 6 hours at 37 ºC in a 5% CO2 incubator. Approximately 1x106 cells/mL were 
seeded in 300μl of EMEM complete medium (EMEM with FBS) in each upper chamber, while 
700μl of serum-free medium (EMEM only) was pipetted into each lower chamber. Lower 
chambers also contained concentrations of 1, 10, 100, and 1000 ng/mL of EGF (Life 
Technologies Corporation, Cat. No. E3476); HGF (R&D Systems, Cat. No.2207-HG/CF); 
PDGF-BB (R&D Systems, Cat. No.220-BB-010); and finally, SDF-1 (PreporTech, Cat. No.250-
20A). All growth factor solutions were diluted in EMEM serum-free medium using serial 
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dilution. After 6 hours of incubation, the membrane was fixed and stained with fixative solutions 
(VWR, Cat. No. B4132-11A), which stained the cell cytoplasm and nuclei. The number of cells 
that migrated to the underside of each membrane was determined by using the convectional 
checkerboard analysis 140, 174, 177.  
2.3.3. Immunostaining of Receptors 
MB cells were plated at a concentration of 1x103 cells/mL in EMEM complete, on borosilicate 
glass well plates (Lab-Tek, Cat. No.155383). The cells were incubated for 2 hours at 37°C in 5% 
CO2 to facilitate attachment. Adhered cells were exposed to ligands at concentrations that 
resulted in the largest numbers of motile cells in the transwell assay results.  At 37°C, each cell 
plate was exposed to 5 minutes of: 100ng/mL EGF (Life Technologies, Cat. No. PGH0311), 
100ng/mL CXCL12 (Life Technologies, Cat. No. PHC1364), 10ng/mL HGF (Life Technologies, 
Cat. No. PHG0324), and 100ng/mL PDGF-BB (Life Technologies, Cat. No. PHG0044). The 
supernatant was then aspirated, and each well was rinsed 3 times with 0.5 mL phosphate 
buffered saline solution (PBS), (Sigma-Aldrich, Cat. No. D8537). Each well was fixed using 
10% paraformaldehyde (Sigma-Aldrich, Cat. No.HT501128) for 10 minutes and rinsed twice 
with PBS. The samples were permeabilized using a 1% solution of Triton-X (Sigma-Aldrich, 
Cat. No.X100) and 0.1%BSA in PBS solution for 10 minutes, then blocked for 60 minutes with 
1% BSA in PBS blocking solution and rinsed twice with the same blocking solution.  
 
Samples were then exposed to the primary antibody for each receptor studied for 2 hours at 
22°C: 5μg/mL anti-EGFR (Life Technologies, Cat. No.700308), 5μg/mL anti-CXCR4 (Life 
Technologies, Cat. No.35-8800), 2μg/mL anti-c-Met (Millipore, Cat. No.07-2242), and 3μg/mL 
anti-PDGFR (Life Technologies, Cat. No.701142). Each well was rinsed 3 times with 1% BSA 
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blocking solution. A fluorescent secondary anti-rabbit IgG (Millipore, Cat. No. AP132F) was 
used for EGFR, c-Met, and PDGFR samples, and a fluorescent anti-mouse secondary antibody 
(Millipore, Cat. No. MAB1976) was used for CXCR4 samples. All samples were exposed to the 
secondary antibody at a concentration of 5μg/mL for 30 minutes at 22°C, and then rinsed twice 
with blocking solution. Nuclear staining (Life Technologies, Cat. No. R37605) was performed 
for 20 minutes at 22°C, after which the samples were rinsed twice with PBS and covered in 
glycerol (Life Technologies, Cat. No.15514-011) for preservation. In addition, the expression of 
EGFR was measured at different time points of 0, 14, 22, 36, and 42 hours. The 
immunocytochemistry assay was performed as described above using goat-anti mouse IgG 
secondary antibody (Life Technologies, Cat. No. A-11005) for EGFR. 
2.3.4. Bridged μLane and Experimental Set up 
Our microfluidic device, the μLane, was utilized to image the real-time migratory responses of 
individual MB cells within microenvironments of defined EGF and SDF-1 gradient profiles. The 
bridged μLane system operates via a combination of uniaxial bulk convection and diffusion to 
achieve controlled chemical concentration gradients over time, as described previously 101, 169, 174. 
This mass transfer mechanism termed as convective-diffusion has been widely-studied by 
several groups for bioengineering applications, to determine the transport of differently sized 
solutes and proteins through the walls of capillaries 178-180 and arteries 181-185, skeletal muscle 
fibers 186-188, and intervertebral discs 189-191. The two-dimensional mass transport of ligands within 
the microsystem was modeled via finite-element-analysis (FEM) in Matlab 7.7 (MathWorks, 
Natick, MA) and verified experimentally as described previously by our group  101, 169.  
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The framework of the μLane system consists of two layers of Polydimethylsiloxane (PDMS) 
(Fisher Scientific, Cat. No.NC9644388) bonded to a glass slide using ozone gas. The first layer 
of PDMS consists of a closed microchannel of 100µm-width and 1.3cm-length with a volume of 
0.1μL, which connects two fluidic reservoirs of 9μL each, called the source (SRR) and the sink 
(SKR) reservoir. The second layer of PDMS consists of two chambers of 170μL each, called the 
source (SRC) and the sink (SKC) chamber, connected by an open, hemispherical bridge channel 
to maintain the hydrostatic equilibrium of the system 101, 169, 170. Both chambers are vertically and 
fluidically connected with both reservoirs (Figure 6).  
The μLane system works by using the larger volumes of the SRC, SKC and bridge channel on 
the second layer of PDMS to generate concentration gradients within the smaller volumes of the 
SRR, SKR and microchannel on the first layer 101, 140, 169, 170. After inserting cells along the 
microchannel length, the cell culture media is used to fill the SRR, SKR, SRC, SKC, and the 
bridge channel. The ligand solutions (EGF or SDF-1) are then manually inserted drop-wise into 
the SRC until the solution makes contact with the cell culture media solution within the bridge 
channel and SKC to initiate the molecular transport within the system. The small differences in 
the density of the reagents and in the liquid levels in the SRR and SKR generate hydrostatic 
pressure differences that initiate an ultra-low bulk flow within the microchannel in the first layer 
101, 169, 170. This minuscule bulk flow was measured to be 0.37 μm/sec using fluorescent beads, as 
described previously 101. Such a low bulk flow facilitates the transport of ligand solutions from 
the SRR to the SKR, to accelerate the time required to attain a steady-state gradient profile of 
ligand solutions along the 13-mm length of the microchannel. In the absence of this bulk flow, 
the transport of our reagent via diffusion alone would require over 470 hours to reach a steady-
state distribution within the length of the μLane instead of the 18 hours measured, as reported by 
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our group 101, 140. Mathematical models of reagent transport within our μLane system were 
performed via MatLab to determine the steady-state concentration distribution as seen in Figure 
7A. The initial EGF or SDF-1 concentration within the SKC, SKR, microchannel and SRR was 
set to 0-ng/mL, as per absence of ligand. The initial ligand concentration within the SRC was set 
to 100-ng/mL to reflect the sample concentration used during experiments. These boundary 
conditions were solved using Equation (1), as shown below 101,  
                                                                                                    (1) 
Where C (ng/mL) is ligand concentration, t (hours) is time, u (μm/sec) is fluid velocity, and D 
(cm2/s) is diffusion coefficient, or diffusivity, of the reagent molecule. Experimental validation 
was also performed using fluorescently labeled Dextran (~ MW 10KDa), to confirm steady-state 
is reached in our system after 18 hours, and is maintained for several days 101, 140.  
 
For our experiments, the μLane system was coated with 10-μg/mL of laminin (Becton, 
Dickinson and Company, Cat. No.354232) 140, 142, which was allowed to gel for one hour at room 
temperature (25°C) under sterile conditions. Unbound laminin was aspirated, and cells were 
manually seeded into the microchannel using a 1-mL syringe (VWR, Cat. No.BD309659). A cell 
solution (1x106 cells/mL) was injected into the SRR and SKR. Cells were allowed to adhere and 
visibly spread prior to the initiation of the experiment as illustrated in Figure 6D. Finally, the 
bridge channel was loaded with EMEM complete medium to connect the SRC and SKC, 
initiating the system. In this work, EGF (100-ng/mL) or SDF-1 (100-ng/mL) was individually 
loaded drop-wise into the SRC and allowed to reach steady state in the microchannel for 18 
hours at 37°C 101, prior to imaging of MB cell migration within this precise biochemical 







24 hours. Our group has previously showed that MB cells migrate and proliferate in-vitro until 
72 hours in the µLane system 140. 
2.3.5. Statistics 
One-way ANOVA and Post Hoc Test (Tukey) were used to analyze the data using IBM SPSS 
Statistics Program (IBM Corp., Released 2011, version 20.0. Armonk, NY). A one-way ANOVA 
test at a 95% confidence interval was performed for statistical significance across growth factors. 
The Post Hoc Test (Tukey) was performed to determine the disparity among different groups. 
Only p-values <0.05 were considered statistically significant. Unpaired student’s t-test at a 95% 
confidence interval was implemented to determine significance of relative receptor expression 
using IBM SPSS Statistics Program (IBM Corp., Released 2011, version 20.0. Armonk, NY).  
2.3.6. Imaging and Processing 
Transmitted light microscopy images were obtained using an inverted microscope (Nikon 
TE2000) and a cooled CCD camera (CoolSNAP EZ CCD Camera, Photometrics, Tucson, AZ) 
with a 20X objective magnification (Nikon Plant 20X, Morrell Instrument Company Inc., 
Melville, NY). Fluorescent imaging was performed using Leica CLSM confocal microscope and 
a Zeiss LSM 710 confocal microscope, both at 63x magnification with oil immersion objective. 
Image J was utilized to track cells and process images (Chemotaxis and Migration Tool plugin 
(ImageJ 1.46r) 140, 192. Fluorescence intensity was measured using an average over the entire cell 
area via ImageJ. Transmitted light image data was analyzed using Nikon software (Nikon 
Instrument Element 2.30 with 6D module, Morrell Instrument Company Inc., Melville, NY) and 
ImageJ (NIH) Software. Bright field images of the microchannel were automatically captured 
every hour for 24 hours at every 1000 microns in the y-direction of the µLane, followed by cell 
tracking (ncells~180 cells) and analysis. Lastly, the cell tracking software was used to develop 
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Wind-Rose plots 169, 170 of cell trajectories in response to EGF and SDF-1 gradient fields, over 24 
hours. 
2.4. Results 
This work examined the migratory and cellular responses of MB-derived cells in response to 
external signaling from EGF, HGF, PDGF-BB, and SDF-1.  
2.4.1. Motility Studies 
The first set of experiments measured the average numbers of MB-derived cells that migrated 
toward different concentrations of EGF, HGF, PDGF-BB, and SDF-1 through transmembrane 
assays, as illustrated in Figure 4 and Table 1. As seen, numbers of motile cells were statistically 
different in response to signaling from different concentrations of EGF and HGF when compared 
to controls (i.e. no ligand). Further, a mid-level concentration of 100-ng/mL of EGF was 
observed to attract the largest numbers of motile cells overall (Fig. 4B.2).  By contrast, the 
number of MB cells that migrated in response to external signaling from concentrations of SDF-
1 did not exhibit statistical difference from controls or each other (Fig. 4B.4). Similarly, the 
number of motile MB in response to signaling from different concentrations of PDGF-BB did 




Figure 4: Migration of MB- derived cells to different concentrations of selective 
chemotactic ligands. (A1) Schematic of transwell assay with motile cells attached to the 
underside of the porous membrane. (A2) Stained nuclei and cytoplasm of motile MB-derived 
cells toward different concentrations of (B1) EGF, (B2) HGF, (B3) PDGF, and (B4) SDF-1. The 
control groups indicate number of cells that migrated towards serum-free medium. An asterisk 
(*) indicates statistically significant data with p-values <0.05 against control group. 
 
2.4.2. Relative Receptor Expression 
The basal expression levels of the respective receptors were then compared against their 
activation levels upon ligand stimulation. Confocal images in Figure 5 illustrate differences in 
cellular distribution of activated receptors, as well as differences in fluorescent intensity after 
ligand stimulation. As seen, basal receptor expression appears to be uniformly distributed 
throughout the cell cytosol, with lowest intensities measured for EGF-R. Upon ligand activation, 
receptor expression is increased, but remains largely distributed throughout the cytosol. 
However, EGF-R expression is also observed to be acutely concentrated along the outer cell 
membrane. Analysis of fluorescence intensity then represented relative receptor expression 
levels upon ligand-stimulation. MB stimulated with EGF exhibited the highest increase in 
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receptor expression for EGF-R, with a 3.5-fold increase in intensity over basal EGF-R 
expression measured in unstimulated controls (Fig. 5A). By contrast, the expression of CXCR4,  
the receptor for SDF-1, was approximately 2-fold higher than its basal intensity levels in cells 
unstimulated with ligand (Fig. 5B), while no statistical difference was measured between the 
activation levels of c-Met, the receptor for HGF (Fig. 5C), and control cells, as well as between 
Figure 5: Receptor activation within motile MB-derived cells. Immunocytochemistry of basal 
receptor expression of MB cells without ligand stimulation to (A1) EGF, (B1) SDF-1, (C1) HGF, 
and (D1) PDGF-BB. Receptor activation post-stimulation with (A2) EGF, (B2) SDF-1, (C2) 
HGF, and (D2) PDGF-BB. The expression level of receptor following ligand stimulation of (A3) 
EGFR, (B3) CXCR4, (C3) c-Met, and (D3) PDGFR-BB normalized to basal control levels. Scale 
bars are 100µm. An asterisk (*) indicates statistically significant data with p-values <0.05. 
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PDGFR-BB (Fig. 5D) in ligand-stimulated cells compared to controls. MB cells stimulated with 
EGF for different time points of 0, 14, 22, 36, and 42 hours displayed no relevant significant 
difference in receptor expression for EGF-R across time points and were all higher than the 
unstimulated control (See supplementary Figure 9). 
2.4.3. Migratory response to controlled concentration and gradient fields  
The migratory behavior of MB was next examined using our microfluidic system, called the 
μLane and shown in Figure 6, for real-time cell imaging and analysis. The transport of EGF and 
SDF-1 along the μLane was modeled computationally, and verified experimentally as previously 
reported by our group 101. The system produced a range of concentration gradients along the 
microchannel length at steady-state, as shown in Figure 7A 140, 169. Concentration gradients of 
this study are defined as the average difference in growth factor concentration (ng/mL) along the 
microchannel length (mm). Five orders of concentration gradient, G1-G5, were delineated along 
the microchannel as illustrated in Figure 7A: 10+1<G1<100 ng/(mL.mm), 100<G2<10-1 
ng/(mL.mm), 10-1<G3<10-2 ng/(mL.mm), 10-2<G4<10-3 ng/(mL.mm), and 10-3<G5<0. The lowest 
gradient, G5, was located near the source reservoir (growth factors only) and occupied 
approximately 1-mm-length of the microchannel, while the highest gradient, G1, was located 
near the sink reservoir and occupied an approximate, 3-mm-length of microchannel. 
Concentration gradients, G2, G3, and G4, occupied the remaining 9-mm-length of microchannel 
(distance in between the source and the sink reservoirs) with approximately 4 mm, 3 mm and 2 
mm segments, respectively. Note, the core distributions of EGF and SDF-1 along the 
microchannel are very similar to one another given their respective molecular weights of 6.045 
KDa and 7.9 KDa, and hence only one representative gradient distribution is shown. Further, 




The migration of MB-derived cells in response to the different concentration gradient fields of 
EGF and SDF-1 were described using three parameters: (1) Fraction of motile cells, f, defined as 
the number of cells that migrated more than two cell diameters in the μLane, normalized by the 
total number of cells within the channel; (2) cell directionality, D, defined as the percentage of 
cells whose net center of mass was preferably towards the positive, x-displacement or along the 
Figure 6: The μLane system and MB migratory responses.  (A) Schematic of the bridged 
μLane system, showing cells inserted within the sink (SKR) and source (SRR) reservoir, and 
adhered along the microchannel. Chemotactic agents (e.g. EGF, SDF-1) are loaded into the 
source chamber (SRC), and transported to SKR to reach steady-state concentration distribution. 
(B) Top view image of the first layer PDMS bonded onto a glass slide. Two 9-nL reservoirs are 
connected by a microchannel of 13mm in length and 100µm in diameter. (C) Top view image 
of second layer PDMS bonded to the first layer. The source (SRC) and sink (SKC) chambers 
are connected by a bridge channel. (D) Raw data image of motile MB cells within μLane 
system at (D1) source reservoir, (D2) mid channel, and (D3) sink reservoir.    
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gradient direction; and (3) Average cell path length, PL, defined as the total distance traveled by 
cells.  
 
Figure 7: Concentration distribution along μLane and number of motile cells. (A) 
Concentration profile of EGF and SDF-1 along 13-mm microchannel length of μLane 
system. Concentration gradients are identified by five orders of magnitude in the 
microchannel: 10+1<G1<100 ng/(mL.mm), 100<G2<10-1 ng/(mL.mm), 10-1<G3<10-2 
ng/(mL.mm), 10-2<G4<10-3 ng/(mL.mm), and 10-3<G5<0 ng/(mL.mm). (B) Fraction of 
MB-derived cells observed to respond via migration to the different concentration gradient 
fields (G1 through G5) of EGF and SDF-1.  
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First, the average percentage of motile cells along the entire microchannel was similar for both 
growth factors. Table 2 shows that 72.82% of MB became motile in response to EGF signaling, 
while an average 67.3% of MB became motile in response to SDF-1 concentration fields. Values 
of motile fraction varied with gradient fields, fG1-fG5, for both EGF and SDF-1, as shown in 
Table 3. As seen, the highest fraction of MB cells became motile when exposed to higher 
concentration gradient fields of EGF, G1 (f1=28.3%) and G2 (f2=18.6%), followed by decreasing 
percentages of motile cells within lower gradient fields of EGF, G3 (f3=11.9%), G4 (f4=10.3%) 
and G5 (f5=3.7%). Similarly decreasing fractions of cells were seen to migrate in response to 
concentration gradient fields of SDF-1, with highest fractions at G1 (f1=18.2%) and G2 
(f2=20%), followed by significant decreases in the fraction of motile cells at concentration 
gradient fields G3 (f3=13.8%), G4 (f4=8.7%) and G5 (f5=6.5%). As shown in Figure 4.B, the 
fraction of nonmotile cells was 27.2% and 32.8%, when exposed to similar concentration 
gradients of EGF and SDF-1, respectively. Statistical significance was observed between 
concentration gradient fields of EGF while no statistically significant difference was found 
across the gradient fields of SDF-1.   
 
Next, the average directionality of motile MB was determined by examining individual cell 
trajectories. The term directionality was previously introduced by our group as the ratio of the 
number of cells whose centroids migrated more than 80 µm to the total number of cells in the 
microchannel 169. The paths of MB cells in the presence of EGF and SDF-1 concentration 
gradient fields were optically tracked within the μLane system to generate the representative 
Wind-Rose plots shown in Figure 8A. Note that although cell trajectories are each positioned at a 
common origin for comparison, cell paths were measured along all microchannel segments, 
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exposed to all gradient fields G1-G5. Representative trajectories illustrate that cells migrated 
preferentially towards lower concentration gradients of EGF (i.e., towards the right). By contrast, 
SDF-1 fields resulted in MB migration that was both towards and away from lower SDF 
gradients without preference. The directionality of motile cells along the entire microchannel 
was higher for cells stimulated with EGF (61.6%) than SDF-1 (44.2%), shown in Table 2. As 
seen, cell directionality within specific gradient fields, DG1-DG5, decreased with decreasing 
gradient for both EGF and SDF-1, shown in Table 3. EGF DG1 indicates that 28.3% of motile 
cells migrated directionally when exposed to G1 of EGF (i.e. within the first 3mm of channel 
length), while SDF DG1 denotes that only 18.4% displayed directional migration for the same 
gradient field of SDF-1.  The highest fraction of MB cells directionality was reported at higher 
concentration gradient fields of EGF, DG1 (28.3%) and DG2 (15%), followed by decreasing 
percentages for directionality within lower gradient fields of EGF, DG3 (7%), DG4 (8.6%), and 
DG5 (2.7%). Similarly decreasing fractions of directionality were reported in response to 
concentration gradient fields of SDF-1, with highest fractions at DG1 (18.4%) and DG2 (10.5%), 
followed by decreasing fractions of directionality at DG3 (9.8%), DG4 (2.2%), and DG5 (3.3%). 
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In addition, Wind-Rose plots display the average maximum cell path length, PL, of motile cells 
tracked along the entire microchannel. Using this data, 32% of motile MB migrated distances 
greater than 200 microns (or 20 cell-diameters) when exposed to EGF gradient fields, as seen in 
Figure 5.B. By contrast, 97.3% of cells exposed to SDF-1 gradients migrated distances less than 
200 microns. MB within our μLane system in the absence of growth factors or concentration 
gradients (i.e. controls) displayed migration distances between 50 and 200 microns 140. As 
Figure 8: Motility of MB-derived cells in the μLane system. (A) Representative 
trajectories of cells that migrated in response to 100ng/mL of EGF and 100 ng/mL of SDF-
1 stimulation. Three cell paths are shown in dashed for EGF and three in solid for SDF-1, 
24 hours post steady-state. Note that concentration gradients decrease from left to right 
within the μLane. (B) Maximum accumulated distance of motile cells stimulated by 
concentration profiles generated by using 100ng/mL of EGF and 100 ng/mL of SDF-1, 
respectively, in the SRR of the μLane. 
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shown, increasing percentages of cells were seen to migrate in response to higher gradient fields 
of EGF. A larger percentage of motile MB were observed in response to G1 fields of EGF at 
every distance, while only cells exposed to G1 migrated the longest distances greater than 300 
microns. In comparison, MB exposed to lower gradient fields of SDF-1 (G3-G5) exhibited the 
longest migration. Notably, zero cells were observed to migrate less than 100 microns when 
exposed to any EGF gradient field G1-G5, while zero cells were seen to migrate greater than 300 
microns when exposed to any SDF-1 gradient fields G1-G5. 
2.5. Discussion 
The chemotactic migration of MB-derived cells has been surprisingly understudied despite its 
well-known metastatic potential and aggressive invasion into the brain and spinal cord 140, 193. 
Our study is among the first to examine and compare the migratory responses of MB to dosage-
dependent signaling from EGF, HGF, PDGF-BB, and SDF-1, the most widely-acknowledged 
chemoattractants of CNS tumor cells 194. The first set of experiments utilized conventional 
transwell assays to illustrate that MB migration was most concentration-dependent to EGF 
signaling. As shown in Figure 4, MB exhibited dosage-dependent migration in response to 
signaling from EGF and HGF, but seemingly dosage-independent responses to PDGF and SDF-1 
signaling. Further, EGF simulated the migration of approximately twice the number of MB cells 
than did PDGF, HGF, or SDF-1. Results from immunocytochemistry support the strength of MB 
chemotactic response to EGF signaling, as activation of its receptor, EGF-R, was two times 
larger than activation of other respective receptors. While strong MB chemotactic response to 
EGF signaling is consistent with previous findings from our group and others 140, 195, it is most 
significant here because it is signaling from SDF-1, rather than EGF, that has been reported as 
the strongest MB chemoattractant 176. Inhibitor AMD310, which cleaves CXCR4, has been 
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reported to decrease MB tumor growth in mouse xenografts, chemotaxis and proliferation 176. 
However, in vivo use of EGF-R inhibitors such as Tarceva and Gefitinib have reported no 
changes in motility of cells derived from glioma 196, and non-small-cell lung cancer 197, and thus, 
were minimally used on MB. We contend that MB chemotactic response may not have been 
measured most meaningfully in the past, which has stymied development of anti-migratory 
therapies for MB metastasis.  For this reason, we used microfluidic systems to more precisely 
study MB migratory responses using parameters relevant to metastasis. 
 
Using the μLane system, we were able to image real-time cell behavior in response to a wide 
range of concentrations and gradients of EGF and SDF-1 and distinguish directed-migration of 
chemotaxis. MB migratory behavior was observed to be concentration gradient-dependent for 
both EGF and SDF-1 signaling, as the fraction of motile cells decreased with decreasing 
concentration gradient in both cases. However, motile MB traveled longer distances within the 
μLane in response to EGF signaling, with an average PL of 264.5 ± 67.8 µm, compared to an 
average PL of 125.5 ± 48.6 µm when responding to signaling from SDF-1. Further, cell 
trajectories illustrated an MB directional bias towards decreasing EGF gradients not present with 
SDF-1 signaling, with 18.3% of cells migrating towards decreasing EGF gradients compared to 
15.3% of MB in response to decreasing SDF-1 gradients. Importantly, this behavior was 
observed along the entire μLane length, for cells exposed to all concentration gradient fields, G1-
G5. Here, the cell directionality compared to other methods provides insight into whether MB 
cells stimulated with ligand solutions (EGF or SDF-1) followed a directional migration along 
gradient fields. Other methods to measure cell migration include the persistence length and 
average velocity to determine the chemotactic sensitivity of stable gradients in 3D 198-201. While 
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the persistence length provides the ratio of the net distance traveled to the total distance, it would 
not report the number of cells that migrate along ligand concentration gradients, which is highly 
significant to studies developing migration-targeted therapies for tumors of the CNS.  
 
This consistent MB behavior illustrates that EGF signaling from high concentration gradients 
initiates the most motile MB, and further enables cells to travel the longest distances. MB cells 
were seen to migrate towards increasing ligand concentration, which also corresponds to 
decreasing EGF gradient fields in our system. This response is significant because it reflects MB 
sensitivity to high concentration gradients (G1-G2), which were generated via much greater 
nonlinear changes in ligand concentration as compared to low gradient fields (G3-G5). Previous 
work from our group has illustrated keen abilities of MB to migrate in larger numbers in 
response to increasing EGF concentration via pERK signaling 140. MB cells were seen to travel 
out of a cell reservoir when exposed to increasing gradients and concentration. In the current 
study, we now demonstrate that MB can become less motile when exposed to signaling from 
increasing concentration but diminishing EGF gradient fields.  
 
Data from the current study highlights the high fraction of motile MB in response to high 
concentration gradients of EGF. These results have high clinical interpretation, as they point to 
high gradient fields and low concentration fields as optimal for MB migration. This is an in vivo 
scenario where paracrine signaling from neighboring cells initiate the most MB migration, such 
that cell displacement diminishes as cells approach the signaling source, where gradients are low, 
and concentration is high. In addition, our findings may aid clinical development of anti-
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migratory therapeutics with the potential to inhibit MB metastasis along the spinal column via 
EGF signaling. 
2.6. Conclusion 
In summary, our results illustrate that MB migration is both concentration and concentration 
gradient-dependent in response to EGF signaling. Further, our findings illustrate that high 
gradient fields of EGF result in the largest number of motile cells which travel long distances and 
in a highly directional manner towards decreasing EGF gradients. These findings point to EGF 















Table 1: Average number of MB-derived cells that migrated in transwell assays toward 
different concentrations of examined growth factors. Values were experimentally measured 
and are shown with mean and standard deviation. (*) denotes growth factor concentrations 
not measured in the current study. 
 
 
Table 2: Migratory parameters of MB-derived cells along the µLane system in response to 
concentration gradients generated by 100ng/mL of EGF and 100 ng/mL of SDF-1, 
respectively.  Values were experimentally measured and are shown as percentages, means 
and standard deviations. (ncells ~180 cells for each ligand). 





[Mean ± SD   cells] 
1 ng/mL 
[Mean ± SD   cells] 
10 ng/mL 
[Mean ± SD   cells] 
100 ng/mL 
[Mean ± SD   cells] 
1000 ng/mL 
[Mean ± SD   cells] 
EGF 102 ± 5 * 156 ± 5 212 ± 7 174 ± 5 
SDF-1 60 ± 2 67 ± 6 69 ± 14 72 ± 5 74 ± 4 
HGF 99 ± 5 126 ± 10 160 ±13 122 ± 7 * 
PDGF-BB 82 ± 5 83 ± 5 93 ± 8 100 ± 5 * 
Migration Parameters EGF SDF-1 
Fraction of motile cells (f) [%] 72.8% 67.3% 
Cell Directionality (D) [%] 61.6% 44.2% 
Average Maximum Cell Path 
Length (PL) in µm [Mean ± SD] 
 
264.5 ± 67.9 µm 
 
125.5 ± 48.6 µm 
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Table 3: Migratory parameters of MB-derived cells in response to gradient fields, G1-G5, 
generated by of 100ng/mL of EGF or SDF-1 along the µLane system. Fraction (f) and 
directionality (D) of motile cells shown as percentages of total cell number. Average 
maximum cell path lengths (PL) shown with mean and standard deviation. (ncells ~ 180 cells 











Supplemental Figure:  
 
               
 
Figure 9: EGF-R activation levels on MB migration. The EGF-R expression measured after 
EGF stimulation (100 ng/mL) for 14, 22, 36, and 42 hours. The expression of receptor was 
normalized to basal control levels (0 ng/mL of EGF) at t=0. (*) indicates statistically significant 
















3. Controlled Microfluidics to Examine Growth-Factor induced 
Migration of Neural Progenitors in the Drosophila Visual System 
(PMID 26738658) 
 
3.1. Chapter Summary 
 
The developing visual system in Drosophila Melanogaster provides an excellent model with 
which to examine the effects of changing microenvironments on neural cell migration via 
microfluidics, because the combined experimental system enables direct genetic manipulation, in 
vivo observation, and in vitro imaging of cells, post-embryo. Exogenous signaling from ligands 
such as Fibroblast Growth Factor (FGF) are well-known to control glia differentiation, cell 
migration, and axonal wrapping central to vision. The current study employs a microfluidic 
device to examine how controlled concentration gradient fields of FGF are able to regulate the 
migration of vision-critical glia cells with and without cellular contact with neuronal progenitors. 
Our findings quantitatively illustrate a concentration-gradient dependent chemotaxis toward 
FGF, and further demonstrate that glia require collective and coordinated neuronal locomotion to 
achieve directionality, sustain motility, and propagate long cell distances in the visual system. 
Microfluidic systems in combination with a genetically-amenable experimental system 
empowers researchers to dissect the signaling pathways that underlie cellular migration during 
nervous system development. Our findings illustrate the need for coordinated neuron-glia 
migration in the Drosophila visual system, as only glia within heterogeneous populations 
exhibited increasing motility along distances that increased with increasing FGF concentration. 
Such coordinated migration and chemotactic dependence can be manipulated for potential 





Microfluidics; Drosophila; Glia; FGF; Visual System 
3.2. Introduction 
Neuronal-glia interactions are critical for the development and function of the nervous system 
(NS) of both vertebrates and invertebrates. Glia and neurons are well-known to migrate to 
specific target locations during NS development, but the molecular signals that orchestrate this 
migration remain incompletely understood. While concentration gradients of a variety of growth 
factors are well-known to determine the positioning and fate of embryonic stem cells 202-204, the 
gradients that mediate the coordinated migration of cells of neuronal-glial lineage are largely 
unexplored. An understanding of the mechanisms that regulate such coordinated neuronal-glia 
migration may provide insights into possible therapeutic approaches for the myriad of 
neurological diseases caused by aberrant migration (e.g. lissencephaly, polymicrogyria, gliomas), 
as well as advance potential regenerative strategies to aid in NS repair.  
 
Neurological study has increasingly embraced microfluidics-based technologies, with numerous 
systems used to examine varied aspects of embryogenesis 205, neural regeneration and growth 206 
and intracellular synaptic activity 207-209, among others 210, 211. Previous work from our group has 
developed microdevices to analyze NS behaviors in response to controlled environments 
generated without the use of forced flow 101, 174, 212, 213.  Such a system is distinctive for study of 
NS cell migration, as the external pumps and micro-valving routinely used to stream biochemical 
agents in many existing devices are well-known to alter the responses of cells unaccustomed to 
physiological flow 182, 214. The developing visual system in Drosophila Melanogaster provides an 
excellent model with which to examine neuronal-glial migration via microfluidics, as the 
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combined experimental system enables direct genetic manipulation, in vivo observation, and in 
vitro imaging of cells, post-embryo.  
 
During the development of the Drosophila visual system, retinal basal glia (RBG) are generated 
in the developing brain and migrate into the developing eye imaginal disc. The RBG have been 
implicated in the targeting of the photoreceptor cell axons to the optic ganglia. While the genes 
involved and the cellular interactions regulating the development of the photoreceptor R-cells 
and RBG have been well studied for Drosophila, the environmental cues that initiate the 
coordinated and/or collective migration of these vision-critical cells remain incompletely 
understood 215, 216. Genetic studies have illustrated that conserved signaling pathways, such as 
Notch-Delta, Epidermal growth factor receptor (EGFR) and Fibroblast Growth Factor Receptor 
(FGFR), are central to cell fate specification and pattern formation in the developing visual 
system 217, 218. In particular, our group has demonstrated that Notch loss of function disrupts 
RBG migration 218, while exogenous EGF signaling has been shown to activate long-distance 
migration of retinal progenitor cells 170. In addition, FGF ligands are known to control glia 
differentiation, migration, and axonal wrapping central to vision 219, 220. FGF signaling molecules 
are believed to be produced at a localized source and then dispersed into targeted tissue. This 
dispersion occurs via the transient formation of concentration gradients that then dictate the 
expression of different genes to lead to tissue patterning and morphogenesis 221.  
 
In the present study, we examined the extent to which FGF concentration profiles and gradients 
play a role in regulating critical neuronal-glia migration during development of the visual 
system. We employed microfluidics to investigate the chemotaxis of RBG cells derived from the 
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third larval instar stage of Drosophila Melanogaster. Our results are among the first to illustrate 
that RBG exhibit concentration-gradient dependent chemotaxis to FGF signaling, and more 
significantly, these glial cells require coordinated and/or collective neuronal locomotion to 
achieve directionality, sustain motility and advance large migration distances.  These results 
highlight the importance of coordinated migration between neuronal-glial cells in the developing 
visual system, as well as reinforce the advantages of microfluidics-based systems for the study of 
integrated neural cell response.  
3.3. Materials and Methods 
3.3.1. Drosophila Stock, Neural Cell Dissociation, Culture and Viability 
Drosophila were cultured on the standard corn meal agar medium and reared at 23° C.  To 
specifically label and mark glia with GFP we used the GAL4-UAS system 222. Briefly, repo-
Gal4/Tb flies were crossed to UAS-GFP flies and the larvae form the progeny of the genotype 
repo-Gal4; UAS-GFP were used for all series of experiments in this study. Flies of this stock 
express GFP+ glial cells that then fluoresce green in the visual system. Flies were mated for 3 
days, and subsequent F1 offspring produced 12 days later were dissected in the 3rd instar larvae 
stage. The procedure for culturing glia was adapted from a widely-accepted method established 
to culture neural cells from Drosophila larvae 223. In brief, third instar larvae were surface 
sterilized with 70% ethanol and placed in PBS (Mediatech Inc., Herndon, VA). Brain complexes 
were then dissected out using fine #5 stainless steel tweezers and placed in a solution of 0.5 
mg/mL collagenase (Gibco, Grand Island, NY) in phosphate buffered saline (PBS). Brain tissue 
was then finely chopped, covered and incubated at 25C room temperature for 1 hour with slight 
manual agitation. The cell suspension was then centrifuged and re-suspended in culture medium 
consisting of 90% revised Schneider’s Drosophila medium (Lonza, Walkersville, MD) and 10% 
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heat-inactivated FBS (Mediatech Inc., Manassas, VA) with 50 mg/mL penicillin (Mediatech 
Inc.) and 50 μg/mL streptomycin sulfate (Mediatech Inc.), as shown in Figure 10. Cells were 
incubated at room temperature at atmospheric CO2 levels. The brain complexes of 50-75 files 
were used per experimental condition. Cells were cultured for 5-6 days and examined via MTT 
assay to verify >93% viability prior to experiments.  
 
 
Figure 10: Derivation of Drosophila-derived neural cell populations. (A) Illustration of 
GAL4-UAS system. Repo-Gal4 flies are mated with UAS-GFP. Offspring express GFP in glia 
only. Drosophila were bred and grown in house and brain complexes of those in the larva stage 
were extracted for cell testing. (B) Confocal image of Drosophila whole brain complex, 
confirming presence of GFP+ glial cells.  
 
3.3.2. Fluorescent Activated Cell Sorting (FACS) 
Experiments were performed using glia from two groups of cells extracted from the drosophila 
NS and sorted via FACS: (A) A heterogeneous neural cell population derived from dissociated 
brain complexes, which contained cells of both neural and glial lineages; and (B) A homogenous 
population of GFP+ cells of glial lineage, only. FACS was performed using a BD FACS Aria II 
(BD Biosciences, San Jose CA) with accompanying FACS Diva 6.1.3 software (BD Biosciences, 
San Jose CA). A 488-nm wavelength laser through a 530/30 filter was used to detect fluorescent 
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signature of GFP (541 nm). The 633 nm laser through a 660/20 filter was used to detect To-pro-3 
Iodide. 10 μL of To-pro-3 Iodide (Invitrogen, Eugene OR) at 25 μg/mL was added to the sample 
and incubated for 15 minutes.  
3.3.3. µLane Microfluidic System 
Experiments used our established microfluidic system, called the bridged μLane, whose design 
and operation has been described previously in greater detail 101, 140, 174, 212. As shown in Figure 
11, the system is fabricated via elastomeric molding of two layers of conventionally-used Poly 
dimethyl siloxane (PDMS,) that are bonded to one another, and to a boron silicate glass 
microscope slide. The first layer includes a 150-μm diameter by 15-mm long microchannel, as 
well as a source and sink reservoir, which have volumes of 9-μL each. The second layer consists 
of 170-μL source and sink chambers, and a larger hemispherical bridge channel connecting them. 
During operation, the biochemical agent of interest, in this case FGF, is inserted into the source 
chamber, while the remainder of the system is filled with PBS or media. The bridge channel is 
filled with media last, as its function is to precisely balances the liquid levels in the source and 
sink chambers to minimize the hydrostatic pressure difference between them 101. Transport of 
FGF via so-called convective diffusion 223-225 then establishes a concentration gradient between 
the source and the sink reservoir that spans several orders of magnitude. This distribution of FGF 
concentration can be maintained for several days and is modeled computationally and verified 
experimentally. Concentrations of 10-ng/mL, 100-ng/mL, and 1000-ng/mL of FGF were used to 
generate concentration profiles for testing of cell migration within the µLane. For control 






Figure 11: Description of Bridged µLane System.  A) Schematic of microfluidic system used 
in the current study. The reservoirs hold a 9µl volume and both chambers hold a 170 µl volume 
each. Images of Lane system B) First layer of PDMS: Two reservoirs connected by a 15-mm-
long microchannel C) Second layer of PDMS: Sink and source chambers connected by a bridged 
channel D) GFP+ glial cells within the microchannel at 0, 24, and 48 hrs, respectively E) FGF 
distribution within laminin-coated μLane system, predicted analytically and measured 
experimentally. Experimental data confirms that a steady-state FGF distribution occurs within 
the entire length of the channel before 24 hours.  
 
To mimic concentrated biological ECM microenvironments in the NS 142, 226-228, μLane systems 
were filled with 50μg/mL of Laminin (BD Biosciences, Bedford, MA, Cat. No. 354232) and 
incubated at 37 C for 1 hour. The source of laminin is from Engelbreth-Holm-Swarm murine 
sarcoma basement membrane. Broadie et. al describe the breakdown of the Drosophila ECM 
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molecules specifically two well conserved laminins, Laminin A and a minor Laminin W both 
sharing common β and γ chains with distinct α, with different tissue distributions 229. Laminin 
was allowed to gel within the Lane for 1 hour at room temperature to generate 2D 
microenvironments. Laminin was then aspirated from the channel interstitial spaces leaving the 
protein adhered to the channel surfaces, only. During experiments, the microchannel, sink 
reservoir, sink chamber, and bridge channel were first filled with PBS solution.  As performed 
previously by our group, fluorescently-labeled FITC-Dextran (20 kDa, Sigma-Aldrich, St. Louis, 
MO, Cat. No. FD20S-100MG) was used to model FGF-8 due to similar molecular weight. For 
2D experiments, Dextran at a concentration of 40μg/mL was added drop wise to the source 
chamber until the reagent made contact with the PBS in the bridge channel, initiating the 
experimental system.  
Two-dimensional numerical simulations of the bridged μLane system were performed in order to 
model the transport within the entire microsystem, i.e. the microchannel, both the SRR and SKR 
reservoirs in the 1st layer PDMS, the bridge channel, and both the SRC and SKC chambers in the 
2nd layer PDMS. The mass transport within the entire microsystem was modeled using the 2-D 
continuity equation, convective-diffusion equation, momentum equation, and hydrostatic 
equation, as described previously in detail by our group. Free solution diffusivities and effective 
diffusivities of growth factor proteins were determined in the microsystem by modeling the 
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                                                                 (1) 
Where C (μg/mL) is concentration, t (s) is time, D (m2/s) is diffusivity, VB (m/s) is bulk velocity, 
and x (m) is position. The time-evolving solution to this equation was modeled computationally 
via finite-element-analysis (FEM) in Matlab 7.7 (MathWorks, Natick, MA). The boundary 
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conditions fixed the source reservoir (X0=0) at 40 μg/mL and the sink reservoir (XL=15mm) at 0 
μg/mL for all experimental times. The system initial condition was set such that the 
concentration along the entire length of the microchannel was 0 μg/mL at t=0. In order to 
determine bulk flow velocity, VB, 1.9-μm-diameter fluorescent beads (Duke Scientific, Palo 
Alto, CA, Cat. No. G0200) were injected in the system and visualized via fluorescence 
microscopy, as done previously. Note that Equation 1 reduces to Fickian diffusion in the absence 
of convective flow.  
3.3.4. Well Plates 
Experiments utilized 96 well plates (Corning Inc., Corning, NY) coated with Laminin as 
described above, and 100-μL of cell solutions per well to image migration of both cell 
populations to defined concentrations of FGF. Concentrations of 1-ng/mL, 10-ng/mL, and 100-
ng/mL of FGF were used for testing, while no FGF was used for controls.  
3.3.5. Microscopy and Imaging 
Dissected eye brain complexes from larvae were cleaned and mounted with Vectashield medium 
(Vector Laboratories, Burlingame, CA). Images were taken with a Zeiss CLSM-510 (Zeiss, Jena, 
Germany) and a 40X objective. An argon laser with excitation of 488 nm was used activate the 
GFP+ cells. Images were obtained as Z-stacks and processed with LSM software, which 
converted the Z stacks to a projection. Imaging within the Lane system was performed using a 
Nikon TE2000 inverted microscope with a 20x objective and a cooled CCD camera (CoolSNAP 
EZ, Photometrics, Tucson, AZ) with Nikon software (Nikon Instrument Element 2.30 with 6D 
module, Morrell Instrument Company Inc., Melville, NY). 
Fluorescent images of the μLane were taken every hour for 72 hours at the points 
x=4mm, x=8mm, and x=12mm, where the origin was defined as the point where the source 
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reservoir abutted the microchannel. Imaging was performed using a Nikon TE2000 inverted 
microscope with a 20x objective and a cooled CCD camera (CoolSNAP EZ, Photometrics, 
Tucson, AZ) with Nikon software (Nikon Instrument Element 2.30 with 6D module, Morrell 
Instrument Company Inc., Melville, NY). 
3.3.6. Data Analysis and Statistics 
Data were analyzed using the Chemotaxis and Migration Tool (Ibidi, Verona, WI) in ImageJ 
(NIH). Cells were individually tracked using the manual tracking plug-in. Cell trajectories were 
plotted, along with accumulated distance and motility. In addition, the Chemotactic index, CI, 
was used as the measure of directed cell migration, as defined in Equation 2 169: 
      (2) 
Where x is distance toward gradient and d is total accumulated distance. Values approach 1 as 
cells move more directly toward the gradient, are negative for cells moving away from the 
gradient. CI approaches zero in the absence of a gradient.  
 
3.3.7. Statistical Analysis 
Statistical significance between groups was evaluated using a student’s t-test. In the gradient 
experiments, the Raleigh test was used to assess uniformity of the cell distribution. 
3.4. Results 
This study examined how the chemical cues from the microenvironment influence coordinated 
migration of cells of glial and neuronal lineages. In general, during Drosophila neural 
development glia have been shown to provide both attractive and repulsive guidance cues to NS 
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neurons as well as require their associated axons for trophic support. Parker and Auld 230 have 
shown specifically that the midline glia are crucial for the proper formation of horizontal 
commissural axon tracts in the Drosophila CNS. In a review by Lemke 231, reciprocal 
interactions between differentiating glial cells and neurons define the course of nervous system 
development even before the point at which these two cell types become definitively 
recognizable. Glial cells control the survival of associated neurons in both Drosophila and 
mammals, but this control is dependent on the prior neuronal triggering of glial cell fate 
commitment and trophic factor expression. The first set of experiments used FACS to generate 
two groups of cells from the drosophila CNS: (A) A heterogeneous population derived from 
dissociated brain complexes, which contained cells of both neural and glial lineages; and (B) A 
homogenous population of GFP+ cells of glial lineage, only. As seen in Figure 12, Drosophila 
brain complexes are imaged after utilizing the Gap4-Repo system to genetically introduce GFP+ 
glia into live Drosophila. As shown, glia are seen to migrate from the optic stalk (~250 microns 
in cross-section) to prescribed locations in the eye upon being ushered by concentration gradients 
of key growth factors 220. These eye complexes were then removed and FACS sorted for GFP+ 
glia, as seen in Figure 13. Here, analysis of FACS revealed less than 10% of the viable cells 
derived from larvae NS presented as GFP+ glia, requiring increased sample sizes to ensure that 
both the heterogeneous and homogeneous populations retained recovery of 105 cells for each 
experimental test.  Furthermore, viability tests were performed on all FACS sorted populations to 
ensure that live cells (>90%) were used for migration testing.   
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Figure 12: Derivation of Drosophila-derived neural cell populations. Drosophila larvae.  
Panel (A) shows an early third instar developing eye imaginal disc attached to the brain lobe. 
Arrow points to the glia migrating from the brain through the optic stalk into the developing eye.  
Panel (B) shows a late third instar eye imaginal disc with glia migration in to the eye disc 
complete.  The glia migrate and stop at the Morphogenetic Furrow (MF) [Arrow]. Ahead of the 
MF dividing undifferentiated cells can be seen labeled with the mitotic marker, anti- Phospho-




Figure 13: Selection of homogeneous and heterogeneous neural cell samples. FACS analysis 
of cells derived from brain tissue of third instar larvae drosophila. A) A four-quadrant 
distribution (Q1-Q4) of cells stained with a To-pro-3 Iodide as a viability marker (APC-A) 
against a GFP signature (FITC-A). Cells in Q3 and Q4 are considered viable cells, while cells in 
Q2 and Q4 are denoted as GFP positive. Points in Q4 represent cells that are both alive and GFP 
positive. B) A representative FACS sorting for cells that are GFP positive/negative only. Points 
denoted in P3 denote cells that are GFP+. 
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Once cell samples were sorted into two populations, their migratory responses to exogenous FGF 
signaling at different concentrations were examined using 96 well plates. As seen in Figure 14, 
glia from homogeneous populations migrated less than 20 microns in response to increasing FGF 
concentrations of 1-, 10-, and 100-ng/mL. By contrast, glia of heterogeneous populations 
migrated steadily larger distances of up to 3-fold higher than that of homogeneous glia when 
exposed to the same FGF concentration fields. Furthermore, Figure 14 illustrates that migration 
of glia from both populations was non-directional and radially semi-uniform within each plate at 
all concentrations examined. In addition, experiments measured the average accumulated 
distances traveled and average motilities of glia from both the heterogeneous and homogeneous 
populations when exposed to different concentrations of FGF, shown in Figure 15. As seen, glia 
from heterogeneous populations migrated statistically-significant larger distances in response to 
increasing FGF concentrations and demonstrated increased average motilities in response to 
signaling from increasing concentrations of FGF. By contrast, populations of homogeneous glia 
illustrated no statistically-significant differences in migration distances or average motilities in 




Figure 14: Trajectories of homogeneous (sorted) and heterogeneous (unsorted) neural cell 
samples in response to FGF signaling.  Plots illustrate representative trajectories from cells of 
homogenous population exposed to (A1) media only (control), (A2) 1-ng/ml (A2) 10-ng/ml and 
(A3) 100ng/ml of FGF.  Plots of representative trajectories of cells from heterogeneous 
populations of (B1) media only (control), (B2) 1-ng/ml (B2) 10-ng/ml and (A3) 100ng/ml of 
FGF.  Each plot contains 10 paths, and each path contains 1 data point every 2 hours for 48 
hours. Concentrations shown are uniform; 10 cells were tracked for each concentration. 
 
The final set of experiments used the Lane system to examine migratory responses from glia of 
both homogenous and heterogeneous cell populations to signaling from defined concentration 
gradients of FGF. Here, the molecular transport within the microchannel was, first, validated 
experimentally to characterize the concentration distribution within the system. Bulk flow within 
the system was examined using fluorescent beads with and without the use of the bridge channel, 
as described previously 101. Beads were seen to migrate with different velocities in the 
microsystem with and without the bridge channel. An average bulk velocity of Vavg=92.3±1.4 
µm/s was measured within the µLane system in the absence of the bridge channel (n=12 
channels), but an average velocity of Vavg=0.27±0.06 µm/s was measured within the bridged 
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µLane system (n=16 channels).  In addition, no bulk flow was measured within the bridge 
channel when beads were used, confirming that transport within the bridge was diffusion-
dominated and did not significantly affect transport within the microchannel nor alter 
concentrations of the large volume SRC and SKC chambers over experimental time scales of up 




Figure 15: Accumulated distances and motilities of heterogeneous and homogeneous neural 
cell populations. (A) Average accumulated distance traveled and (B) Average motility of cells 
from both populations.  Values reported are mean with error bars (+/-) standard deviation. An * 
Indicates p<0.05 compared to the control.  
 
The spatial and temporal patterns of FGF profiles generated within this system were rigorously 
analyzed by solving the convective–diffusion flux between the system reservoirs and channels, 
exactly. As seen in Figure 11, the Lane was able to generate multiple concentration gradient 
fields within one experimental setting. The spatial distribution of ligand within the microsystem 
generated a wide range of gradients along the 12-mm-long channel length that were sustained for 
5-7 days. Here, some gradient fields were generated via small changes in absolute concentration 
of attractant, and were therefore shallow and approximately linear, while other gradient fields 212 
were created via much greater changes in attractant concentration, and were thus steeper and 
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highly non-linear. Lastly, as seen in Figure 11, the experimentally-obtained data were within 2% 
of the analytically-predicted value. 
 
With a validated Lane system, heterogeneous and homogenous populations of neural-derived 
cells were then inserted into the Lane to examine glia viability, morphology and migration in 
response to different concentration gradients of FGF. Raw data images illustrate that glia do not 
modify their rounded morphology within any portion of the channel when exposed to varied FGF 
concentrations and gradients. Further, continued GFP expression from glia denoted that cells 
remained viable throughout the experimental test period of 72 hours. Figure 16 illustrates 
sample trajectories of glia derived from both homogenous and heterogeneous populations in 
response to signaling from different concentration gradient fields of FGF.  As seen, glia from 
homogeneous samples did not exhibit statistically-significant differences in accumulated 
distance or motility, with values of each remaining approximately constant for the different FGF 
profiles studied. By contrast, the trajectories of glia from heterogeneous populations illustrate 
that cells increased their migration distance up to 6-fold when responding to concentration 
gradients of increasing FGF concentration. Further, glia from heterogeneous populations 
illustrated optimal CI values at gradient fields of intermediate FGF concentration of 10-ng/ml. 
Lastly, average motility of these cells was seen to increase in a statistically significant manner in 
response to gradient fields of increasing FGF concentration.  
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Figure 16: Migration of heterogeneous cell populations to concentration gradients of FGF. 
A) Plot of cell trajectories normalized to the origin. Each plot contains 10 trajectories generated 
using data points gathered every 2 hours. Gradient increases from left to right as indicated by the 
arrows. Each line on the grid is 20 microns. B) Values of chemotactic index for all experimental 
conditions. C) Values of average motility for all experimental conditions. Reported values are 
mean data with standard deviation error bars. An * indicates p<0.05 compared to control. 
 
3.5. Discussion 
Coordinated neuronal-glia interactions are known to be critical for the development, function and 
response of the visual system. Yet, how the collective but finely-tuned migration of these cell 
populations is regulated by their microenvironment remains incompletely understood. Results of 
the current study illustrated distinct migratory behaviors between homogenous populations of 
glia, and glia from heterogeneous populations containing cells of both glial and neuronal 
lineages. Using conventional well technology, glia of the homogeneous populations were seen to 
migrate radially, and with constant motility and distance independent of the FGF concentration 
used. By contrast, glia within heterogeneous populations exhibited increasing motility along 
migration distances that increased with increasing FGF concentration. We propose that these 
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differences can be attributed to glia-neuronal interactions that are absent in the homogeneous 
glial population. We note that while FACS is known to influence cell viability 232-234 glia from 
both populations expressed comparable intensity levels of GFP and their migration remained 
constant over multiple experiments for several days.  Our migration data is significant because 
RBG glia were initially only believed able to migrate into the eye disk via physical mechanisms 
of haptotaxis, i.e. crawling along a substrate 235, 236. However, more recent work suggested 
abilities of RBG to migrate towards differentiating photoreceptors without using a continuous 
physical substratum 216. The data from our study support this later phenomenon, which point to 
short-range diffusible signals as regulators of RBG-neuron interactions, in addition to 
hypothesized contact-mediated processes that require physical interactions between cell types. 
Such neuronal-glia coordinated migration has been previously unstudied, and points to the 
importance of examining so-called collective migration 237-241 for potential therapeutic avenues 
for NS repair and/or disease treatment.  
  
We next utilized a microfluidics system, the Lane, to examine the migration of RBG in the 
presence of defined concentration gradients of FGF.  While traditional benchtop technologies 
such as Boyden chambers and agarose assays have contributed greatly towards identifying 
combinations of cytokines that generate directed cell movement (Reviewed in 242-245), these 
systems cannot be used to measure mechanistic parameters of migration, such as motility and 
directionality. By contrast, our quantitative and tunable Lane system empowers researchers to 
examine the migration of cell populations as a function of the ligand(s), concentration(s), and 
concentration gradient field(s) used.  While it is well-established that no in vitro system can 
physiologically replace the in vivo environment, microfluidics offer unique advantages of 
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biological scale that enable closer approximation to in vivo conditions.  For instance, the Lane 
device creates a microenvironment for RBG that is 100um in diameter, which approaches 
dimensions of the in vivo optic stalk 246. This creates an experimental test system where cells 
experience diffusible signals, matrix interactions, and cell to cell contacts on physiological 
scales. Thus, in this work, we used FGF as a diffusible signal because of its well-established role 
in signaling transduction critical to eye development 220, laminin as ECM because it is ubiquitous 
in the developing visual system of Drosophila 142, and neuronal-glia cell densities that approach 
physiological numbers based on in vivo spacing and dimensions 106.  
 
Using FGF as a model cytokine in this work, the Lane was able to generate multiple 
concentration gradient fields within one experimental setting that were sustained for 5-7 days.  
This exploits the analytical nature of microfluidic devices as the Lane can examine which 
ranges of concentration and gradient (i.e. concentration distribution over specified distances) 
stimulate migratory responses from cells. Such a tunable system facilitated the experimental 
tracking of 25–50 distinct cells for each FGF gradient field. Three different concentrations of 
FGF were used to generate gradient fields within the Lane.  Glia of the homogenous population 
were not observed to migrate appreciable distances (less than 1 cell diameter) in our system, 
although cells remained viable within the device for several days as evidenced by their GFP 
expression and unchanged morphology. Amazingly, glial cells of the heterogeneous population 
were seen to migrate in highly directed trajectories along increasing FGF gradient, and with 
increasing motility. These results point to an obvious chemotactic dependence on FGF 
concentration gradient, as cell trajectories and distances traveled were much larger for cells 
exposed to signaling from FGF gradient fields than from concentration alone. Our results further 
 78 
underscore the presence and significance of coordinated neuronal-glia migration in the 
development of the Drosophila visual system. Cells of the homogeneous glial population did not 
exhibit measurable movement, while glia of the heterogeneous population illustrated directed 
migration within gradient fields, as well as sensitivity to specific FGF concentration. These data 
underscore the impact of the coordinated migration of neuronal-glia cells requisite for 
development of the visual system.  
 
3.6. Conclusion 
Our studies presented here illustrate the efficacy and power of microfluidic systems in 
combination with a genetically amenable experimental system to dissect the signaling pathways 
that underlie cellular migration during nervous system development. Taken together, these 
findings illustrate the significance of the coordinated neuron-glia interaction for migration in the 
development of the Drosophila visual system. Our results show that glia within heterogeneous 
populations exhibited increasing motility along migration distances that increased with 
increasing FGF concentration. Such coordinated migration and chemotactic dependence of these 














4. Neurons Enhance Schwann Cell Migration in a Microfluidic 
Device 
 
4.1. Chapter Summary 
 
Schwann cells (SCs) are the primary glial cells of the peripheral nervous system (PNS) where 
they play a vital role in maintenance 6, repair, and regeneration of neuromuscular junctions 
(NMJs). They migrate along outgrowing axons and associate with axons along their entire length 
prior to ensheathment or myelination. How axonal growth and the migration of Schwann cells 
are coordinated at the level of neuron-glial signaling is the fascinating subject of ongoing 
research. Literature has shown chemoattraction of glial cells towards neurotrophic factors. But 
neurotrophin signaling still remains very complex because it is involved in mechanisms as 
distinct as the regulation of cell migration, cell proliferation, cell survival, and chemotaxis 125, 247, 
248. Various neurotrophins and neurotrophic factors have been implicated to play key roles in the 
regeneration of damaged axons, but the distinct roles played by neurons and SCs are unclear. In 
this study, we evaluated adult S42 SC chemotactic migration towards a panel of growth factors 
with varying concentrations to elucidate a key chemoattractant for SC-MN (motor neuron) co-
cultures. Additionally, we utilized a microfluidic system, the Lane system, to provide highly 
controlled chemical environments in order to quantify migratory patterns in SC-MN co-cultures. 









The complex interplay between glia and neurons is essential for the development and function of 
the nervous system. Schwann cells (SCs) are the myelinating glia of the peripheral nervous 
system (PNS) that originate during development from the highly motile neural crest125 and 
ensheath peripheral nerve axons to help propagate action potentials. SCs are also present at the 
synapse between motor neurons (MNs) and skeletal muscle fibers. SCs cap the nerve terminal. 
The terminal capping SCs are non-myelinating and are known as the perisynaptic SCs (PSCs). 
This three-cell structure is known as the neuromuscular junction (NMJ), as shown in Figure 17, 




Figure 17: Illustration of the Neuromuscular Junction (NMJ). This schematic shows two of 
the three primary NMJ cellular components and their positioning with respect to the synapse. 
Schwann cells (SCs, green) are seen to myelinate the axon and cap the end of the Motor Neuron 
(MNs, yellow) whose motor terminals comprise the pre-synaptic bulb of the NMJ. 
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SC proliferation, migration, and myelination are controlled by signals released from neurons in 
the form of neurotrophins, a family of growth factors initially found to be critical for neuronal 
survival, development, and outgrowth in both central and peripheral nervous systems 249. 
Neurotrophins have been implicated recently as key factors involved in SC development 250. 
Although, the effects of neurotrophins on survival and differentiation of various neuronal 
populations have been well studied, little is known about their role in synaptic development, 
function 251, guidance signals, and migration for SCs, especially during nerve repair. 
 
In peripheral nerve injury, neurotrophins and neurotrophic factors play a key role in the 
regeneration of damaged axons but the distinct roles played by neurons and SCs are unclear 
252.  Peripheral nerve injuries occur as a result of sudden trauma and can lead to loss of sensory 
and motor function to peripheral limbs. Peripheral nerve injury affects up to 2.8% of trauma 
patients and leads to high rates of morbidity and healthcare expenditure 253, 254.  
 
Injured peripheral axons have a certain degree of capacity for axonal regrowth, but the 
regenerative process is slow and generally functional recovery is very poor and far from 
satisfactory 252, 255. One reason for decreased regeneration could be due to a decline in 
neurotrophic support in tissue surrounding the regenerating axons over time (reviewed in 256). To 
facilitate regeneration, treatment approaches have included manipulation of neurotrophins. In 
particular, brain derived neurotrophic factor (BDNF) has been shown to be important in the 
growth of regenerating axons into peripheral nerve grafts 257, 258.  
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Cell migration is a complex phenomenon. Cells need to re-arrange their cytoskeleton, become 
polarized if responding to a guidance molecule; make adequate plasma membrane protrusions; 
and simultaneously generate traction and retraction of the cell body 125, 259, 260. Literature has 
shown chemoattraction of glial cells towards neurotrophic factors, but neurotrophin signaling 
still remains very complex because it is involved in mechanisms as distinct as the regulation of 
cell migration, cell proliferation, cell survival, and chemotaxis 247, 248, 261.  
 
BDNF can be produced and secreted by Schwann cells (SCs) following peripheral nerve 
injury. An elevated level of BDNF prevents neuronal death, enhances neuronal activity, and 
promotes axon growth 262-264. Inversely, a reduced level of BDNF retards neurite elongation 
and inhibits axon regrowth and remyelination 252, 257, 258. Obviously, BDNF plays important 
roles in peripheral nerve development and regeneration. Although it is still not clear which cell 
type produces BDNF or how it is being transported. Alternatively, BDNF has been shown to 
enhance myelination in SCs through p75NTR and to subsequently inhibit migration through the 
RhoA/Rho kinase pathway 265-267.  
  
Recently BDNF has also been implicated to play an important role in the pathophysiology of 
many neurodegenerative disorders 268. Clinical use of exogenous BDNF, however, is limited by 
its short half-life, potential side effects, and delivery problems such that systems can provide 
sustainable growth factor concentrations over time 255, 269, 270. As well as, limited studies in 
research exploiting how these concentrations gradients affect adult SCs, in controlled 
microfluidic environments. Therefore, searching for an effective strategy for clinical 
application of BDNF has become an interesting topic in recent years. In this work, we aimed to 
 83 
identify adult S42 SC chemotactic migration towards a panel of growth factors including BDNF, 
Glial-cell derived neurotrophic factor (GDNF), Ciliary neurotrophic factor (CNTF) epidermal 
growth factor (EGF), and stromal derived factor-1 (SDF-1), known to stimulate migration. As 
well as utilize a microfluidic platform to quantify collective response of SC-MN co-cultures and 
to subsequently deduce S42 SC chemotaxis parameters. Two distinct seeding protocols were 
tested to infer upon series (time-dependent) versus parallel (mixed population) effects on co-
cultures. We demonstrated that BDNF has a dose-dependent response on adult S42 SC 
migration. Additionally, our microfluidic studies highlight that adult S42 SCs, in the series 
condition, traversed longer distances within the μLane system in the presence of BDNF versus 
no BDNF. This was also true when compared to the parallel conditions in the presence of BDNF.  
4.3. Materials and methods 
4.3.1. Cell Culture 
S42 Schwann cell (S42, ATCC CRL-2942) and B35 motor neurons (B35, ATCC CRL-2754) 
were thawed, plated, and cultured in sterile Dulbecco’s Modified Eagle Medium (DMEM, 
ATCC Cat. No. 30-2002) containing 10% fetal bovine serum, and 1% penicillin-streptomycin 
(Gibco Cat. No. 15070063). Before passaging, B35 cultures were rinsed with 0.05% trypsin 
(Gibco Cat. No. 25300) for 4 min at 37 ºC and centrifuged at 200Xg for 4 min. Cells were 
cultured (37 ºC, 95% humidity, 5% CO2) and passaged (80-90% confluency) on sterile tissue 
culture treated flasks. Similarly, S42 cells were thawed and plated as stated in the above culture 
conditions for B35 cells but were plated on culture flasks treated with 15 ug/mL poly-L-lysine 
(Sigma Cat. No. P-9155) for at least 2 hours at 37 ºC. Before using the flasks, poly-L-lysine 
solution was removed, flask was rinsed once with DPBS and allowed to air dry, uncapped, in an 
upright position in a biological cabinet for 30 min before introducing cells.   
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Cell proliferation medium was changed every 2 days and cultures were allowed to reach 80% 
confluency before harvesting for use in the μLane system. Prior to microchannel seeding, B35 
motor neurons and S42 Schwann cells were stained with CytoTracker Green (Thermo Fisher 
Scientific Cat. No. C7025) at a concentration of 15M and CytoTracker Red (Thermo Fisher 
Scientific Cat. No. C34552) at a concentration of 10M respectively. 
 
4.3.2. Cell Migration Assay & Quantification 
The Boyden chamber assay 140, 174 was used to measure the number of S42 Schwann cells that 
migrated towards different concentrations of brain derived neurotrophic factor (BDNF, Sigma-
Aldrich, B3795-10UG). This widely-used assay consists of two compartments filled with 
DMEM medium and separated by an 8 micron-porous (polyethylene terephthalate (PET) 
membranes, tissue culture treated) transwell (VWR, Cat. No.62406-198). S42 cells were seeded 
in the apical compartment and were allowed to migrate through the porous membrane into the 
basolateral compartment overnight at 37 ºC in a 5% CO2 incubator. Approximately 5x104 
cells/mL were seeded in 300 μL of DMEM complete medium in the apical compartment, while 
700 μL of serum-free medium was pipetted into the basolateral compartment for control samples. 
Basolateral compartments also contained concentrations of 10, 100, and 200 ng/mL of BDNF in 
serum-free DMEM. 
 
After overnight incubation, excess media was aspirated, and the non-motile cells were removed 
from the apical surface of the membrane by quickly cleaning the insert surface with a cotton 
swab. Following, all transwell samples were exposed to 700 μL of 0.25% trypsin (Gibco) for 15 
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min to dislodge cells on the basal membrane. Samples were then neutralized with DMEM, 
collected in microcentrifuge tubes, centrifuged at 200Xg for 5 min, supernatants were aspirated, 
and pellets were frozen for up to 2 weeks.  
 
A CyQuantTM cell proliferation assay kit (ThermoFisher Scientific, C7026) was utilized to 
quantify frozen pellets. The pellets were thawed at room temperature. Following which, 200 μL 
of the CyQuant GR dye/cell-lysis buffer was prepared according to manufacturer protocol and 
added to each sample. Samples were gently mixed and incubated for 2-5mins at room 
temperature. Solutions were then placed in 96 well plates, and sample fluorescence was 
measured using a microplate reader at 480 nm excitation/520 nm emission maxima. Further, a 
standard curve for S42 cells was generated, via manufacturer protocol. Cell pellets were 
generated as mentioned before at a density of 105 cells/mL. Pellets were thawed, 1.0mL of 
CyQuant GR dye/cell-lysis buffer was added, and cells were resuspended via vortexing. A 
dilution series with cell numbers ranging from 50 to 50,000 cells in 200 μL volumes was 
generated and a 200μL sample with no cells was used as a control and fluorescence was 
measured at 480/520 nm.  
4.3.3. Microfluidic Device Design and Fabrication 
The μLane system has been previously described 271 by our group to analyze chemotactic and 
chemokinetic movements of cells derived from various sources 61, 272. The μLane system was 
utilized to image real-time migratory responses of individual S42 Schwann cells co-cultured with 
B35 motor neurons. The system consists of two layers of polydimethylsiloxane (PDMS) that 
serve to connect the upper source & sink reservoirs with a microchannel bonded onto the glass 
slide.  
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Devices were fabricated in a two-step process using a 10:1 prepolymer mixture of PDMS 
elastomer mixture (Sylgard 184, Dow Corning). The first layer consists of a closed microchannel 
with a length of 13 mm, width of 100 μm, and volume of 0.1 μL which connects two 9 μL 
reservoirs. The second layer consists of two 170 μL chambers connected by an open bridge 
channel. These source and sink reservoirs are connected to the respective source and sink 
chambers (Figure 18). Glass slides were cleaned via Piranha overnight, rinsed with deionized 
water, and gently dried with nitrogen gas. Microfluidic devices were then ozone-bonded to glass 
slides to create a closed system. 
    
 
Figure 18: μLane System. (A) Schematic illustration of the µLane system, including source and 
sink chambers with a connecting bridge channel, as well as source and sink reservoirs with a 
connecting microchannel (B) Side-view schematic of the µLane system, illustrating the two 
layers of PDMS and the connecting chambers and reservoirs and (C) image of µLane system 
with red dye. 
 
Transport within the adjoining microchannel is defined via the convective-diffusion equation (1), 
used to quantitatively determine the concentration profile within the system:  
 
                   
ⅆ𝐶
ⅆ𝑡
+ ?̅? ⋅ 𝛻𝐶 = 𝐷 ⋅ ∇2𝐶                                           (Eqn. 1) 
 
Where C represents ligand concentration in ng/ml, t is time measured in seconds or hours, u is 
bulk velocity in m/s, and D represents molecular diffusivity in m2/s.  
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4.3.4. Experimental Set-up 
 
Glass bonded devices were coated with laminin (LAM) (Thermo Fisher Cat. No. 23017015) at a 
concentration of 10 μg/mL, incubated for one hour, and rinsed with PBS before use. Cells were 
then seeded into the microchannel according to three different seeding conditions, all of which 
are illustrated in Figure 19. The first condition, the control samples, Schwann cells (SCs) only, 
involved seeding SCs within the microchannel via 1 mL syringe (BD Biosciences Cat. No. 
309659) into the source and sink reservoirs. The source and sink chambers, as well as the 
connecting bridge channel, were immediately filled with the cell proliferation medium. Post-
adhesion, recombinant BDNF protein (R&D Systems Cat. No. 248-BD-005) at a concentration 
of 100 ng/mL was introduced in a dropwise fashion into the source chamber and allowed to form 
a steady-state gradient over 18 hours before imaging. The second condition, series samples, 
involved seeding both cell types, injected into the microchannel, in a time-dependent manner. 
Motor neurons (2 x 106 cells/mL) were first seeded and allowed to adhere overnight, ultimately 
forming a sheet of branching neurons (Figure 19). Following, Schwann cells (8 x 106 cells/mL) 
were injected over the neuronal sheet in the microchannel, forming a co-culture, the next day. 
After an hour of incubation, BDNF (100 ng/mL) was introduced in a dropwise fashion into the 
source chamber and allowed to form a steady-state gradient before imaging. The third condition, 
parallel samples, also involved seeding both cell types simultaneously into the microchannel as a 
single population. As in the other conditions, BDNF was added to the source chamber and 




Figure 19: Experimental Setup. Schematic illustration of the three conditions tested in this 
study: (A1) Schwann cells only, (A2) parallel seeding of motor neurons and Schwann cells, and 
(A3) series seeding of motor neurons (MN) and Schwann cells (SC). Bright-field microscope 
images of seeded motor neurons in the µLane at the (B1) mid-microchannel and (B2) 




Real-time cell images were gathered using a Nikon TE2000 epi-fluorescence, inverted 
microscope equipped with short-and-long-range objectives and a cooled CCD camera 
(CoolSNAP EZ, Photometrics, Tucson, AZ). Images were obtained in both phase-contrast and 
fluorescence modes (for stained cultures) and images were captured every 30 minutes over eight 
hours at five positions along the microchannel. The Manual Tracking tool in the ImageJ (Fiji) 
software was used to track cells within the μLane system over time and the Chemotaxis and 
Migration tool for subsequent analysis. All images were analyzed using the National Institute of 
Health (NIH) ImageJ software.  
 
Confocal imaging via Zeiss LSM 710 microscope was utilized to visualize the TrkB integrin 
expression. Mean values of integrin expression were assessed by measuring the fluorescence 
intensity of individual cells (total sample size n=12) using Image J (Fiji) software and their 
protocol for measuring cell fluorescence 
(https://theolb.readthedocs.io/en/latest/imaging/measuring-cell- fluorescence-using- imagej.html). 
 89 
4.3.6. Cell Metrics 
The projected area (A) and the perimeter (P) for each cell were measured under the defined 
culture conditions. The average cell morphology was analyzed using the cell shape index (CSI) 





               (Eqn. 2) 
Where A and P represent the surface area and perimeter of individual cells. A CSI value of 1 
represents a perfectly round object while a value approaching 0 indicates a more oblong shape. 
Between 15-50 cells for each testing condition were used to determine the respective, average 
values of CSI reported as reported in Table 5. 
 
The cell path length (d) represents the accumulated trajectory lengths from start to end and was 
calculated by summing the traveled distances over time for each individual cell. The chemotactic 
index (CI) is defined as the ratio of cells displaced in the direction of the gradient (Δ𝑥) to the 





                                                              (Eqn. 3) 
Directionality (D) is defined as the net distance between the cell trajectory start point and last 
point (n) divided by the total accumulated distance (d), represented in Equation (4). 
𝐷 =  
𝑛
ⅆ
               (Eqn. 4) 
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4.3.7. Immunostaining 
Samples were prepared, as per the three conditions mentioned in section 2.4 Experimental Set-
Up on NuncTM Lab-TekTM Chambered, 4well, confocal coverglass (ThermoFischer, Cat. No. 
155383PK) coated with LAM at a concentration of 10 g/mL and control (CTRL) with B35 and 
S42 cells plated on uncoated well plates for 10 min and 2 hours. Cells were seeded at a ratio of 
1:4 (B35 MN:S42 SCs). Post overnight incubation, cell medium was aspirated, samples were 
rinsed 3x with 1X PBS, and fixed with 2-4% formalin for 10 min. Substrates were then rinsed 
3x, permeabilized with 0.1% Triton-X in PBS for 15 min and incubated for 60 min with 1% 
blocking solution (PBSA). After incubation, the substrates were washed with 1% PBS-BSA 
solution, exposed to 0.873 μg/mL (1:1000 dilution) of anti-TrkB antibody [EPR17805-146] 
(Abcam, ab187041) and incubated overnight at 4 °C. Following, samples were washed with 
0.2% PBS-BSA, incubated with 2.5 μg/mL (1:800 dilution) goat anti-rabbit IgG (Invitrogen, 
A32732) secondary antibodies for 30 min. Samples are then rinsed 3x with 0.2% PBS-BSA, 
incubated with DAPI (Hoechst 33342) for 5 min, and rinsed again 3x with PBS.  
 
4.3.8. Statistical Analysis 
A paired t-test at a 95% confidence interval was performed using the Matlab software 
(MathWorks, Natick, MA) to compare the different seeding conditions and concentrations as 
well as student t-tests, with two-tailed distributions and two-sample unequal variance 
assumptions. Further, one-way ANOVA was utilized to test significance between growth factor 
groups followed by Tukey post-hoc. Significance level was set to p<0.01.  
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4.4. Results 
4.4.1. Cell Migration Assay 
Initial experiments measured the number of S42 Schwann cells that migrated towards varying 
concentrations of BDNF through transwell membranes as shown in Figure 20. The figure 
highlights that the number of motile S42 Schwann cells were statistically different in response to 
signaling from 100 and 200 ng/mL when compared to control and 10 ng/mL (p<0.01). The 
average number of motile cells for control were 5859.7  509.8 whereas the averages for 10, 
100, 200 ng/mL where 4284.9  597.5, 11671.58  3120.1, and 12978.8  2618.5 respectively. 
No statistical significance was found between control and 10 ng/mL, and between 100 and 
200ng/mL concentrations. On the other hand  supplemental figure 26, CNTF showed the highest 
chemoattraction for S42 SCs at 100ng/mL similar to that of EGF, but EGF was not statistically 
significant. Lower CNTF readings were measured at 10 and 200ng/mL, only 200ng/mL was 
statistically significant to control. SDF-1 showed higher fluorescence reading at 10 and 200 
ng/ml and this response was much lower for 100ng/mL, indicating fewer cells were stimulated, 
but overall SDF-1 stimulation was not statistically significant. GDNF stimulation was 
statistically significant to control only at 10ng/mL concentration, as well showing the highest 
chemoattraction within its group. With 100 and 200ng/mL stimulation showing decreasing 




Figure 20: Transwell cell migration in response to BDNF. The graph shows the relative 
number of cells measured per transwell to indicate cell migration towards increasing growth 
factor concentrations (ng/ml). *indicates p<0.01 against control and # indicates p<0.01 against 
10ng/ml treatment. N=5.  
 
4.4.2. Migratory Response to BDNF Gradient Fields 
S42 Schwann cell migratory responses were then quantified with and without the presence of 
BDNF and motor neurons in a co-culture μLane system. As shown in Table 4 and 5, the 
following migratory parameters were considered for each of the three conditions tested as 
mentioned in materials and methods section 4.3.6: cell path length (m), chemotactic index (CI), 
directionality, cell shape index (CSI), fraction of motile cells (FMC), and maximum accumulated 
distance (M.A.D; m). Schwann cell migration to a BDNF gradient of 100 ng/mL was measured 




the conditions were statistically significant (p < 0.001) when compared to the control condition. 
The series condition exhibited the greatest cell movement, with an average of 94 ± 28 μm (Table 




Figure 21: Summary of Schwann Cell Migration. (A) Average accumulated distances (± SD) 
of motile Schwann cells within the microchannel in each condition. (B) Fraction of motile 
Schwann cells in the absence or presence of 100 ng/mL of BDNF, displayed as percentages of 
total cell numbers. * indicates significance against controls p<0.001 
 
Directionality is defined as the percentage of cells whose center of mass migrates preferentially 
toward the source reservoir along the gradient direction. The directionality of motile cells was 
higher for the parallel condition than the series condition as summarized in Table 5. CSI was 
calculated using the circularity formula as stated in section 2.6, in which a value of 1 represents a 
perfectly circular cell and a value approaching 0 indicates a more elongated cell shape. As our 
data highlights for each condition tested, S42 Schwann cells with and without the presence of 
BDNF maintain a more circular shape except in the case of Schwann cell only +BDNF, the cells 
exhibit a more elongated morphology. Overall, Schwann cells without the presence of BDNF 







The fraction of motile Schwann cells with and without the presence of BDNF was assessed, with 
the majority of cells in the control condition migrating a total distance of less than 50 μm, Fig. 
22A. For the series condition, the fraction of motile cells as shown in Fig. 22B with respect to 
M.A.D, were seen to traverse longer distances, >150 μm, in the presence of BDNF versus no 
BDNF. Without BDNF most motile cells were binned between 0-25 μm M.A.D, whereas in the 
presence of BDNF cell M.A.D were more distributed with many more cells traversing >50 μm 
bins. For the parallel condition, with and without BDNF, M.A.D is more distributed between 0-
25, 25-50, and 50-100 μm bins, with the least FMC seen in the 100-150 bin.  
 
 
Figure 22: Quantitative metrics to elucidate Schwann cell behavior within the µLane 
system. (A) Average accumulated distances (± SD) of motile Schwann cells within the 
microchannel in each condition. Fraction of motile Schwann cells in the absence & presence of 
100 ng/mL of BDNF, added (B) serially and (C) in parallel, into the µLane system, displayed as 
percentages of total cell numbers. * indicates significance against controls p<0.001 
 
4.4.3. Co-culture BDNF receptor expression 
Further all three test conditions, SC only, series, and parallel samples, were exposed to 100ng/ml 
BDNF for 10mins & 2hs to monitor the presence of the relative upregulation of its receptor-
TrkB, shown in Figure 23. The mean fluorescence intensity expression levels for test samples 
were compared against their controls. As seen in Figure 24, for the SC only condition, samples 
A B C 
Series Parallel SC only 
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exposed to BDNF at 10min & 2h were both statistically significant compared to control with 
p<0.05 for control vs. SC (2h) & p<0.0001 for control vs. SC (10min) & SC (10min) vs. SC 
(2h). For the parallel condition, samples exposed to BDNF for 2h were statistically significant 
compared to its control (p<0.05), but no significance was found for parallel samples exposed for 
10 min. Also, the average fluorescence intensity expression was much lower (1.12  0.95) for 10 
min parallel samples when compared to SC only (4.80  2.13) & series (5.18  1.43) at 10min. 
By contrast, the series test conditions at 10 min and 2h were highly significant to its control, 
p<0.0001.  
 
Figure 23: Receptor expression of brain-derived neurotrophic factor (BDNF), TrkB, in 
culture samples. Three different seeding conditions, (A1-A3) Parallel seeding of B35 MNs and 
S42 SCs, (B1-B3) Series, and (C1-C3) S42, Schwann only were imaged- with three different 






Figure 24: Mean fluorescent intensity values of brain-derived neurotrophic factor (BDNF) 
receptor, TrkB expression, in culture samples. Three different seeding conditions-S42 only, 
Series, and Parallel seeding of B35 MNs and S42 SCs- with three different treatment conditions: 




Schwann cells (SCs) originate during development from the highly motile neural crest and are 
the primary glial cells of the PNS. During development varying cell chemotactic cues are 
responsible for the migration of SC precursors to their proper targets in the periphery. Such 
diffusible signals become important not only for determining cell fate but also provide 
chemotactic and chemokinetic signals for growing axons and stimulating the motility of other SC 
precursors. Adult SCs also play a vital role in the maintenance 6, nerve damage repair, and 
regeneration of NMJs in case of injuries. Specifically, SCs remove myelin debris and guide 
directed growth of regenerating axons by undergoing dedifferentiation, proliferation, and 






NGF, and NT-3, which are necessary for neuronal growth and survival. Current use of 
neurotrophic factors such as BDNF for clinical use is limited due to the absence of safe and 
reliable delivery systems that can provide sustainable effective concentrations over time 270, 278. 
Additionally, there are limited studies exploiting how these concentrations gradients affect adult 
SCs, in controlled microfluidic environments. This work illustrates an in vitro co-culture model 
aimed to quantify and elucidate SC chemotactic behavior in the presence of BDNF and other 
neurotrophins. We further utilized a microfluidic system to provide highly controlled chemical 
environments in order to quantify migratory patterns in SC-MN co-cultures. As well as highlight 
two different seeding mechanisms and their effect on neuron-glia relationship.  
  
Our study is among the first to examine and characterize the chemotactic response of S42 adult 
rat Schwann cells to varying concentrations of BDNF, GDNF, CNTF, EGF, and SDF-1. BDNF 
is widely reported to enhance synaptic vesicle exocytosis and neurotransmitter release279 as well 
as regeneration of axons into the distal stump, as there is an upregulation of BDNF mRNA in 
axotomized motor neurons as well as SCs distal to injury252. GDNF is a known survival factor 
for neurons and has been shown to stimulate migration of Schwann cells95 thus leading to 
subsequent enhancement of axonal regeneration280. CNTF is a cytosolic molecule, expressed 
selectively by SCs and astrocytes. Their endogenous release from lesioned SCs supports the 
survival of motor neurons undergoing rapid degeneration 281. Whereas EGF and SDF-1 are 
shown to be important for stimulating migratory responses within glial cell populations. Hence, 
we tested these growth factors to elucidate their influence on S42 SCs. Initial experiments 
illustrated that S42 SCs responded to BDNF in a dose-dependent manner, illustrating that 
increasing concentrations resulted in increased number of motile cells traversing the transwell 
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membrane. SC chemotactic response at sites of injury in the PNS can aid in effectively 
maintaining growth factor release in order to improve repair. This behavior is important as 
BDNF is implicated in increasing the levels of the synaptic vesicle proteins, synaptophysin, and 
synapsin 1 in the spinal neurons 251, enhance both spontaneous and evoked synaptic transmission 
at NMJs 279, 282, and therefore could aid in developing an in vitro model for nerve repair in adults.  
 
Cells stimulated with GDNF showed the inversed response with lower concentrations resulting 
in greater cell motility and higher GDNF concentrations resulted in fewer populations of cells 
were stimulated to traverse the transwell membrane. Whereas, CNTF showed the highest 
chemoattraction for S42 SCs at 100ng/mL similar to that of EGF. EGF is known to be an 
important mediator of cell proliferation and migration in the adult brain 283, but it does not seem 
to have as large a stimulatory response from SCs in the PNS. SDF-1 only showed significant cell 
stimulation at 200ng/mL, indicating that only higher concentration of SDF-1 can stimulate adult 
S42 cells. This can be of importance for combinatory reparative studies as SDF-1 has been 
indicated to increase stem-cell migration and their fusion with myoblasts in vitro for skeletal 
muscle regeneration 273.    
 
Traditional in vitro culture techniques have elucidated significantly to our understanding of how 
cells behave. But these models lack the ability to provide controlled environments to enable 
precise probing of cells. Microfluidic technologies facilitate the development of powerful 
platforms to grow and manipulate cells such as neurons in order to model and study axon 
injuries. Therefore, to further delineated S42 Schwann cell migratory behavior a microfluidic 
platform, called the Lane system, was utilized to generate concentration gradients of BDNF. As 
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well as a co-culture with motor neurons (MNs) using two separate seeding conditions: series and 
parallel. Using the Lane system, we were able to image real-time cell behavior in response to 
100ng/mL of BDNF. S42 migration was observed and BDNF was shown to not be effective in 
the parallel seeding condition. The cell distribution in the percent motility bins are similarly 
distributed for + and – BDNF conditions. Whereas, the series condition showed larger 
distributions of cell motility for +BDNF condition.  
 
Overall, S42 Schwann cells did not exhibit a highly directional migratory behavior towards 
BDNF. Although, the total cell path length is the highest for the +BDNF series condition, 
indicating the ability of S42s to be stimulated to traverse larger distances. In this case, 15% of 
cells in +BDNF series condition traveled between 100-150 m compared to the 5% of cells seen 
in +BDNF parallel condition. The CSI values, for control samples, indicate that BDNF causes 
morphological changes where S42 SCs appear more circular when exposed to BDNF, but these 
effects are minimized in the presence of motor neurons, regardless of seeding condition. 
 
We further probed this SC-MN seeding conditions and hypothesized that the parallel seeding 
results in down-regulation of TrkB or saturation of TrkB. Results from the 
immunocytochemistry data elucidated that the parallel seeding condition showed significant 
down-regulation of TrkB when compared to the series and control conditions at 10 min, to 
exogenous BDNF stimulation. For long-term BDNF stimulation, 2h in this case, resulted in 
receptor down-regulation as is indicated by the significant drop from 10 min to 2h in both, 
control and series conditions. The data here confirmed that seeding SC-MNs as a mixed 
population, in the parallel condition, is causing TrkB receptor down-regulation when compared 
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to the other conditions. This could mean that MNs or SCs are producing BDNF or that their 
communication is causing receptor modulation. Further studies are needed to confirm this 
behavior.  
4.6. Conclusion 
Our results are among the first to illustrate the dose-dependent response of BDNF on adult S42 
Schwann cells. As well as, utilizing microfluidics to deduce SC migratory behavior towards 
BDNF in a controlled microenvironment. Motile SCs, in the series condition traversed longer 
distances within the μLane system in the presence of BDNF versus no BDNF. This was also true 
when compared to the parallel conditions in the presence of BDNF. We also show that parallel 
seeding has a similar effect on TrkB expression as continuous exogenous BDNF stimulation. 
Future work will investigate adult SC behavior using populations of primary adult cells as well 
as incorporation of growth factors in a tri-culture model to develop an NMJ repair model. Further 
studies are also needed to elucidate the mechanisms causing TrkB down-regulation within mixed 





















Table 4: Schwann cell migratory parameters in response to BDNF (100 ng/mL) within the 


































Figure 25: Growth factor transwell migration of Schwann cells. This graph shows the 
relative number of cells measured per transwell to indicate cell migration towards increasing 






















5. Time-Dependent Addition of Neuronal and Schwann Cells 
Increase Myotube Viability and Length in An In vitro Tri-Culture 
Model of the Neuromuscular Junction 
 
5.1. Chapter Summary 
 
The neuromuscular junction (NMJ) is a specialized chemical synapse between motor neurons 
and muscle fibers that enables voluntary movement of somatic muscle. Study of NMJ physiology 
and pathology has used various animal models and cell lines to recapitulate critical features of 
neuromuscular disease and increase our understanding of NMJ disruption. In vitro co-culture 
platforms have also been used to evaluate NMJ development using different combinations of 
motor neurons (MNs), glial Schwann cells (SCs), skeletal muscle (SKM) and biomaterials to 
advance translation of regenerative therapies. Schwann cells (SCs) of the peripheral nervous 
system are essential to the development and function of the NMJ. Although recent evidence has 
revealed the significant roles of these glia in NMJ remodeling and regeneration, SCs have been 
largely overlooked in NMJ culture models. In this report, we use a compartmentalized, 
microfluidic platform to develop a novel, tri-culture model of the three cell types that comprise 
the NMJ: SKM, MNs and SCs. Results illustrate reproducible differentiation of SKM myotubes 
with increased viability and length following the time-dependent addition of neuronal and glial 
cells. The data point to Schwann Cells as key players to stabilize and maintain in vitro NMJ 
models that will aid development and testing of emerging therapies for neuromuscular 
dysfunction. 
Keywords   





The neuromuscular junction (NMJ) converts action potentials into somatic muscle contraction 
via coordinated responses between motor neurons (MNs), skeletal muscle cells (SKM) and 
Schwann cells (SCs), as shown in Figure 26284. MNs communicate with glial SCs to coordinate 
release of the neurotransmitter, acetylcholine (ACh) from the motor terminals of MNs peripheral 
axons, which comprise the NMJ pre-synaptic bulb. Packets of Ach then diffuse across the so-
called NMJ synaptic cleft, which is defined as the nanometer gap-spacing between MNs and 
SKM membranes. ACh molecules then bind to ACh surface receptors (AChR) on the membrane 




Figure 26: Schematic of the Neuromuscular Junction (NMJ). This schematic illustrates the 
major cellular components at the NMJ synapse. Schwann cells (SCs, blue) cap the end of the 
Motor Neuron (MNs, yellow) whose motor terminals comprise the pre-synaptic bulb. Packets of 
acetylcholine (ACh, dots) released from MNs transport across the nanometer gap-spacing 
between the MNs and Skeletal Muscle (SKM), called the synaptic cleft.  Receptors of ACh then 




NMJ disruption is a hallmark of neuromuscular disease 87, 88, 285, 286, prompting advances of 
numerous in vivo models that recapitulate critical features of NMJ development and pathogenesis 
75, 79, 114, 287-290 in both vertebrates 79, 114, 287, 288 and invertebrates 75, 289, 290 . Several in vitro models 
90, 91 have used two-dimensional co-culture of heterologous cells 270, 291, 292 as well as  three-
dimensional tissue constructs to incorporate progenitor and stem-like cells 90, 91 in the study of 
NMJ formation. Such established co-cultures have helped advance fundamental models of the 
myelination process 56, 91, 94, 293, 294 as well as innervation 86, 112. 
  
Emerging studies have begun to develop microfluidic environments to evaluate NMJ 
development and regeneration 90, 91, 112, 113, as microfluidics are able to replicate unique NMJ 
anatomical constraints and cellular interactions using precise and highly-controlled approaches 
295-297. Microfluidics can reproduce the chemical and physical microenvironment of the spinal 
cord in which the neuronal cell bodies reside 113, 298, as well as evaluate the collective interactions 
of, both, peripheral glia and neuronal axons required for functional synapse across the central to 
peripheral nervous system (NS) 294, 295, 297, 299.  Although many existing microsystems have 
examined co-cultures of neuronal-glial 94, 300-302 and neuronal-muscle cells 84, 114, 303  as well as 
functional motor units in the form of muscle cells cultured with spinal cord explants 298, 304-306, 
few platforms have evaluated the integrated behavior of neuronal, glial and muscle cells of the 
NMJ 307, 308. Further, while a small number of microfluidic studies have incorporated CNS-
derived astrocytes and oligodendrocytes in NMJ models 113, 294, these studies disregard the 
significant roles of PNS-derived Schwann cells in NMJ remodeling and synaptic development 
following nerve injury 309, 310.  
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Schwann cells (SCs) are known for their regenerative and maintenance capacity 311, 312 as well as 
their ability to modulate synapse activity via changes in Ca2+ and release growth factors, such as 
Glial-cell derived neurotrophic factor (GDNF), Ciliary neurotrophic factor (CNTF) and Brain 
derived neurotrophic factor (BDNF)311. SCs also promote post-synaptic NMJ signaling and 
synaptogenesis in nerve-muscle contacts (in Xenopus 313), where SCs expression of TGF-B in 
Xenopus models was seen to double the size of AChR clusters by 3 times more than control. In 
addition, neurons treated with SC-CM (Schwann cell-conditioned medium) illustrated increased 
AChR clustering as a result of TGFβ1-induced agrin expression in spinal neurons 313.  
 
In this report, we used a tri-culture, microfluidic platform to evaluate the role of SCs towards the 
differentiation of skeletal muscle (SKM) cells into SKM myotubes, a central element of 
reparative therapies that utilize stem like-cells to recapitulate regeneration 314-318. The three 
distinct NMJ cellular populations were introduced in a time-dependent manner to facilitate 
integrated cellular behaviors at the microscale as seen in vivo. A compartmentalized microfluidic 
device previously developed by our group 319 was used to evaluate differentiation, growth and 
viability of SKM myotubes for over two weeks in vitro when cultured sequentially with MNs 
followed by SCs. Our results illustrate reproducible differentiation of progenitor SKM cells into 
SKM myotubes with increased viability and longer average lengths 320 following time-dependent 
and sequential addition of Schwann cells in a tri-culture model. These data highlight the 
importance of PNS-derived SC, surprisingly neglected in the majority of published NMJ models. 
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5.3. Methods and Materials 
5.3.1. Cell culture 
A neuronal cell line (B35, ATCC CRL-2754), Schwann cell line (S42, ATCC CRL-2942) and 
myoblast cell line (C2C12, ATCC CRL-1772) were cultured independently, in co-culture and in 
tri-culture with one another. C2C12 and B35 cells were thawed, plated, and cultured in sterile 
Dulbecco’s Modified Eagle Medium (DMEM, ATCC Cat. No. 30-2002) containing 10% fetal 
bovine serum, and 1% penicillin-streptomycin. Before passaging, plates are washed 1x with PBS 
without Ca or Mg; followed by treatment of cultures to 0.25% trypsin for C2C12s (Gibco Cat. 
No.  25200) and 0.05% trypsin (Gibco Cat. No. 25300) for 4 mins at 37C and centrifugation at 
200Xg for 4 mins. Cells were cultured (37C, 95% humidity, 5% CO2) and passaged (80-90% 
confluency) on sterile tissue culture treated plastic petri dishes at a density of 500-1000 cells per 
cm2. Similarly, S42 cells were thawed and plated as stated in the above culture conditions for 
C2C12 cells. But S42 cells are plated on culture flasks treated with 15ug/mL poly-L-lysine 
(Sigma Cat. No. P-9155) for at least 2 hours at 37C. Before using the flasks, poly-L-lysine 
solution is removed, flask is rinsed once with DPBS and allowed to air dry, uncapped, in an 
upright position in a biological cabinet for 30 minutes before introducing cells.   
  
5.3.2. Rat Dorsal Root Ganglion (DRG) co-cultures 
DRG were isolated using well-established protocols described by a number of research groups 
321, 322 Briefly, pregnant Sprague-Dawley rats were asphyxiated via CO2, abdominal muscle and 
suspensory ligaments incised, with blunt forceps embryos near cervical insertion were obtained, 
and placed in sterile 10cm tissue culture dishes with Leibovitz’s L-15 medium (Gibco 11415-
064). Embryos were placed under dissection microscope, the ventral (belly) portion was removed 
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to isolate the dorsal (back) structures containing the spinal cord, slowly working through to 
remove excess tissue surrounding the DRGs. DRGs were then plucked off using forceps and 
transferred to a 6cm dish with L-15 medium. Using forceps, deposit 1 DRG in 185 µL C-
medium 322 onto the center of each Matrigel (BD Biosciences, 356230; 1:10 dilution in DMEM) 
coated coverslip. Cells were grown and purified for 18-21days and cycled between Neurobasal 
Medium (NB, Gibco 21103-049) and NB medium containing 10 µM FdU (Sigma F-0503) and 
10 µM uridine (Sigma U-3003) to eliminate dividing cells such as fibroblasts. On day 19, 
Schwann cells were added onto purified DRG explants at a final concentration of 1x105 
cells/400µL. From days 22-36, cultures were maintained in C-medium containing 50 µg/mL 
ascorbic acid (vitamin C; Sigma A4544). Medium was changed every 2 days for myelination to 
proceed over the next 14 days.  
5.3.3. Differentiation  
C2C12 cells were grown on, both, tissue culture treated plastic dishes and on plates coated with 
Matrigel (Growth Factor Reduced- BD Catalog # 354230). Matrigel (MGL) was thawed 
overnight on ice at 4o degrees and further diluted 1:2 in Dulbecco’s Modified Eagle Medium/ 
Nutrient Mixture F-12 (DMEM/F-12, Gibco Catalog # 11320) and made into 1 mL aliquots 
stored at -20o. These aliquots were then thawed overnight at 4o degrees on ice and further diluted 
1:50 in DMEM/F-12. Dishes of 100 mm diameter were coated with 6 mL of 1:50 MGL solution 
for all tests. Once MGL was diluted it was used within 2 weeks. Dishes were coated for 1 hour at 
room temperature and then washed 2 times with 1x PBS.   
 
Cells were seeded at a density of 10,000 cells per cm2 in proliferation media and allowed to 
attach overnight, followed by 1x wash with Hank’s Balanced Salt Solutions (HBSS, 
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ThermoFisher Catalog #1402592). Further, cell culture medium was changed from proliferation 
media (10% FBS) to differentiation media (0.5% heat inactivated FBS) the following day.  
Media was changed every 2 to 3 days thereafter.  
5.3.4. Fusion Index 
C2C12 cells were washed 3x with PBS followed by fixation in Paraformaldehyde (PFA) for 10 
mins. Cell plates were then rinsed 2x and permeabilized with 0.1% Triton X-100 in PBS for 10 
mins, rinsed 2x with PBS, and stained with a nuclear stain, DAPI (Hoechst 33342, 
ThermoFisher). The fusion index was calculated as the ratio of the nuclei number in myotubes 
with two or more nuclei versus the total number of nuclei 323, 324.  Image J plug-in analyze 
particle was utilized with high contrast, and watershedding to visualize nuclei fusion, as per 
Equation (1).  
𝐹𝑖 =
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑛𝑢𝑐𝑙𝑒𝑖  𝑖𝑛 𝑚𝑦𝑜𝑡𝑢𝑏𝑒𝑠  
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑛𝑢𝑐𝑙𝑒𝑖
   (Eqn. 1) 
 
5.3.5. Immunostaining  
Samples were prepared on No.1 confocal coverslips (Electron Microscopy Sciences, 63758-01) 
coated with Matrigel (MGL) at a concentration of 100 mg/ml and control (CTRL) with C2C12 
cells plated on uncoated well plates. Cells were seeded at a density of 5,000 cells per 500 ml, 
incubated on substrates, and differentiated for 10 days. After 10 days, cell medium was aspirated, 
substrates were rinsed 3x with 1X PBS, and fixed with 2-4% formalin for 10 min. Substrates 
were then rinsed 3x, permeabilized with 0.1% Triton-X in PBS for 10 min and incubated for 60 
min with 1% blocking solution (PBSA). After incubation, the substrates were washed with 1% 
PBS-BSA solution, exposed to 1 g/ml of -actinin, 25μg/ml of anti-neurofilament-M+H, and 
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5μg/ml of α-bungarotoxin conjugated antibodies, and incubated overnight at 4 °C. Following, 
substrates were washed with 0.2% PBS-BSA, incubated with 10μg/ml goat anti-rabbit IgG 
(Invitrogen, A32723), and 10μg/ml goat anti-mouse IgG (Invitrogen, A32732) secondary 
antibodies for 30 min. Samples are then rinsed 2x with 0.2% PBS-BSA, incubated with DAPI 
(Hoechst 33342) for 5 min, rinsed again 2x with PBS.  
 
DRG cell cultures were immunostained with myelin basic protein (MBP) and neurofilament 
(NF). Samples were quantified for MBP+ segments in n=12 micrographs to show presence of 
myelination as a total average, as per Equation (2). Each segment represents an internode made 
by a single SC such that the number of internodes observed was equal to the number of 
myelinating SC.  
𝑁𝑠𝑐 =  
 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑀𝐵𝑃+ 𝑠𝑒𝑔𝑚𝑒𝑛𝑡𝑠
𝐴𝑟𝑒𝑎 𝑜𝑓 𝑚𝑖𝑐𝑟𝑜𝑔𝑟𝑎𝑝ℎ
 (Eqn. 2) 
 
5.3.6. Microfluidic Platform 
The Mμn system was designed and fabricated as described previously by our group 319, 325. It 
consists of two large cell chambers that are connected by a nanoarray of channels 3 µm in 
diameter and 10 µm in length, as shown in Figure 27. In brief, devices were patterned via 
photolithography and micromolded using polydimethylsiloxane (PDMS) (Sylgard 184, Dow 
Corning, Midland, MI) to create elastomeric stamps of the design. Mμn devices were assembled 
by bonding PDMS to chemically-cleaned glass slides via ozone plasma (Electro-technic Products 
Inc., Chicago, IL).  Two photomasks were designed in 2D using computer aided design software, 
AutoCAD 2017 (Autodesk Inc.). The first mask consisted of the device design with open 
channels in the center (channel mask), while the second mask contained a 100µm-wide strip that 
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blocked the channel array from further exposure (seeding region mask). A two-step 
photolithography protocol was performed to produce a 5μm-thick channel array connecting two 
50μm-thick cell seeding regions and inlet/outlet ports as seen. 
           
 
Figure 27: Schematic of the Mμn system used for single, co- and tri-cultures of NMJ cell 
types. Two cell seeding regions (SR) of 1-mm-width and 10-mm-length are connected by a 
nanoarray of channels having 800-nm-diameter and 100-μm-length, spaced 10μm apart. SR are 
connected to independent inlet and outlet ports for parallel loading of cells and reagents, as 
needed. 
 
5.3.7. Viability Assay 
Myotubes cultured within the microdevice were stained with Calcein AM (ThermoFisher, 
C3100MP) at 2.5µM concentration to detect live cells, as well as DAPI nuclear staining prepared 
as per manufacturer protocol (Hoechst 33342) to detect dead cells per area.  Recorded grayscale 
images were processed using ImageJ to determine the portion of live cells. In short, images were 
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binarized and nuclei were separated using standard watershed commands 326.  Cells were counted 
using the built in Particle Analysis command with a minimum size threshold to prevent 
recording noise 326. 
5.3.8. Analysis 
The average cell morphology was analyzed using the cell shape index (CSI) 273 described by 




              (Eqn. 3) 
Where A and P represent the surface area and perimeter of individual cells, respectively. 
Between 15-50 cells for each testing condition were used to determine the respective, average 
values of CSI reported. CSI was also used to define an elongation rate, ER, of SKM defined in 
Equation (4):             
   𝐸𝑅 =
(𝐶𝑆𝐼𝑡2 −𝐶𝑆𝐼𝑡1 )
𝐶𝑆𝐼𝑡1
 × 100%                                              (Eqn. 4) 
Where t1 and t2 represent different time points for measurement of CSI values.   
 
To measure myotube length, recorded grayscale images of myotube differentiation were 
analyzed using ImageJ and the available plugin Ridge Detection to automatically detect ridges 
and lines for determining myotube length. Parameters (sigma, upper intensity and lower 
intensity) were set for each image to optimize the detection algorithm. Sigma is used based on 
the expected ridge width and is used to set the steepness of the derivative calculation used in the 
detection algorithm.  The upper and lower intensities are used to set the thresholds for 




Figure 28: Description of the Cell Shape Index (CSI) used to quantitatively describe cell 
morphology.  CSI is a dimensionless parameter measured by diving the cell surface area by its 
perimeter, as shown. (A) Cells with an idealized, rounded morphology will exhibit a CSI value 
of 1.0. (B) A more typical cell morphology will exhibit average CSI values between 1.0 and 0.0. 
(C) Cells with an idealized, elongated morphology will exhibit a CSI value of 0. 
 
5.3.9. Imaging 
Cell images were gathered using a Nikon TE2000 epi-fluorescence, inverted microscope 
equipped with short-and-long-range objectives and a cooled CCD camera (CoolSNAP EZ, 
Photometrics, Tucson, AZ). Images were obtained in both phase-contrast and fluorescence 
modes (for stained cultures) and analyzed using the National Institute of Health (NIH) ImageJ 
software.  
Confocal imaging via Zeiss LSM 710 microscope was utilized to visualize the integrin 
expression as well as DRG co-culture of cells seeded on each matrix. Mean values of integrin 
expression were assessed by measuring the fluorescence intensity of individual cells (total 
sample size n=15) using Image J software and their protocol for measuring cell fluorescence 326.   
5.3.10. Statistical Analysis 
Statistical significance of data points was analyzed using the post-Tukey and student t-tests, with 
two-tailed distributions and two sample unequal variance assumptions. One-way analysis of 
variance (ANOVA) was performed using JMP statistical software (SAS Institute, Cary, North 
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Carolina, USA) for significant differences between testing conditions. Significance level was set 
to p<0.001 unless otherwise noted in the results section.  
5.4. Results 
5.4.1. PNS Co-culture of Neural Cells 
The first experiment of this study examined time-dependent behaviors of PNS-derived neural 
cells in a co-culture model of primary dorsal root ganglion (DRGs) and Schwann cells (SCs) on 
laminin, as shown in Figure 29. The figure illustrates the significance of in vitro models able to 
investigate NMJ formation via the influence of glia, which have been shown within the last 
decade to be a crucial stabilizing and supportive influence for the NMJ 67, 310. SCs were seen to 
extend and begin wrapping around neuronal axons in manners demonstrated to be suggestive of 
the SC myelination process in vitro 90, 94, 300, 301. Fluorescence staining of myelin basic protein 
(MBP) and neurofilament validated cellular interactions in co-culture between neurons and glia 
within the PNS. The average number of internodes per surface area of micrographs was 
measured as NSC= 113.5 segments per 1.5 x 105 µm2, as per Equation (2). To mimic these stable 
results for an NMJ model, we developed a robust, tri-culture model of SKM cells within a MN-




Figure 29: Primary cultures of dorsal root ganglions (DRGs) cultured with Schwann cells 
(SCs). (A) One-week post SCs seeding onto DRG cultures on coverslips, with SCs extending 
processes and beginning the myelination process. (B) SCs and MNs co-cultured within the 
microdevice, arrows point to SCs extending processes (C, D) Fluorescent images of DRG-SC 
co-cultures (n=6 independent experiments); Green dye: Myelin basic protein; Blue dye: 
Neurofilament; Scale Bar: 100µm  
 
5.4.2. Formation and Characteristics of SKM cells into SKM Myotubes 
SKM cells were first observed to grow and differentiate in culture lacking interaction with neural 
cell types. SKM plated upon substrates treated with Matrigel (MGL) and untreated (CTRL) were 
observed to differentiate into myotubes over 10 days. As seen in Figure 30 A & B, a large 
number of cells with highly-elongated morphology was seen upon MGL-coated substrates (MGL 
+/+), while a smaller number of less-elongated cells were seen upon CTRL (MGL-/-), although 
each condition contained populations of both.  Cells for both conditions were then stained for α-
actinin, Figure 30C, a marker used to identify cell populations that have begun to differentiate 
into myotubes 328. This marker was expressed in 98% of cells upon MGL substrates but only 2% 
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of cells upon CTRL. Changes in the average morphology of cells upon MGL +/+ and CTRL 
were measured via CSI and demonstrated significant cell elongation from an average CSI value 
of 0.14±0.05 at Day 1 (p = 2.22e-06) to an average CSI value of 0.04±0.01 at Day 10 (p = 1.86e-
06). By contrast, the morphology of cells upon CTRL exhibited less elongation with an average 
CSI value of 0.44±0.08 at Day 1 and 0.24 ± 0.09 on Day 10, or an elongation rate of 86%. 
Further, data in Figure 30E illustrates SKM differentiation seen upon CTRL plates, MGL-/+, 
where a small population of cells differentiated into myotubes exhibiting an average CSI of 0.08 
± 0.04 over time. Similarly, in MGL treated plates approximately 2% of the population of SKM 
cells did not differentiate (MGL+/-), maintaining an average of CSI of 0.36 ± 0.02. High 







Figure 30: Differentiation of C2C12 myoblast cells into myotubes. Brightfield image of cells 
(A) adhered upon Matrigel-coated (MGL) substrates after 10 days and (B) undifferentiated cells 
in culture adhered upon non-coated plastic. (C) Fluorescence image of α-actinin staining for cells 
adhered upon MGL after 6 days. Blue dye: DAPI; Green: α-actinin. (D) Mean values of α-actinin 
expression in cell samples adhered with and without MGL (n=4 independent experiments).  (E) 
Changes in cell shape index (CSI) over 10 days for cells adhered with and without MGL. Here -
/+ and -/- represent cells cultured without MGL that did and did not differentiate, respectively.  
And +/- indicates C2C12 cells that did not differentiate when cultured on MGL and +/+ indicates 
cells that did differentiate. All MGL+/+ data points were statistically significant from control 
(MGL-/-) (p<0.01). Scale Bar = 100 µm; n=3 independent experiments. 
 
5.4.3. Increased Numbers of Myotubes per Unit Area (NT/A) and Tube Length (LT) 
over Time 
The number of differentiated myotubes upon MGL+/+ were seen to increase exponentially after 
10 Days in culture, as per Figure 31C. The average number of myotubes observed on Day 1 was 
NT/A = 2.3±1.2μm per mm2 and increased to NT/A = 42.4±3.2μm per mm2 by Day 10. Similarly, 
the average length of myotubes was seen to increase over time to a maximum and then decrease. 
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The average length of myotubes was measured to be LT = 307±77.9μm on Day 1 and increased 
to a peak average length of LT = 1307.6±89.2μm on Day 8 before decreasing to LT = 
735.4±153.1μm on Day 10. Further, the percent fusion index, F i, was calculated every other day 
for SKM myotubes in culture. Figure 31E shows a linear increase in Fi until reaching a 
maximum at Day 7 of Fi = 88.8±10.5%. No significant increases were observed through Day 11 
of testing.  
 
 
Figure 31: Differentiation of C2C12 cells into myotubes over time. Brightfield image of 
C2C12 cells (A) adhered upon Matrigel-coated (MGL) substrate in 100mm dishes, on Day 1 of 
the differentiation process and (B) show large, elongated myotubes in culture after 9 days of 
differentiation in coated dishes. (C) The total number of myotubes per unit area increases over a 
10-day period and (D) the average length of myotubes increases over time to reach a maximum 
and then decrease. (E) Percent fusion index, Fi, was measured to increase for the first 7 days and 
then plateau. (F) The average length of myotubes over time was measured using Ridge detection 
analysis via NIH ImageJ. Scale Bar: 100µm; n=6 
 
5.4.4. SKM Myoblast Tri-culture with Neural-Glial Cells 
The next experiments examined the formation of myotubes when in contact with MNs and SCs 
cells individually and collectively. Figure 32 illustrates the growth of SKM in isolation and 
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alongside collective cell interaction. The addition of each cellular component was done in a time-
dependent manner, where MNs were added into SKM culture on Day 5 and SCs were added on 
Day 9. A significant increase in the length and viability of SKM myotubes in tri-cultures of 
[SKM+MN+SC] was measured in contrast to co-cultures of [SKM-SKM], [SKM+MN] and 
[SKM+SC] cells over 11 days. An increase in the number of myotubes per unit area, NT/A, in tri-
culture was measured  on Day 7 (NT/A = 16.3±2.0μm) compared to  [SKM-SKM] cultures (Day 
7: NT/A = 10.6±3.6μm), [SKM+MN] co-culture  (NT/A =10.2±1.4μm) and [SKM+SC] co-culture 
(NT/A =10.1±1.3μm), as shown in Figure 32A.  Tri-cultures produced a 55% increase in the 
number of myotubes per unit area compared to control [SKM-SKM] by Day 7 of growth. SCs 
were added on Day 9 and 2-fold increase in NT/A of [SKM+MN+SC] tri-culture was observed 
compared to [SKM+MN] and a 72% increase when compared to control [SKM-SKM] on Day 
11. Further, the number of myotubes per area in [SKM-SKM] cultures on Day 11 was NT/A = 
8.2±1.5μm, in [SKM+MN] co-culture was NT/A = 6.5±0.8μm, and in [SKM+SC] co-culture was 
measured to be NT/A = 8.3±1.7μm. These values were significantly lower from [SKM+MN+SC] 
tri-cell cultures at NT/A= 14.0±1.1μm, as seen on Day 11 of Figure 32A. No significant 
differences in NT/A were measured between [SKM+MC] and [SM+SC] co-culture groups on days 
7, 9, and 11. However, on day 11, NT/A values in [SKM-SKM] cultures (NT/A = 8.2±1.5μm) were 
significantly higher than that of [SKM+MN] co-cultures (NT/A = 6.5±0.8μm). The average length 
of myotubes was similarly measured over time and shown in Figure 32B. With the time-
dependent addition of MNs and SCs in [SKM+MN+SC] tri-cultures as well as [SKM+MN] and 
[SKM+SC] co-cultures, the overall average length of myotubes was greater than [SKM-SKM] 
cultures. On day 7, [SKM+MN] groups showed significant differences of LT  values (LT  
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=344.84±40.96μm) against [SKM+MN+SC] tri-culture (LT  =273.38±23.08μm) and [SKM+SC] 




Figure 32: Motor neurons  (MNs) and Schwann cells (SCs) aid C2C12 (SKM) survival and 
increase myotube length over time in the Mn microfluidic system. (A) Graph displays time 
dependent addition of MNs (Day 5) and SCs (Day 9) to illustrate increases in the number of 
SKM differentiated myotubes per unit area. (B) The average length of myotubes increased over 
10 days (p=0.003), while no significant increases were seen in SKM-MC and SKM-SC co-
culture groups, separately. A sample of n=3 for each condition were used; * indicates p<0.05, ** 
indicates p<0.001 
 
The addition of SCs showed a slight, but statistically significant increase in the maintenance of 
myotube length on Day 11 at LT  = 293.73±27.03μm in [SKM-MN-SC] tri-cultures versus [SKM-
SC] co-cultures at LT  = 307.42.42±42.66μm, as shown in Figure 32B. Both groups were 
statistically significant compared to [SKM-SKM] cultures on day 11 (p<0.05). 
Further, tri-cultures [SKM+MN+SC] were stained for the presence of alpha-bungarotoxin with 
respect to control [SKM-SKM] within the Mμn system, Figure 33 C & D. Mean fluorescence 
intensity of alpha-bungarotoxin expression was calculated in Figure 33E and showed a 




Figure 33: Images of NMJ co-and tricultures within the Mn microfluidic system over 
time. (A) The addition of SCs in culture with SKM+MN display cell-to-cell interaction as 
highlighted by white arrow. (B) SKM-SKM only cultures illustrate long, tubular-like 
morphology to indicate SKM differentiation on MGL. (C) Fluorescence image of alpha-
bungarotoxin (α-BTX) and neurofilament (NF+H) staining for tri-cultures [SKM+MN+SC] 
adhered upon MGL after 12 days. Blue dye: DAPI; Red: α-BTX; Green: NF+H. (D) Control 
samples, [SKM-SKM], stained with α-BTX and DAPI (E) Mean values of α-BTX expression in 
culture samples within microdevices. Scale Bar: 50 µm & 200 µm; n=4 independent experiments      
 
5.4. Discussion 
Degeneration of the NMJ is a key and early pathological feature of many muscular dystrophies 
and demyelinating disorders. Traditional in vitro systems have greatly advanced our 
understanding of neuronal behavior in the presence of SCs and SKM cells but cannot guide 
axons or enable controlled manipulation of cells. Microfluidics has become a powerful tool for 
researchers in the Nervous System (NS) 56, 104, 296, 308, 314, 329, 330, as these systems enable precise 
control, monitoring and manipulation of cellular microenvironments. A small, but growing 
number of researchers have developed microfluidic systems to evaluate mechanisms of NMJ 
formation and maintenance with mixed success 114, 294, 331.  Our project utilized microfluidics for 
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two goals. One, experiments incorporated SCs to build a tri-culture NMJ model, and two, we 
mimicked the time-dependent and sequential addition of SKM, MNs and SCs cells seen in vivo 
to influence myotube maturation and length over time. We used a compartmentalized, 
microfluidic system, called the MμN, that consisted of parallelized microchannels representing 
geometric and chemical cues experienced by cells 319. The MμN enabled this study to evaluate 
NMJ formation over time that approximates its step-wise formation in vivo, following series of 
cues involving each cellular component.  
 
Numerous SKM+MN co-culture models exist to study NMJ development and disruption 75, 76, 90, 
91 aided via genetic techniques and suitable animal models. This project used C2C12 cells 332-334 
as a model system for SKM differentiation because of their extensive use for in vitro models of 
muscular dystrophies. Further, the cells are marked by myoblast proliferation and progressive 
fusion that form large multinucleated myotubes which synthesize muscle-specific proteins 335. 
Differentiation of myoblasts into SKM is well-known to depend on physiochemical cues of the 
surrounding extracellular matrix (ECM). However, numerous studies have reported inconsistent 
differentiation on single protein matrixes such as Laminin, Collagen and Fibrin 336-338 . This 
project selected Matrigel as ECM because a large number of publications have demonstrated its 
abilities to promote myotube maturation 339, 340 via expression of the well-established muscle 
markers: Pax7, MyoD, and myogenin 339. The underlying mechanisms of these cellular responses 
is only partially understood but points towards maintenance of the muscle differentiation process 
336. The positive effects of MGL were apparent in our data where myotubes maintained a highly 
elongated and multinucleated state on MGL versus CTRL over time, as measured by CSI (Figure 
30E). In contrast, myotubes developed without MGL did not a achieve highly elongated 
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morphology and resulted in wider and shorter dimensions, as previously reported when C2C12 
SKM cells were grown on collagen I 339.  
 
Initial experiments illustrated that the myotube differentiation process required up to 10 days in 
vitro when supporting MN or SC cells were not present 320, as similarly reported by several 
groups 320, 323.  Time-dependent addition of MNs and SCs generated large numbers of myotubes 
hundreds of microns in length with a more highly-elongated morphology than control (SKM-
SKM) that lacked MNs and SCs (Figure 32). Fluorescent immunostaining was performed to 
validate differentiation of myotubes, highlighting the presence of mature, z-line striation bands 
seen in mature muscle 328, 341 (Figure 30C).  The time-dependent, sequential addition of MNs and 
SCs increased the number (NT/A) and length (LT) of myotubes maintained over 14 days versus 10 
days when SKM-derived cells were present alone in culture (Figure 32) 67. Our data highlights 
the importance of the synergistic relationship between each cellular component in 
[SKM+MN+SC] tri-cultures versus [SKM-SKM], [SKM+MN], and [SKM+SC] co-cultures 
(Figure 32). In the tri-cell cultures, the average number of myotubes per unit area (NT/A) was 
approximately 70% higher than control groups [SKM-SKM] by Day 11. Specifically, 
[SKM+MN+SC] groups exhibited a 2-fold increase (116%) against [SKM+MN] co-cultures and 
a 70% increase when compared to [SKM+SC] co-cultures in the maintenance of the number of 
SKM myotubes per unit area. The data demonstrate a degree of stability in our microdevice 
system. Throughout the 11 days of culture, the overall SKM myotube lengths are maintained 
within groups providing a consistent system to help differentiate SKM myotubes. This was 
further validated by examining the presence of alpha-bungarotoxin in tri-cultures 
[SKM+MN+SC] versus control [SKM-SKM] where there was a significant increase in its’ 
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expression in tri-cultures, which demonstrates the interdependent relationship of the cellular 
components.  
     
5.5. Conclusion 
Our results are among the first to illustrate the significance of Schwann cells on the development 
and viability of an in vitro NMJ culture platform. Microfluidically-controlled testing platforms 
able to evaluate the effects of time-dependent cell to cell interactions and connectivity will 
greatly aid regenerative strategies that seek to recapitulate NMJ formation. Future work will 
investigate a tri-culture, microfluidic model using populations of stem-like cells, as well as 
include controlled biochemical environments growth factors known to be secreted by Schwann 




























Figure 34: Percent Viability of C2C12 myotubes within the Mn device over time. C2C12 
differentiated myotubes were cultured in the microdevice and stained with Calcein AM and 
DAPI to visualize live and dead cells. Data showed no significant difference in percent viability 



















Understanding the mechanisms of cell migration and interaction with the microenvironment is 
not only critical to the significance, function, and biology of cells, but also has tremendous 
relevance and impact on physiological processes and diseases such as wound healing, neuron 
guidance, cancer metastasis, and morphogenesis. External guidance factors such as physical, 
ECM rigidity, and contact guidance cues of the microenvironment promote directional and/or 
chemotactic migration and can target specific changes in cell motility and signaling 
mechanisms45.   
Taken together, this thesis has advanced our understanding of NG populations, specifically in the 
realm of cell migratory response to external stimuli, the interdependent relationship between NG 
populations, and lastly in the development of a tri-culture model to highlight glial significance at 
the NMJ for future repair strategies to acute spinal cord damage. In vivo, the interaction of 
neurons and glia are crucial for the development of the nervous system (NS). These interactions 
are facilitated by the fine-tuned migration of neurons and glia along dedicated trajectories. 
Neurons are widely known to conduct electrical impulses/currents, elucidating their role in the 
transfer of information throughout the NS. Glial cells, in the central (CNS) and peripheral 
nervous systems (PNS), are mostly known to support the nervous tissue. The global objective for 
this project was to examine emergent NG behavior in response to chemical stimuli within 
microfluidic environments. Understanding how the environment stimulates NGs to precise 
locations in the nervous system is of fundamental importance in biology and medicine, as 
abnormal migration is the basis of a variety of human neurological diseases and dysfunction 6. In 
this body of work, we observed the synergistic relationship of NGs in three cellular models 
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encompassing the central and peripheral NS. Hence the following aims are proposed to help 
elucidate their influence.  
 
Aim 1: Evaluate the chemosensitivity of transformed-glial progenitor cells (t-GPCs). In the 
brain, cell migration is important during development, plasticity, function, and repair. In 
addition, it’s also important in cancers and diseases as it is well accepted that cancer cells have 
progenitor and stem-cell like properties in that they have the ability to de-differentiate. The focus 
of this aim is on directed cell migration to external chemical cues also known as chemotaxis. We 
utilize GPCs from Medulloblastoma (MB), which is a CNS glial tumor that metastasizes to the 
spinal column. Due to these cells ability to retain their stem and progenitor like properties we 
refer to them as t-GPCs. MB provided a model for t-GPCs, believed to be critical for motility 
and metastasis. These studies include:  
1A: Identify growth factors with highest chemosensitivity for t-GPCs. 
1B: Measure in vitro migratory behavior of t-GPCs in controlled microenvironments. 
Summary: The behavior of transformed NG progenitors was examined (in the form of 
Medulloblastoma (MB)), known to emulate developmental processes, to external stimuli 
using controlled microenvironments. We used a microfluidic system called the bridged 
lane, which allows for steady-state, 1D, controllable concentration gradients along the 
length of its’ microchannel. The system was used to evaluate in vitro migratory responses 
of MB-derived cells such as the fraction of motile cells, directionality, and cell path 
length under Epidermal Growth Factor (EGF) and stromal cell-derived factor 1-alpha 
(SDF-1) stimulation. The data demonstrated MB cells traverse from high to low ligand 
concentration gradients and respond strongly to EGF in a dosage and gradient-
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dependent manner while exhibiting increased EGF-R activation. In addition, high 
concentration gradient fields of EGF caused more cells to move longer distances in a 
highly directional manner as opposed to SDF-1. This work provides evidence that EGF 
and its receptor play an important role in MB migration than previously documented. 
 
Aim 2: Examine how GPC chemotaxis is influenced by NG collective behavior. Analyzing 
migration responses of neural-glial progenitor cells derived from Drosophila Melanogaster 
towards fibroblast growth factor (FGF). These studies include: 
2A: Evaluate the behavior of GPCs collectively with Neuronal Progenitor Cells (NPCs). 
2B: Examine the collective chemotaxis behavior in a microfluidic environment. 
Summary: A more comprehensive neural model was utilized to examine the collective 
behavior of neural progenitors in response to chemotactic stimulation. Experiments 
examined the collective behavior of NG progenitor cell populations in response to 
stimulation via fibroblast growth factor (FGF) gradients using a developmental model of 
the central nervous system (CNS) in the Drosophila Melanogaster, 3rd instar larvae 
stage.  Surprisingly, our data demonstrated that cells migrated larger distances and with 
higher directionality within collective groups of both neuronal and glial progenitors than 
in populations of glia only.    
 
Aim 3: Manipulate collective NG behavior to develop an in vitro model of the 
Neuromuscular Junction (NMJ). SCs originate from the highly motile neural crest. However, 
the guidance signals for these SCs are unknown. Neurotrophins are expressed early in 
 129 
developing embryos and have been shown to be critical for the survival and pattering of glia and 
neurons 125. These studies aim to examine:  
3A: Modality of collective chemotactic NG response in the PNS. 
3B: Examine the influence of NG response for tri-cellular NMJ model.  
Summary: This model was developed to build upon our previous understanding of 
coordinated NG responses. We also hypothesized that glial involvement is much more 
dynamic and is necessary for synaptogenesis as well as overall remodeling and regeneration. 
Therefore, we moved into a larger system in the PNS-the Neuromuscular Junction (NMJ), to 
further our understanding into NG responses for repair strategies. Initially this study probed 
the guidance cues and migratory patterns of NGs towards various growth factors to 
elucidate emergent NMJ response. Our data illustrated there is a co-culture effect on 
receptor expression dependent on stimulation time. This study aimed to identify different 
growth factors potential for migratory response. BDNF was utilized in microfluidic studies, 
as it is known for its maintenance capacity upon neurons & to observe its collective response 
on NGs. Subsequently, the experiments utilized a compartmentalized microfluidic platform to 
demonstrate reproducible differentiation of skeletal myotubes with increased viability and 
length following the time-dependent addition of NG cells. Our data validated our hypothesis 
and showed that NG interactions are important in their maintenance capacity for the number 
of SKM myotubes present for the tri-culture model. We further validated this response by 
observing mean fluorescence activity in tri-cultures versus SKM myotubes alone (control). 
Results displayed higher presence of alpha-bungarotoxin, post-synaptic nicotinic 
acetylcholine receptor marker on SKM myotubes, in tri-cultures versus control samples.  
 130 
6.2. Limitations 
The primary limitation of this work is the challenge of in vitro systems generally. While the 
µLane provides controlled concentration gradients, the system is not suitable for studying effects 
of external stimuli in a compartmentalized way for multi-cellular system applications. The Mµn 
platform, although it mimics the geometry and diffusible signaling across its compartments, still 
lacks the specificity required to study NMJ models. NMJs are quite complex and if we are to 
fully grasp and parse out the mechanisms involved in an in vitro model, a new system design is 
needed.  
 
Another limitation to this study is the rigorous complexity of obtaining progenitor NGs from 
Drosophila brains and keeping these cell populations alive to perform any long-term, 24h, 
microfluidic and mechanistic studies to further our understanding of developmental processes. 
We have tried to optimize cell survival of NGs from 12% 342 to 40% after 24 of dissection (Pena 
et al., in submission), which previously has not been reported.  
 
Further for subsequent studies utilizing C2C12 cells, one issue that has been widely noted by 
various collaborators is that the spontaneous twitching associated with them is not consistently 
observed. One potential could be that a high passage of these cells could yield an absence of 
contractions. Hence it has been suggested that these cells be used between passages 2-7, if 
contraction is to be considered a marker of a functional NMJ. Subsequently, optogenetics could 
be utilized to control the contractile behavior of C2C12 cells. A limitation for the in vitro NMJ 
model that was developed herein utilized two cell lines-SCs and MNs. For proof of concept and 
initial model development within a microfluidic system, cell lines provide the robustness needed 
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for experimentation but to really understand emergent or collective NG behavior at the NMJ 
primary cells are a must.  
6.3. Future Works 
For future work, C2C12 SKM contraction can be explored to develop a more controlled 
emergent NMJ response model since SKM contraction is considered to be a sign of a mature 
myotubes. One could explore staining with alpha-actinin of SKM myotubes for maturation as 
another indicator. Further C2C12 myoblasts can be electrically stimulated or mechanically 
stretched to make sure cells have reached their differentiated state. A follow up study could 
utilize optogenetic C2C12s, which are readily available for our use through our collaborators at 
MIT. Another theory to explore is that C2C12 cultures should only contract when they are 
exposed to motor neurons and glia as they provide an environment more conducive for 
contraction. The exact mechanisms as to why is yet to be elucidated, but some studies have been 
performed to shed some light into this and hypothesize that trophic support and the support from 
end-to-end organ, MN-MC contact, is necessary for proper functioning. In addition, our work 
primarily utilized cell lines to establish an NMJ model with some preliminary work with stem-
cells (work not shown) and co-cultures between DRGs and purified rat SCs (Chapter 5). To 
further our understanding of glial influences, specifically at the NMJ, a shift towards utilizing 
primary/progenitors cell populations is a necessary next step.  
 
Axonal extension is influenced by a variety of external guidance cues; therefore, the 
development and optimization of a multi-faceted approach is probably necessary to address the 
intricacy of functional regeneration following nerve injury for repair. To that end, below we have 
briefly explored the influence of glial cells within retinal models as well as exploring 
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applications of galvanotaxis, movement towards or away from an electric current. Further we 
have proposed a microfluidic device design, taking into account a multi-faceted approach, with 
some initial characterization.  
 
Schwann cells with retinal models: The adult mammalian central nervous system (CNS) does 
not repair after injury. However, researchers have shown that the neonatal CNS is capable of 
repair and importantly of allowing regenerating axons to re-navigate through the same pathways 
as they did during development. This phase of neonatal repair is restricted by the fragility of 
neurons after injury and a lack of trophic factors that enable their survival 343.  
 
Electro-Stimuli Response: Electrical cues can affect cellular behavior (electrotaxis) and suggest 
possible practical therapeutic strategy to activate signaling pathways that would contribute to 
control cell functionality 45. Recent studies have shown that cells can directionally respond to 
applied electric fields (EFs), in both in vitro and in vivo settings. Applied electric fields may have 
a potential clinical role in guiding cell migration and present a more precise manageability to 
change the magnitude and direction of the electric field than most other guidance cues such as 
chemical cues alone45.  
 
The current understanding of how EFs affect cells directly is that the cells sense the EFs through 
matching pathways involved in chemotaxis but do not operate simply by modulating the 
chemotactic systems of cell 45, 344. Microfluidic chambers hold great promises for better field 
shaping and control in order to analyze and compare multiple –taxis and electrotaxis of cells.  
Most of these devices are fabricated in polydimethylsiloxane (PDMS, a transparent flexible 
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polymer) or PMMA and provide excellent scalable environments for manipulation, 
immobilization and live imaging of cells 45, 345, 346.  
 
Response of neurons to EF: Electrical stimulation in the field of neuroscience is well 
established as a concept and is a powerful and broadly applicable therapeutic technology 
utilizing the voltage sensitivity of transmembrane ion channels and other fundamental processes 
of cellular electrical signaling 347. The ability to direct the outgrowth of neuronal processes 
through the use of an extracellular electric field is renowned as galvanotropism.  Recent research 
has shown therapeutic potential of EFs to promote nerve growth and axon regeneration under 
electrical stimulation or guiding long distance migration but the guidance effect of EFs for cell 
migration and neurite outgrowth has significant interspecies difference and has shown to be cell 
type dependent. For example, neuritis from Xenopus neurons have been shown to respond to 
field of less than 10mV mm-1 growing toward the cathode 348. The neurons were shown to not 
only orient their neuritis towards the cathode but also extended longer processes in the presence 
of a field (i.e. rat neurons grow perpendicular in an EF) 349. Whereas neurons from zebra fish do 
not respond to an 100 mV mm-1 applied EF in vitro at all 350.  
 
Further, a change in field polarity changes direction of neuron migration as well. High field 
strengths (>10mV mm-1) promotes clear and sustained directional migration towards the cathode. 
Furthermore, reversing the field direction with a high exogenous potential (50mV mm-1) caused 
cells to steer off course and move in the direction of the imposed field 45.  
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Calcium has been widely thought to play a controlling role in neurite outgrowth but has shown 
inconclusive evidence. Neurite outgrowth of neurons co-cultured with Schwann cells and 
electrical stimulation was examined by Koppes et al.351 in the presence of both biophysical and 
cellular cues. Following 8h of electrical stimulation (0-100 mV mm-1), a moderate electric field 
of 50 mV mm-1 resulted in significantly greater neurite outgrowth (114%) than both the 
unstimulated controls and all other field magnitudes test (10, 100 mV mm-1) 351. This electrically 
induced increase in neurite length may promote regrowth following injury. Based on these 
studies we have designed a compartmentalized microfluidic device with the capacity for 
electrical stimulation to study various aspects of cell behavior within NG populations either in 
the CNS or PNS. Below are details on device fabrication and preliminary results from 
computational modeling, which was further, validated with dextran within our device. 
 
(Preliminary Data) 
6.4. Methods and Materials 
6.4.1. System Fabrication  
The system is fabricated using conventional multistep photolithography to create a master mold 
and elastomeric molding to stamp this mold into polymer of polydimethylsiloxane (PDMS). The 
design was imprinted onto a 4-in-diameter silicon wafer in a 2-step process.  The first 10 um 
layer, composed of the negative photoresist polymer SU-8 10 (MicroChem, Westborough, MA) 
was spin-coated at 3000 rpm for 30 seconds onto the wafer surface using a Laurel WS 650 spin 
coater (Laurel, North Wale, PA).  The wafer was then soft baked, on a hot plate, at 65oC for 2 
min, followed by an additional 5 min at 95oC. Exposure was performed using the open channel 
mask via an automated mask aligner (EVG620, EV Group, Austria) with an exposure dose of 
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180 mJ/cm2.  The wafer was then post-baked at 65oC for 1 min followed by an additional 2 min 
at 95oC.  The photoresist was developed in PEGMA developer (MicroChem Corp., 
Westborough, MA) for 5-10 min and rinsed with isopropyl alcohol and deionized water.  The 
wafer was then dried under nitrogen and dehydrated prior to the second step of lithography.  The 
next layer used photoresist SU-8 2075 (MicroChem, Westborough, MA) spun on at 4000 rpm for 
30 sec.  The resist was then prebaked for 2 min at 65oC followed by an additional 7 min at 95oC.  
The wafer and second mask were aligned via mask aligner and exposed at 180 mJ/cm2.  The 
wafer was then baked for 1 min at 65oC and 6 min at 95oC.  The wafer was developed in 
PEGMA developer for ~5-10 min with slight agitation.  The wafer was then rinsed with 
isopropyl alcohol and deionized water and dried under nitrogen. 
To improve contact molding reliability and master longevity, the finished wafer was then 
silanized, by liquid deposition. Wafer was submerged mixture of methanol, water and 
Trichloro(1H,1H,2H,2H-perfluorooctyl) silane mixed at a ratio of 20 mL:1 mL:100 uL, 
respectively, and gently agitated for 1-2 hours. The wafer was rinsed consecutively with 
isopropyl alcohol and deionized water, and dried under nitrogen. Elastomer molds were cast with 
polydimethylsiloxane (PDMS) (Silgard 184, Dow Corning).  PDMS prepolymer was mixed at a 
ratio of 9:1 with its curing agent to a final volume of 30 mL.  This mixture was then poured onto 
the master and degassed for 20 mins in a restricted light environment to remove air bubbles.  The 
PDMS was baked until set for 20 mins at 75oC and then demolded.  The devices were assembled 
by ozone plasma bonding the PDMS casts to cleaned glass coverslips (#1.5, VWR).  The fluidic 
seal was tested by flowing deionized water or phosphate buffered saline (PBS) at 1 mL/min 
through both sides of the device via syringe pump (NE-1000, Newera Syringe Pump Systems, 
Farmingdale, NY).  For electric field studies, silvered PDMS electrodes were inserted on either 
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side of the culture chambers in the designated electrode wings.  To create the silvered PDMS, 
PDMS pre-polymer was mixed with powdered silver (2-3.5 um, Sigma Aldrich, #327085-50g) to 
a final concentration of 80 wt% silver.  The resulting mixture was mixed at a ratio of 9:1 with the 
curing agent to a final volume of 5 mL.  This mixture was then cast into disks .5cm in height and 
degassed as above.  The silvered PDMS was baked until set for 20mins at 75oC .  Once cooled, 
1.5mm cylinders were punched out using a 1.5mm biopsy punch (Harris Uni-core).  Platinum 
wires were inserted into each cylinder before inserting finished electrodes into electrode wings. 
6.4.2. Computational Model 
A two-dimensional, coupled multiphysics numerical simulation of molecular transport within the 
µCricket device was performed using both pressure-driven creep flow and electric fields within 
the device. These simulations utilized a two-way coupled finite element model of the device 
created using COMSOL Multiphysics 5.3a (COMSOL Inc., Burlington, MA).  First, the model 
solves the continuity equations for flow velocity and current density at steady state: 
 ∇ ∙ 𝒖 = 0 (Eq. 1) 
 ∇ ∙ 𝒊 = 0 (Eq. 2) 
Here u denotes the velocity (m/s) and i represents the current-density vector (A/m2).  The 












Where A is the cross-sectional area of the channel, µ is the dynamics viscosity (Pa*s), L is the 
length of the channel (m), p is the pressure (Pa), 𝜖𝑤  is the fluid’s permittivity (F/m), 𝜁 is the zeta 
potential (V) and V is the electric potential (V).  The current density is defined as: 
 137 
 𝒊 = −𝜅∇𝑉 (Eq. 4) 
Where 𝜅 denotes the conductivity (S/m).  At the solid walls, the normal velocity component goes 
to 0: 
 𝒖 ∙ 𝒏 = 0 (Eq. 5) 
Flow was modeled as creep flow with a mean inflow rate of 1e-9m^3/s.  This flow rate was 
chosen because it imposes a fluidic shear stress within the culture chambers below the 5 dynes 
threshold known to affect cell behavior352.   The electrode voltages were set at ±1V to achieve an 
electric field of intensity 100mV/mm, a biologically representative value353. 
Second, the mass transport was modeled via COMSOL’s Transport of Dilute Species package 
using the velocity and electric potential parameters from the above equations to solve the mass-
transport equation for an injected tracer: 
 𝜕𝑐
𝜕𝑡
+ ∇ ∙ 𝑵 = 0 
(Eq. 6) 
Where c is concentration and N is the flux vector given by the Nernst-Planck equation354: 
 𝑵 = −𝐷∇𝑐 − 𝑧𝑢𝑚𝐹𝑐∇𝑉
+ 𝑐𝒖 
(Eq. 7) 
Here D denotes the tracer’s diffusivity (m2/s), c gives the concentration (mol/m3), z represents 
the tracer’s partial charge number, F is Faraday’s constant (C/mol), and um is the mobility of the 







Where Rg = 8.314 J/(mol*k) is the gas constant and T (K) is the temperature. 
An effective diffusivity of 4.57 x10-7cm2/s was used to model transport of BDNF through 
tissue356. All physical boundaries of the microsystem were regarded as insulated boundaries of 
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mass transfer, momentum transport and electron transport. The boundary conditions for the 
current-density balance are insulating for all boundaries except the electrode surfaces, where the 
potential is fixed.   
6.5. Results 
6.5.1. System Design  
The µCricket device was designed to facilitate parallel or uneven flow in three cell culture 
compartments connected by an array of microchannels (n=500), Figure 35A.  This system was 
adapted from a design previously developed by our laboratory325 to incorporate controlled 
galvanic and chemical fields across three chambers. The three cell culture compartments are 600 
µm -wide by 10 mm-long by 50 µm in height. Within the two outer cell culture compartments 
are an array of 70 µm -diameter micropillars situated 400 µm from the edge of the compartment 
and 200 µm from the array.  The culture regions are separated by an array of 50 µm-long 
channels spaced 10 µm apart, Figure 35B. Each channel is 3 µm-wide by 5 µm in height, 
preventing full bodied cellular migration of neural cells of diameter greater than or equal to 10 
µm 357, 358, while still facilitating the transport of small molecules from one side to the other. 
Lastly, silvered PDMS electrodes are located on either side of the culture chambers in the 
designated electrode wings.  A finished µCricket can be seen in Figure 35C. The microchannel 
array was designed as a barrier to restrict neural cells to their designated seeded culture 
compartments, while enabling transport to generate stable, steady-state chemical concentration 
gradients across the channel array.  The concentration profile, or distribution, of these gradients 
across the microarray and opposite cell compartments is dependent upon the input flow rates, Q1 
and Q2 and Q3, Figure 36.  As Q1 Q2 and Q3 are independent of one another, the flow rates can 
be changed with respect to each other, to provide the desired transport ratios, Q1:Q2:Q3.  
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Controlling this ratio allows for the control of the pressure differential across the channel array. 
When Q1 = Q2 = Q3, Figure 36A, the system is in a state of even flow.  When Q1 ≠ Q2 ≠ Q3, 
the system is in a state of uneven flow, Figure 36B.  While the flows can be set in counter-flow, 
all flows used in this study are in a parallel state.  These flow characteristics were modelled 
computationally and verified using fluorescently tagged dextran, Figure 36C and D. 
 
The purpose of this design is to create a compartmentalized model to study multiple cellular 
systems in a time-dependent manner to observe their collective behavior. Generating multiple 
compartments allows the user to test multiple variables affecting a system of study such as 
axonal regeneration for a nerve injury model, with high precision. In this system, the slivered 
electrodes provide for electrical stimulation of cellular systems to approach wound-healing 
mechanisms in combination with cell migratory events. As discussed previously, EF stimulation 
of neurons helps in axonal regeneration events and thus, this system can provide a controllable 
way to observe these events. The pillars are important for two reasons 1) they act to isolate 
neurons closer into the channels so when you load cells at low speeds, they will be closer to the 
channel and 2) when applying higher flow rates, the pillars will provide a barrier thus reducing 





Figure 35: Device Schematic of cricket. (A) Dimensioned CAD mask of the µCricket device. 
(B) Magnified view of red box in the center of the device, highlights the large seeding chambers 
separated with a nanoarray, along with micro-pillars spanning the entire length of the seeding 
chambers. (C) Image of the bonded cricket with electrodes in place. (D) Computational 







               
 
Figure 36: µcricket characterization. (A) Computationally determined 2D chemical 
concentration profile within the device with equal flow ratios, 1:1:1. (B) Computationally 
determined 2D chemical concentration profile with the device with flow ratios 1:20:1. (C) 
Computationally determined 1D chemical concentration profile across the observation window 
demonstrating flow control. (D) Experimental validation of flow control using 10kD 




We have designed a microfluidic system that allows for compartmentalized separation of cellular 
systems. This allows for ease of controlled, systematic, and time-dependent studies of multi-
cellular systems especially for the study of nerve damage repair. Further understanding of the 
mechanistic changes induced in neurons and Schwann cells by the application of the biophysical 
forces generated during electrical stimulation will allow for appropriate applications of this 
stimulus in vivo for neural engineering solutions relevant to peripheral and central nervous 
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